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Skeletal muscle is a highly metabolically active tissue, both in the adult and the fetus. 
Mitochondria are essential in providing energy in the form of ATP from the oxidative 
metabolism of carbohydrates, fats and amino acids. Mitochondrial function is influenced by 
the abundance and activity of the complexes comprising the electron transfer system (ETS) 
and the balance between mitochondrial fusion and fission. Any factors which affect the 
development of skeletal muscle, and mitochondria in particular, may have an impact not only 
on neonatal health but also on the metabolic health of the adult offspring. However, the 
normal developmental profile of skeletal muscle mitochondrial function as the fetus prepares 
for the increased metabolic challenges associated with extrauterine life, is not well 
characterised. The hormones, cortisol and triiodothyronine (T3) are known to be crucial in the 
maturation of several physiological processes during late gestation. Further, their role in 
regulating adult metabolism is well-documented. However, whether they play a role in 
regulating fetal mitochondrial function is unknown. Using fetal sheep, the aims of this project 
were twofold: 1) to determine any changes in skeletal muscle mitochondrial function which 
occur over the last third of gestation and in the first two days of neonatal life and 2) to 
determine any regulatory roles of cortisol and T3 in these developmental changes.  
Mixed fibre-type skeletal muscle was collected from fetuses at 3 time points over late 
gestation and from newborn lambs. In addition, skeletal muscle samples were taken from 
fetuses which had been thyroidectomised (TX) and fetuses infused with either T3 or cortisol. 
Respirometry, enzyme assays, qRT-PCR and western blotting were carried out on the skeletal 
muscle samples in order to assess mitochondrial parameters.  
Mitochondrial activity, as measured by carbohydrate- and fat- stimulated ADP-coupled 
oxygen uptake, increased with age in a thyroid hormone dependent manner, rising 
predominantly postnatally. Mitochondrial density, abundance of ETS complexes I-IV and ATP-
synthase and expression of the adenine nucleotide transferase 1 and mitofusin 2 were all 
positively influenced by age, with the natural prepartum rise being prevented in the 
thyroidectomised fetuses. However, T3 infusion alone was insufficient to raise any of these 
factors prematurely. Cortisol infusion resulted in an increase in some aspects of mitochondrial 
oxidative capacity in a muscle-specific manner.  
Overall, the data presented shows that there are developmental changes in skeletal muscle 
mitochondria during the perinatal period. They also suggest that these changes are regulated 
by both cortisol and thyroid hormones in preparation for birth, although neither hormone 
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1 General Introduction 
Metabolic syndrome is increasing in incidence in the adult population in both developed and 
developing countries (Kaur, 2014). It is characterised by conditions including obesity, glucose 
intolerance, insulin resistance, dyslipidaemia, type 2 diabetes and cardiac dysfunction, all of 
which reduce the quality of life and shorten lifespan (Alberti et al., 2005). Worldwide, 20-25% 
of the adult population has metabolic syndrome, a figure which rises to 35% in the USA and 
to 50% in American citizens over the age of 60 years (Kaur, 2014, Aguilar et al., 2015). Of 
increasing concern is the fact that diagnoses of metabolic syndrome are occurring at younger 
and younger ages (Reinehr, 2013, Cook et al., 2003). Amongst the overweight and obese 
adolescent population, the incidence of metabolic syndrome is estimated to be between 30-
50% with 40% of all adolescents and nearly 90% of obese adolescents having at least one of 
the risk factors (Weiss et al., 2004, Cook et al., 2003). In developed countries, the rising 
prevalence and predisposition to metabolic syndrome closely tracks with more sedentary 
lifestyles and increasing consumption of diets high in fats and sugar (Hu, 2011). However, in 
developing countries like India where there is rapid urbanisation of the population within a 
single generation, prevalence of metabolic syndrome and its risk factors is already at 40% of 
the population with the incidence rising rapidly even in the poorest states (Ramachandran, 
2005, Ramachandran et al., 2003). This suggests a disparity between the environments 
experienced by an individual during early life and adulthood may also play a role in 
determining the subsequent risk of developing metabolic dysfunction.  
 
1.1 Developmental programming of metabolic dysfunction 
The ‘developmental origins of health and disease’ theory was first put forward by David Barker 
after noting a geographical correlation between areas with high infant mortality and high 
incidence of adult cardiovascular disease (Barker and Osmond, 1986). Since then, several 
human epidemiological studies have shown associations between low birth weight and a 
predisposition not only to impaired cardiovascular function but also to metabolic dysfunction 
in adult populations of different ethnicity (Barker et al., 1989, Barker et al., 2002, Hales et al., 
1991, Chaudhari et al., 2017). The hypothesis is that exposure to suboptimal conditions in 
utero can affect fetal growth and development which, through poorly understood 
mechanisms, programmes a predisposition to symptoms of the metabolic syndrome, including 
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obesity, insulin resistance and hypertension (McMillen and Robinson, 2005, Roseboom et al., 
2006). 
Numerous studies on experimental animals have also shown that a low birthweight is 
associated with long term adverse effect on offspring metabolic health (Bertram and Hanson, 
2001). Intrauterine growth restriction (IUGR) induced by maternal undernutrition, placental 
insufficiency and glucocorticoid overexposure have all been shown to cause glucose 
intolerance, insulin resistance and pancreatic β cell dysfunction in the adult offspring (Petrik 
et al., 1999, Nyirenda et al., 1998, Ozanne et al., 2003, Ozanne et al., 2005, Nyirenda et al., 
2009, Owens et al., 2007). These changes in metabolic phenotype are multifactorial in origin 
and involve functional and morphological alterations from the gene to the system level 
(Bertram and Hanson, 2001). For instance, there can be changes in the number and type of 
cells within a tissue or organ and at the cellular level, there are alterations in the abundance 
of enzymes, hormone receptors, ion channels and transporters as well as in the expression 
and activity of key signalling pathways (Bertram and Hanson, 2001). All these alterations will 
affect the tissue functional capacity and ability to maintain homeostasis in response to 
environmental challenges. In addition, there is increasing evidence that mitochondria have a 
role in the developmental programming of metabolism through their central roles in cellular 
energetics and oxidative stress (Lee et al., 2005). 
  
1.2 Mitochondria  
Mitochondria are vital components of eukaryotic cells, thought to originate from α-
Proteobacterium (Yang et al., 1985, Gray, 2012). They contain their own genome of 37 genes, 
13 of which encode proteins expressed via mitochondrial-specific transcriptional and 
translational mechanisms (Taanman, 1999). The majority of mitochondrial proteins, however, 
are encoded by nuclear DNA, translated in the cytoplasm and translocated to their required 
location in the mitochondria (Neupert, 1997). Their basic structure, as first viewed by 
transverse electron microscopy in the 1950s, consists of a highly folded inner membrane 
(IMM) surrounding the inner matrix, and an outer membrane (OMM) separated from the IMM 
by the intermembrane space (IMS; Figure 1.1; Palade, 1953).  
Mitochondria have a number of functions essential for life. Their best-known role is in the 
production of energy, in the form of adenonsine triphosphate (ATP), for cell metabolism. They 
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are also important in cell signalling as they are a site of production of reactive oxygen species 
(ROS) and contribute to intracellular calcium regulation. In addition, they play a role in cell 
death and, in some cells, are the site of steroid hormone synthesis (Brand and Nicholls, 2011, 
Miller, 2013). Abnormalities in mitochondrial function can be fatal and are associated with 
several diseases including neurodegenerative disorders, cardiomyopathy and metabolic 
dysfunction (Duchen, 2004).   
The pathways of ATP and ROS generation, the primary focus of this thesis, are outlined in 
Figure 1.1. Briefly, carbohydrate and fatty acid metabolism result in the production of reducing 
equivalents (NADH and FADH2) from glycolysis, the link reaction (catalysed by pyruvate 
dehydrogenase), the tricarboxylic acid (TCA) cycle and β-oxidation. In turn, these donate 
electrons to protein complexes of the mitochondrial electron transfer system (ETS) situated 
in the IMM. The ETS harnesses the energy from a series of reduction and oxidation (redox) 
reactions to pump protons into the IMS. The resulting proton-motive force drives ATP 
synthase, which phosphorylates adenosine diphosphate (ADP) to form ATP (Nunnari and 
Suomalainen, 2012). Oxygen acts as the final electron acceptor at complex IV and the rate of 
oxygen uptake is proportional to the electron flux through the ETS and the proton current 
(Brand and Nicholls, 2011). The overall process is known as oxidative phosphorylation 
(oxphos). ROS are generated by electron leak onto oxygen at complexes I and III, particularly 
if there is an altered oxygen supply or a high proton gradient (Murphy, 2009). More details of 




Figure 1.1 A simplified diagram of mitochondrial metabolism (modified from Murray, 2012). 
OMM, outer mitochondrial membrane; IMS, intermembrane space; IMM, inner mitochondrial 
membrane; NADH, reduced nicotinamide adenine dinucleotide; FADH2, reduced flavin adenine 
dinucleotide; TCA, tricarboxylic acid; ETS I-IV, electron transfer system complexes I-IV; V, ATP-
synthase; Q, ubiquinone; c, cytochrome c; ROS, reactive oxygen species; ANT, adenine 




1.2.1 ATP production 
1.2.1.1 Substrate uptake and utilisation 
Mitochondria are able to metabolise carbohydrates, fatty acids, ketone bodies and amino 
acids for energy production (Figure 1.1), although the vast majority of energy production 
comes from carbohydrates and lipids in the fed-state (Hoppeler, 1999). These substrates are 
obtained either from the blood supply or from endogenous reserves when there is a rise in 
energy demands or a fall in the circulating substrate concentrations. Intracellular stores of 
glycogen (carbohydrate) and lipid droplets are present in skeletal muscle, observed in close 
proximity to the mitochondria (Hoppeler, 1999, Philp et al., 2012).  
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As the primary source of ATP, the mitochondria play a key role in the metabolic response to 
changes in the cellular environment such as altered energy demands, substrate supply and 
oxygen availability. Fatty acid oxidation produces more ATP per gram than carbohydrate (Hall 
et al., 2012), however, produces less ATP for the same amount of oxygen consumed (Spriet, 
2014). Therefore, carbohydrate oxidation occurs preferentially in several tissues, although 
fatty acid oxidation is essential in skeletal muscle at rest and during endurance exercise to 
preserve glycogen stores, and for use when the glycogen stores are depleted (Hood et al., 
2006, Kimber et al., 2003, Spriet, 2014).  
Substrate availability is also important to mitochondrial function and significant interaction 
has been observed between the carbohydrate and lipid oxidation pathways, allowing for 
metabolic flexibility both at the whole body level (Randle et al., 1963, McGarry et al., 1977, 
Lossow and Chaikoff, 1955) and at the mitochondrial level (Jorgensen et al., 2017). The 
‘glucose/fatty acid cycle’ has been used to describe the inhibitory effect of carbohydrates on 
fatty acid oxidation while upregulating glucose oxidation, and vice versa (Dimitriadis et al., 
2011).  
 
Glycolysis and glucose oxidation 
Glucose is transported into the cell via facilitated diffusion through glucose transporters 
(GLUTs) in an insulin-dependent or independent manner (via GLUT4 and GLUT1 respectively 
in skeletal muscle; Ebeling et al., 1998, Gaster et al., 2000). Glycolysis takes place in the 
cytosol, whereby one glucose molecule undergoes a series of 10 enzyme-catalysed reactions 
resulting in its conversion to 2 molecules of pyruvate, with a net production of 2 ATP through 
substrate-level phosphorylation and 2 reduced nicotinamide adenine dinucleotide (NADH; Li 
et al., 2015). In anaerobic conditions, glycolysis is the primary source of ATP. In order to 
maintain glycolysis, the resulting NADH must be re-oxidised to NAD+, which occurs through 
the reduction of pyruvate to lactate. Under aerobic conditions glycolysis and lactate 
production still occur (Almeida et al., 2010), however, the glucose molecule can be completely 
oxidised in the mitochondria producing approximately 30 ATP per glucose molecule. Thus, 
when oxygen is available, the pyruvate produced by glycolysis is preferentially transported 
into the mitochondria for oxidative phosphorylation (Figure 1.1). 
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Pyruvate must be transported into the mitochondrial matrix. This occurs first via passive 
diffusion through non-selective channels in the OMM (Schell and Rutter, 2013, Huizing et al., 
1996) followed by more restricted transport through the IMM mitochondrial pyruvate carrier 
utilising the proton gradient (Bricker et al., 2012, Halestrap and Denton, 1974, Halestrap, 
1978). In the matrix, the pyruvate dehydrogenase complex catalyses the conversion of 
pyruvate to the 2-carbon moiety acetyl-coenzyme A (acetyl-CoA) which can enter the TCA 
cycle (Schell and Rutter, 2013).  
 
Fatty acid oxidation 
Fatty acid oxidation via the β-oxidation pathway is a source of energy in numerous tissues 
although it is of particular importance in adult cardiac and skeletal muscle (Bartlett and Eaton, 
2004). Fatty acids (FAs) enter the cell rapidly by simple or facilitated diffusion using FA 
transport proteins (Su and Abumrad, 2009, Simard et al., 2008). In the cytosol the FA is 
conjugated to Coenzyme A to form a fatty acyl-CoA. When conjugated instead with a carnitine 
molecule, forming acyl-carnitine, the FA can be transported into the mitochondria (Figure 1.2) 
(Sharma and Black, 2009). This reaction is catalysed by carnitine palmitoyltransferase I (CPTI), 
with the reverse reaction to re-form the acyl-CoA catalysed by carnitine palmitoyltransferase 
II (CPTII) in the mitochondrial matrix (Figure 1.2).  
The acyl-CoA then undergoes β-oxidation as shown in Figure 1.2. Each cycle of the β-oxidation 
pathway removes a 2-carbon moiety from the FA chain, producing acetyl-CoA which can enter 
the TCA cycle, and a shorter FA chain which can undergo further cycles of β-oxidation (Bartlett 
and Eaton, 2004). Additional products of the β-oxidation pathway are the reducing 
equivalents NADH and flavin adenine dinucleotide (FADH2) which donate electrons to 




Figure 1.2 Fatty acid uptake and β-oxidation. PM, plasma membrane; OMM, outer 
mitochondrial membrane; IMM, inner mitochondrial membrane; CPTI and II, carnitine 
palmitoyltransferase I and II; CoA, Coenzyme A; NAD+/NADH, oxidised/reduced form of 
nicotinamide adenine dinucleotide; FAD/FADH2, oxidised/reduced form of flavin adenine 




Amino acids, obtained from the diet or by protein catabolism, cross the cell membrane using 
amino acid transporters (Hyde et al., 2003). In the liver and skeletal muscle, amino acids can 
be deaminated and, for certain amino acids, the product can be converted to pyruvate or 
acetyl-CoA which can feed into the TCA cycle (Chang and Goldberg, 1978). Alternatively, some 
amino acids, such as glutamate, can be converted into TCA cycle intermediates which can 






1.2.1.2 The tricarboxylic acid cycle 
The TCA cycle was first elucidated by Hans Krebs in 1937 (Krebs and Johnson, 1937). Briefly, 
citrate synthase catalyses the entry of acetyl-CoA into the cycle with its reaction with the 4-
carbon oxaloacetate to form the 6-carbon molecule citrate. Substrate oxidation and 
decarboxylation through the 7-step pathway outlined in Figure 1.3 regenerates oxaloacetate 
and produces 3 NADH and 1 FADH2 for each acetyl-CoA molecule that enters the cycle. NADH 
and FADH2 produced from the TCA cycle provide the majority of the reducing potential 
required for ATP synthesis via oxidative phosphorylation.  
 
 
Figure 1.3 The tricarboxylic acid cycle. NAD+/NADH, oxidised/reduced form of nicotinamide 
adenine dinucleotide; FAD/FADH2, oxidised/reduced form of flavin adenine dinucleotide. 




1.2.1.3 Oxidative phosphorylation 
In 1961, Peter Mitchell described the theory of chemiosmotic coupling, the concept describing 
the coupling of substrate oxidation to ATP synthesis by a proton gradient generated across a 
membrane by the energy released from electron transfer (Mitchell, 1961). In the 
mitochondria, the highly invaginated IMM acts as the energy-transducing membrane as it is 
the site of ETS complexes I-IV and ATP-synthase (Figure 1.1).  
Complex I (NADH dehydrogenase; CI) and complex II (succinate dehydrogenase; CII) accept 
electrons from NADH and FADH2 respectively and at both complexes this potential is used to 
reduce ubiquinone to ubiquinol through the addition of 2 protons and 2 electrons (Sazanov, 
2015, Murray, 2012). The drop in redox potential at CI is sufficient to pump protons from the 
matrix into the IMS. Ubiquinol migrates through the IMM to be oxidised at complex III 
(cytochrome bc1 complex; CIII) and the protons are released into the IMS contributing to the 
proton gradient (Huttemann et al., 2007). One electron is used to reduce a separate 
ubiquinone, therefore, greatly increasing the efficiency of the process while the second 
electron is passed onto complex IV (cytochrome c oxidase; CIV) via cytochrome c (Sazanov, 
2015). Cytochrome c is loosely bound to the IMS side of the IMM (Kuznetsov et al., 2008). At 
CIV, oxygen acts as the final electron acceptor and is reduced to water. CIV also pumps protons 
into the IMS and is the enzyme controlling the rate of flux through the ETS and thus the 
respiratory rate (Huttemann et al., 2008). The complexes may be physically separated from 
one another in the IMM although recent evidence is emerging of the existence of 
‘supercomplexes’. The most common of these, the respirasome, is thought to comprise of 
complex I, a dimer of complex III and complex IV and has been identified in ovine cardiac 
mitochondria (Letts et al., 2016).  
The protons pumped into the IMS build up a concentration difference across the relatively 
impermeable IMM. The result is that the IMS becomes positively charged and acidic relative 
to the matrix. The proton gradient across the membrane, made up of a chemical (pH) gradient 
and electrical potential difference, provides a free energy driving force of ~200mV, the proton 
motive force (PMF; Mitchell and Moyle, 1969). The PMF is used to drive a secondary proton 
pump, ATP-synthase, to synthesise ATP from ADP and inorganic phosphate (Pi). Energy from 
the PMF is required for the rotation of the protein motor and each full rotation results in the 
release of 3 ATP from the catalytic binding sites (Noji et al., 1997). ATP is transported out of 
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the mitochondria in exchange for ADP by the adenine nucleotide translocase (ANT) located in 
the IMM (Figure 1.1).  
 
1.2.2 Reactive oxygen species production 
Reactive oxygen species (ROS) play a role in physiological signalling but in excess are 
implicated in oxidative damage and the pathogenesis of numerous diseases. The predominant 
contribution to mitochondrial ROS is from electron leakage onto oxygen at complex I and 
complex III to form the superoxide free radical, Ȯ2- (St-Pierre et al., 2002). Although a high 
proportion, up to 90%, of total ROS production is often assumed to be of mitochondrial origin, 
evidence for this is limited and it is a point of current controversy (Aledo, 2014, Brown and 
Borutaite, 2012). Additionally, cell culture studies estimate that 1-2% of oxygen consumed is 
converted to the superoxide anion rather than water, although whether this is true in vivo 
remains unclear (Kudin et al., 2004).  
The production of ROS is a normal component of cell signalling, for example they are believed 
to be involved in mediating the response to hypoxia (Mansfield et al., 2005). However, when 
excessive ROS generation occurs, ROS cause damage to cellular proteins, nucleic acids and 
lipids, as well as having an inhibitory effect on mitochondrial energy production (Aledo, 2014). 
The risk of excessive ROS production increases at higher metabolic rates, as there is an 
increased risk of electron slippage from the ETS. Therefore mechanisms that increase 
respiratory rate (section 1.2.6) may also increase ROS production (Peng and Jou, 2010). 
Additionally, a very high PMF is associated with increased ROS production as is a high NADH 
concentration and abnormally high or low oxygen levels, or fluctuations in oxygen, seen in 
hypoxia-reperfusion as occurs, for instance, during labour and delivery (Lambert and Brand, 
2004, Boveris and Chance, 1973, Mansfield et al., 2005).  
In order to prevent excessive oxidative damage, ROS detoxifying enzymes are expressed. The 
superoxide anion is converted to hydrogen peroxide (H2O2) by superoxide dismutase (SOD) 
enzymes (Figure 1.4; Loschen et al., 1974). There are 3 different forms of SOD, of which one, 
MnSOD (SOD2), is mitochondria-specific (Weisiger and Fridovich, 1973, Fukai and Ushio-Fukai, 
2011). Catalase is required to breakdown the H2O2 (Figure 1.4) to prevent its conversion in the 




Figure 1.4  Reactive oxygen species formation and detoxification. SOD, superoxide dismutase.  
(Jaimes et al., 2001) 
 
Additional protective mechanisms against oxidative damage may include a decrease in specific 
ETS complex abundance and an increase in uncoupling protein abundance (discussed in 
section 1.2.3.1), which have been reported in mitochondria of hypoxic muscle (Levett et al., 
2012). Additionally, the existence of ETS supercomplexes have been suggested to reduce ROS 
production at CIII at the expense of lowering the maximal capacity of this complex due to 
conformational limitations of electron transfer (Letts et al., 2016).  
 
1.2.3 Regulators 
The ability of the mitochondria to carry out oxphos is highly reliant on the maintenance of the 
proton gradient. However, leak of protons across the membrane has been reported to account 
for about half of the resting oxygen consumption of skeletal muscle (Brand et al., 1994). While 
reducing the efficiency of ATP production, proton leak is important for physiological processes 
including protection against excessive ROS production. The mechanism by which ‘proton leak’ 
occurs is very poorly understood and whether the lipid composition of the IMM plays a role 
in regulating proton leak is under debate (Brookes et al., 1997, Chen and Li, 2001, Pehowich, 
1999). Uncoupling proteins (UCPs) are present in the IMM and provide one route by which 
the proton gradient might be dissipated, while transport of substances into and out of the 
mitochondria (for example ATP export via the adenine nucleotide translocase) often 
harnesses the proton gradient and, therefore, provides an alternative route for proton re-






1.2.3.1 Uncoupling Proteins 
There are 3 major uncoupling proteins: UCP1, 2 and 3. UCP1 was the first to be identified and 
is present predominantly in brown adipose tissue (BAT) where it has an essential role in non-
shivering thermogenesis by dissipating the proton gradient as heat (Heaton et al., 1978, 
Enerback et al., 1997). It may also have a role in regulating energy balance (Oliver et al., 2007, 
Kontani et al., 2005, Rippe et al., 2000). However, mice lacking UCP1 do not become obese 
(Enerback et al., 1997), which suggests UCP2 and UCP3 may ‘rescue’ the metabolic phenotype 
and they show a 59% and 57% homology to UCP1 respectively (Fleury et al., 1997, Vidal-Puig 
et al., 1997). UCP3 and to a lesser extent UCP2 are expressed in skeletal muscle (Ricquier and 
Bouillaud, 2000). Indeed UCP3 is specific to skeletal-muscle in humans (Vidal-Puig et al., 1997, 
Ricquier and Bouillaud, 2000) and has been shown to contribute significantly to proton leak 
(Gong et al., 2000). Although the major roles of UCP2 and UCP3 in skeletal muscle are yet to 
be determined, they both appear to have metabolic effects (Schrauwen and Hesselink, 2002). 
The uncoupling effect of UCP2 has been associated with regulating energy balance and 
metabolic rate (Nordfors et al., 1998, Barbe et al., 2001) and may play a tissue-wide role in 
minimising oxidative stress through preventing excessive ROS production (Arsenijevic et al., 
2000). UCP3, on the other hand, may play a role in thermogenesis alongside influencing 
metabolic efficiency and may be particularly important in regulating lipid metabolism (Russell 
et al., 2003, Schrauwen et al., 2001, Clapham et al., 2000, Simonyan et al., 2001).  
 
1.2.3.2 Adenine nucleotide translocase 
The predominant role of ANT is to catalyse the exchange of ATP and ADP in a 1:1 ratio across 
the IMM, a process driven by the PMF (Pfaff et al., 1965, Pfaff and Klingenberg, 1968). The 
essential role of ANT in oxidative metabolism necessitates a very high abundance of ANT 
within the mitochondria. Three isoforms have been identified in the human, ANT1, 2 and 3 
and, of these, ANT1 is the predominant form expressed in skeletal and cardiac muscle (Stepien 
et al., 1992). Mouse Ant1 knockout and overexpression studies indicate that half to two-thirds 
of the basal proton conductance of the IMM is due to the presence of ANT (Brand et al., 2005). 
Altered expression of UCPs and ANTs provide a mechanism by which oxphos efficiency and 
metabolic rate can be regulated. Changing mitochondrial abundance and network dynamics 
are two other such mechanisms and these are discussed below.  
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1.2.4 Mitochondrial biogenesis 
Increasing the density of mitochondria, by organelle growth and division, occurs when energy 
supply is insufficient to meet the cellular demands (Hood et al., 2011, Nunnari and 
Suomalainen, 2012). The process of mitochondrial biogenesis requires the coordination of 
several processes including regulation of both the mitochondrial and nuclear genomes, lipid 
and protein synthesis for the assembly of the ETS complexes, import of metabolic enzymes 
and membrane expansion (Hood et al., 2006). Several messengers have been shown to 
influence biogenesis, including thyroid hormones, calcium and adenine monophosphate 
(AMP)-activated protein kinase (AMPK), and the biogenic response is thought to often involve 
one key transcriptional regulator, peroxisome proliferator-activated receptor gamma (PPARγ) 
coactivator 1 alpha (PGC1α; Irrcher et al., 2003, Ojuka et al., 2003, Jäger et al., 2007).  PGC1α 
is capable of driving mitochondrial biogenesis through its interaction with a range of 
transcription factors (Scarpulla et al., 2012, Lehman et al., 2000). Some of the best-
characterised mitochondrial biogenesis activators regulated by PGC1α are the transcription 
factors nuclear respiratory factor (NRF) 1 and 2. NRFs upregulate the expression of several 
nuclear-encoded components of the ETS complexes and proteins involved in mitochondrial 
DNA biogenesis (Marin-Garcia, 2010). 
 
1.2.5 Mitochondrial fusion and fission 
For over a century, mitochondria have been known to be highly dynamic organelles, 
constantly changing location within the cell and altering their conformation, in part through 
fusion and fragmentation (Lewis and Lewis, 1914). Since then, the importance and mechanism 
of the fusion and fission events have been the subject of numerous studies. Fission and fusion 
allow mitochondria to share solutes, metabolites, membranes and electrochemical gradients 
(Schrepfer and Scorrano, 2016). Maintaining a dynamic network is thought to be important in 
balancing energy supply and demand, with increased fusion observed when demand for ATP 
is high (Schrepfer and Scorrano, 2016). Network plasticity is also vital for mitochondrial quality 
control and mediating organelle and cellular degradation in response to damage (Jin and 
Youle, 2012).  
The complex mechanisms of fusion and fission are yet to be fully elucidated, however 4 key 
dynamin-like GTPases have been identified as integral to maintaining the mitochondrial 
network plasticity: mitofusins (MFN 1 and 2) and optic atrophy protein 1 (OPA1) are important 
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in driving mitochondrial fusion of the OMM and IMM respectively and dynamin-related 
protein 1 (DRP1) is involved in fission (Cipolat et al., 2004, Schrepfer and Scorrano, 2016). All 
4 are important during development as inhibiting their expression results in embryonic 
lethality in mice (Chen et al., 2003, Ishihara et al., 2009, Davies et al., 2007). 
 
Fusion  
MFN1 and 2 are located on the OMM and are thought to increase the number of 
mitochondrial contact events resulting in fusion through predominantly homotypic 
interactions of their cytosolic coiled coil domains (Rojo et al., 2002, Cipolat et al., 2004, 
Ishihara et al., 2004). Mouse embryonic fibroblasts (MEFs) derived from Mfn-knockout 
embryos have a fragmented mitochondrial network with reduced motility and fewer fusion 
events (Chen et al., 2003), whereas Mfn overexpression results in increased mitochondrial 
clustering (Rojo et al., 2002). MFN1 and MFN2 show 70% sequence homology and 
overexpression of MFN1 can rescue mitochondrial morphology defects in MFN2-deficient cells 
and vice versa (Chen et al., 2003). However, there is evidence that MFN1 and MFN2 carry out 
distinct functions in regulating fusion.  
The morphology of the mitochondria differ between the Mfn1- and Mfn2-knockout MEFs; the 
mitochondria are all very small in the Mfn1-knockout, whereas in the Mfn2-knockout, the 
mitochondria are of varying sizes but are all spherical (Chen et al., 2003). MFN1 tethering 
efficiency and GTPase activity were shown to be significantly greater than MFN2, which again 
suggests that while both are required for fusion, they perhaps are important at distinct stages 
of the process (Ishihara et al., 2004). In skeletal muscle specifically, while MFN1 and MFN2 are 
both expressed in human and mouse muscle cell lines (Rojo et al., 2002), only MFN1 was 
associated with fusion events in the rat (Eisner et al., 2014).  
OPA1 is located on the IMM and, like the mitofusins, regulates mitochondrial fusion through 
GTPase activity and interaction of the coiled coil domain (Cipolat et al., 2004). Further, OPA1 
has been shown to be important for mitochondrial fusion in skeletal muscle (Eisner et al., 
2014, Cipolat et al., 2004).  OPA1 stability and function are dependent on the mitochondrial 
membrane potential which is hypothesised to be an important check-point in place to prevent 





Mitochondrial fission is associated with a decreased energy demand but also with apoptosis. 
Experiments inhibiting DRP1 function reveal an excessive fission defect with closed networks 
of elongated mitochondria, which have collapsed around the nucleus (Pitts et al., 1999, 
Gandre-Babbe and van der Bliek, 2008). The overall mechanism of fission is thought to involve 
the recruitment of DRP1 and other proteins involved in forming a ‘scission complex’ which 
form a ring to constrict the mitochondrion and divide the organelle. The GTPase activity of 
DRP1 is thought to drive the final constriction events, but ultimately the mechanism and role 
of individual proteins remain unclear (Gandre-Babbe and van der Bliek, 2008).  
 
1.2.6 Responding to the environment 
The rate of respiration must be appropriate for both the cellular energy demand and the 
substrate availability. Coordinating this balance is mediated through cellular messengers 
conveying the current metabolic environment, as well as by endocrine messengers allowing 
an appropriate response at the organ and organism level. The interactions between substrate 
levels and metabolic response has already been discussed (Section 1.2.1.1). Additional 
mechanisms are numerous and interlinked, but some of the key regulatory pathways in 
skeletal muscle are summarised below. 
 
Monitoring cellular energy demand 
AMPK monitors cellular AMP:ATP levels to convey the energy status of the cell. Skeletal 
muscle undergoes high energy turnover for example during exercise, and this results in a 
greater increase in AMP than the concomitant decrease in ATP (Jäger et al., 2007). When AMP 
levels are high, AMP molecules bind to AMPK, resulting in an increased likelihood of 
phosphorylation to the active form, pAMPK (Long and Zierath, 2006). Activated AMPK then 
regulates downstream pathways in order to upregulate metabolism and provide the ATP 
required by increasing mitochondrial biogenesis and upregulating TCA cycle enzymes and 
components of the ETS (Winder et al., 2000, Bergeron et al., 2001). In addition, increased 
AMPK during times of energy deprivation and during exercise is believed to be linked to a 
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switch to fatty acid oxidation, which spares glucose for use by the brain (Jeoung et al., 2006, 
Winder and Hardie, 1996).  
 
Monitoring whole body energy demand 
Numerous hormones, including insulin, glucocorticoids (GCs), catecholamines and thyroid 
hormones (THs), are involved in regulating a whole body metabolic response. Insulin, secreted 
in response to high circulating glucose levels, is important in regulating substrate preference 
and driving carbohydrate metabolism. This is achieved predominantly by upregulating GLUT4 
delivery to the sarcolemmal membrane thereby increasing glucose uptake, the rate limiting 
step in glucose metabolism (Holman and Cushman, 1994, Leto and Saltiel, 2012). Additionally, 
high insulin and glucose availability have been shown to limit fatty acid oxidaiton 
(Wagenmakers, 1996), and have a general stimulatory effect on mitochondrial protein 
expression (Boirie et al., 2001, Stump et al., 2003).  
The predominant metabolic effect of GCs and catecholamines is to increase the availability of 
glucose during times of stress (Newton, 2000, Barth et al., 2007). Although the regulatory role 
of both GCs and cathecholamines on mitochondrial function has not been widely investigated, 
there are some studies reporting that GCs (Weber et al., 2002, Scheller et al., 2000, Morgan 
et al., 2016) and catecholamines (Shukla et al., 2000) upregulate mitochondrial oxidative 
metabolism.  
The best studied endocrine regulators of mitochondrial activity are the THs which are 
important metabolic regulators, and associations between TH levels, body weight and energy 
expenditure in adults are clear (Mullur et al., 2014). Human and animal studies investigating 
the effects of THs on specific mitochondrial protein expression and activity have suggested 
several mechanisms by which THs increase metabolic rate. First, THs have been associated 
with an increase in expression and activity of components of the TCA cycle and ETS (Winder, 
1979, Clement et al., 2002). Secondly, THs increase metabolic rate through decreased oxphos 
efficiency, both by altered IMM leak and increased UCP and ANT expression (Dummler et al., 
1996, Barbe et al., 2001, Pehowich, 1999). Additionally, THs are involved in promoting lipid 
metabolism via the inhibition of the pyruvate dehydrogenase complex and activation of AMPK 




1.2.7 Mitochondrial dysfunction and metabolic syndrome 
As central coordinators of energy balance with substrate uptake and utilisation, mitochondrial 
damage and dysfunction have been linked to the metabolic syndrome (Duchen, 2004). A 
reduction in mitochondrial density, due to decreased mitochondrial number and size, a more 
fragmented mitochondrial network and structural abnormalities have been reported in tissues 
from patients with obesity and insulin resistance (Kelley et al., 2002, Bach et al., 2003, 
Hernandez-Alvarez et al., 2010). Whether the reduction in oxidative capacity seen in type 2 
diabetes, both at basal level and in response to exercise, is simply down to the reduced 
mitochondrial content in muscle is unclear (Boushel et al., 2007, Antoun et al., 2015, Ritov et 
al., 2005, Burns et al., 2007). As well as morphological abnormalities, a reduction in ETS 
activity, ATP-synthase content and maximal mitochondrial respiration rates have been 
reported in muscles of diabetic patients (Hernandez-Alvarez et al., 2010, Antoun et al., 2015, 
Ritov et al., 2005). 
Whether mitochondrial dysfunction is a cause or consequence of insulin resistance is a topic 
of debate (Muoio and Neufer, 2012). A reduction in mitochondrial density specifically in the 
subsarcolemmal region of muscle fibres may contribute to insulin resistance by affecting 
substrate delivery and signal transduction (Ritov et al., 2005). Additionally, altered lipid 
metabolism and increased ROS production in obesity may down-regulate the insulin signalling 
pathway (Muoio and Neufer, 2012). Metabolic syndrome is associated with aging, which itself 
is associated with mitochondrial defects including reduced enzyme activity, lower respiratory 
capacity and increased ROS production (Sun et al., 2016). Mitochondria, therefore, are of 
interest in understanding any underlying predisposition to symptoms of the metabolic 
syndrome. As discussed in Section 1.1, fetal growth restriction has been associated with 
predisposition to symptoms of metabolic syndrome. In addition, as summarised in Table 1.1, 
numerous animal studies have demonstrated a link between prenatal insult and mitochondrial 
dysfunction of the postnatal offspring. However, whether these changes occur predominantly 
in utero and continue until adulthood or arise postnatally as a result of other programmed 
metabolic changes and/or when additional stress is placed on the system, is not well 
understood.  
Prenatal insults are likely to have tissue-specific effects as when fetal growth is compromised, 
blood is preferentially shunted towards more vital organs such as the brain and heart, leaving 
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other tissues including skeletal muscle more vulnerable to insult (Brown, 2014). Skeletal 
muscle is a highly metabolically active tissue and, hence, any impairment in its energetic 
potential is likely to result in a predisposition to metabolic syndrome (Brown, 2014, Hoppeler, 
1999). However, in order to further investigate the role of mitochondria in intrauterine 
programming of metabolism and to determine the mechanistic pathways involved, a better 
understanding of the normal developmental profile of mitochondria is required, as currently 







Table 1.1 Intrauterine programming of mitochondrial dysfunction in postnatal offspring  
Challenge in utero Species Tissue Mitochondrial Dysfunction Reference 
Maternal high fat diet Rat Skeletal muscle (soleus) ↓CI and CIII (g,a), ↓NRF1 (g) (Pileggi et al., 2016) 
 Rat Skeletal muscle (soleus) ↓CI-IV and ATP-synthase (p) (Latouche et al., 2014) 
 Rat Heart ↑mtDNA (Mdaki et al., 2016) 
 Rat Liver ↓mtDNA, ↓PGC1α (g) (Burgueno et al., 2013) 
 Rat Kidney ↓mtDNA (Taylor et al., 2005) 
Maternal obesity Rat Skeletal muscle (gastrocnemius) ↓MFN1 (g), ↓PGC1α (g) (Borengasser et al., 2014) 
 Rat Liver ↓MFN2 (g) (Borengasser et al., 2014) 
Maternal low protein 
diet 
Rat Skeletal muscle (vastus lateralis) ↓CS (a), ↑CI-IV (a normalised to CS), 
↑SOD1, SOD2, catalase (p) 
(Tarry-Adkins et al., 2016) 
 Rat Skeletal muscle (quadriceps) ↓mtDNA (Park et al., 2004) 
 Rat Liver ↓mtDNA (Park et al., 2003) 
 Mouse Skeletal muscle (gastrocnemius) ↑CIV (p,g,a normalised to CS), ↓density (Jousse et al., 2014) 
 Mouse Adipose tissue ↑PGC1α, NRF1, UCP2 (g), ↑density (Jousse et al., 2014) 
Undernutrition Mouse Skeletal muscle (various) ↓respiratory capacity, ↓density (Beauchamp et al., 2015a) 
 Mouse Heart ↓respiratory capacity (Beauchamp et al., 2015b) 
Maternal diabetes Rat Heart ↓respiratory capacity, ↓mtDNA (Mdaki et al., 2016) 
Maternal hypoxia Guinea pig Heart ↓CIV (p,g,a), ↓PGC1α (g) (Al-Hasan et al., 2014) 
Uteroplacental 
insufficiency 
Rat Skeletal muscle (unspecified) ↓carbohydrate oxidation and ATP 
production 
(Selak et al., 2003) 
 Rat Skeletal muscle (unspecified) ↓CI, ANT1, ATP-synthase (g) (Lane et al., 1998) 
 Pig Skeletal muscle (unspecified) ↓CS (g), ↓CIV (g), ↓biogenesis (Liu et al., 2012) 
CI-IV, ETS complexes I-IV; NRF1, nuclear respiratory factor 1; mtDNA, mitochondrial DNA; MFN1/2, mitofusin 1/2; PGC1α, Peroxisome proliferator-
activated receptor γ coactivator 1α; SOD1/2, superoxide dismutase 1/2; UCP2, uncoupling protein 2; ANT1, adenine nucleotide translocase 1; CS, citrate 




1.3 Fetal development and maturation 
Over late gestation, physiological systems of the fetus need to undergo maturational 
processes to prepare for postnatal life. In particular, organs including the lungs, gastro-
intestinal tract and kidneys must be able to immediately take over the role of the placenta in 
supplying metabolic substrates and oxygen and in removing waste products (Fowden et al., 
1998). In babies born preterm, immaturity of these organ systems and of the brain and 
immune system dramatically increase the risk of acute neonatal illness and mortality which 
highlights the importance of prepartum tissue maturation in ensuring a smooth transition to 
extrauterine life (Behrman and Butler, 2007). Several of the key maturational processes 
essential for neonatal viability are known to be driven by fetal hormones, in particular by GCs 
(Fowden et al., 1998).  
 
1.3.1 Endocrine regulation 
1.3.1.1 Glucocorticoids 
In the adult, GCs are generally released in response to physiological or mental stress and carry 
out roles including immunosuppression and the regulation of several metabolic processes to 
increase the glucose availability (Newton, 2000). Glucocorticoids are also secreted in response 
to stressful conditions in the fetus (Giussani et al., 2011, Roelfsema et al., 2005). However, 
they have additional roles in utero as they act both as the normal maturational signal towards 
term and as programming signals in determining the physiological phenotype of the offspring 
in relation to the prevailing environmental conditions in utero (Fowden et al., 1998, Kapoor et 
al., 2006). 
Cortisol is the predominant GC circulating in both humans and sheep (Challis et al., 2001). It is 
synthesised in the zona fasciculata of the adrenal cortex and secreted in response to 
adrenocorticotropin hormone (ACTH) released from the pituitary gland under the control of 
hypothalamic corticotropin releasing hormone (CRH, Figure 1.5; Newton, 2000).  The 
hypothalamic-pituitary-adrenal (HPA) axis is controlled, in part, by negative feedback of 
cortisol which inhibits production of CRH and ACTH (Figure 1.5). This results in cortisol 
concentrations being maintained within a narrow range around a set point, at least in adult 






Figure 1.5 A simplified diagram of the hypothalamic-pituitary-adrenal axis. CRH, corticotropin 
releasing hormone; ACTH, adrenocorticotropic hormone (Newton, 2000).  
 
The fetal HPA axis is functional from early on in gestation although fetal cortisol 
concentrations are lower than maternal values for most of pregnancy (Wintour et al., 1975). 
However, in every species studied to date, there is a surge in the circulating concentration of 
cortisol in the fetus just before term, which often exceeds maternal values (Fowden et al., 
1998). The mechanism for the prepartum rise in cortisol appears to involve species-specific 
positive and negative influences on the HPA axis acting through central and peripheral 
mechanisms (Wood and Keller-Wood, 2016). In fetal sheep, the concentrations of CRH and 
ACTH rise towards term and the adrenal glands become progressively more responsive to 
ACTH over late gestation with increases in ACTH receptor abundance and activity of the 
enzymes involved in cortisol synthesis (Saoud and Wood, 1996, Castro et al., 1992, Jacobs et 
al., 1994, Fraser et al., 2001). In the last few days before term, the sensitivity to the negative 
feedback of cortisol on ACTH production seen earlier in gestation (Wood and Rudolph, 1983) 
is also reduced significantly (Wood, 1988). This may be achieved by downregulation of the 
glucocorticoid receptor (GR) or reducing bioavailability of cortisol in the pituitary gland (Challis 
et al., 2001). Thus, the prepartum increase in fetal cortisol concentrations is a normal 
developmental event unrelated to stress of the fetus.  
As lipophilic steroid hormones, GCs can bidirectionally cross the placenta, and therefore a 




varying by species and gestational age (Migeon et al., 1957, Hennessy et al., 1982). Despite 
the protection offered by the activity of placental 11β-hydroxysteroid dehydrogenase-2 which 
converts cortisol to its inactive metabolite, cortisone (Stewart et al., 1995, Wyrwoll et al., 
2009), high maternal GC concentrations can lead to fetal GC overexposure and alter HPA 
activity with detrimental impacts on offspring development both in the short- and long-term 
(Seckl, 2004, Wood and Rudolph, 1984). Similarly, adverse intrauterine conditions which raise 
fetal GC concentrations independently of the mother in late gestation affect fetal 
development with potential consequences long after birth.  
In the fetus, the role of cortisol is predominantly to initiate the switch from cell proliferation 
to terminal differentiation (Fowden et al., 1998). As such, fetuses exposed to high levels of 
cortisol before term, due to stress during pregnancy, are more likely to be born small for 
gestational age (Jensen et al., 2002). In addition, in some species such as sheep, the cortisol 
surge also drives parturition (Liggins, 1969). Cortisol can act directly, but also many of the 
cortisol-driven maturational changes are mediated by other hormones, whose bioavailiabilty 
or receptor expression is regulated by cortisol. Examples include insulin-like growth factors, 
leptin and triiodothyronine (T3; Figure 1.6; Fowden et al., 1998). 
 
Figure 1.6 The profile of plasma cortisol and tri-iodothyronine (T3) in the ovine fetus over late 






1.3.1.2 Thyroid hormones 
Thyroid hormones act on almost every cell in the body and carry out numerous roles in a 
regulated cell-specific and time-dependent manner (Brent, 2012). As discussed in Section 
1.2.6, THs play an important role in upregulating metabolic rate in adult organisms (Mullur et 
al., 2014). Additionally, in adult tissues, including skeletal muscle, THs are involved in normal 
cell proliferation, homeostasis and repair (Milanesi et al., 2016, Wu and Koenig, 2000) and can 
alter the contractile properties of skeletal muscle (Larsson et al., 1994, Salvatore et al., 2014). 
They also have an important role in the development of fetal tissues including skeletal muscle 
(Forhead and Fowden, 2014).  
Thyroid hormones are produced from the thyroid gland under control of the hypothalamic-
pituitary-thyroid axis (HPT; Figure 1.7). The predominant secretory product of the thyroid 
gland in sheep and humans is thyroxine (T4), a relatively biologically inactive molecule in adults 
(Gereben et al., 2008). TH transporter proteins are required for the uptake of THs into cells, 
the best characterised of these being the TH-specific transporter, monocarboxylate 
transporter 8 (MCT8; Visser et al., 2011). Within peripheral tissues, further metabolism of the 
THs by deiodinase enzymes alter the local TH bioavailability (Figure 1.7). Deiodination of T4, 
by type 1 deiodinase (D1) in liver is believed to supply the majority of the circulating T3, the 
most active form of TH (Gereben et al., 2008). D2, present in tissues including skeletal muscle, 
increases the local bioavailability of T3 (Figure 1.7) via the same mechanism as D1 (Gereben et 
al., 2008). Type 3 deiodinase (D3) is also expressed in skeletal muscle and inactivates THs 
through the conversion of T3 to di-iodothyronine (T2) and T4 to reverse T3 (rT3; Figure 1.7) 
which cannot bind to the thyroid hormone receptor (THR; Gereben et al., 2008). In the human 
fetus, T4, T3 and thyroid-stimulating hormone (TSH) are produced early in pregnancy and 
continue to rise during gestation (Thorpe-Beeston et al., 1991a). The timings of TH system 






Figure 1.7 A simplified diagram of the hypothalamic-pituitary-adrenal axis. TRH, thyrotropin 
releasing hormone; TSH, thyroid-stimulating hormone, T4, thyroxine; T3, tri-iodothyronine; rT3, 
reverse T3; D2 and D3, deiodinases (Forhead and Fowden, 2014).  
 
A further mechanism of regulating TH activity is sulfation of THs by sulfotransferases, which 
prevents T3 binding to the TH receptor (THR) and increases the likelihood of T4 conversion to 
rT3 (Visser, 1994). Sulfatases can convert the sulfated hormones back to their biologically 
active forms, and this may be an important source of tissue T3 during fetal development 
(Santini et al., 1992). Overall, the response to THs is highly complex, dependent not only on 
the activity of the HPT axis maintaining the circulating TH pool, but also on the cell-specific, 
environmentally and temporally regulated expression of deiodinases, sulfotransferases, 
sulfatases and transcriptional regulatory elements (Wu and Koenig, 2000, Silva and Larsen, 
1985, Visser, 1994). As in adult tissues, bioavailability of TH in the fetus is under the control of 




As shown in Figure 1.7, the HPT axis is subject to negative regulation in order to tightly control 
the circulating TH levels, in a similar manner to the regulation of the HPA axis. Ligand bound 
THR suppresses the expression of TSH and thyrotropin releasing hormone (TRH). Conversely, 
the THR without ligand is thought to upregulate the expression of TSH and TRH (Wu and 
Koenig, 2000). In the fetus, this negative feedback mechanism is evident from early in 
gestation (Polk et al., 1991, Greenberg et al., 1970). The importance of maintaining the 
optimal level of circulating THs in utero is shown as both under- and over-exposure to THs 
result in altered development (Hernandez et al., 2006, Erenberg et al., 1974). Additionally, 
fetal T3 concentrations are low in cases of IUGR (Thorpe-Beeston et al., 1991b).  However, 
there is a surge of T3 towards term (Figure 1.6) which has led to the hypothesis that the set 
point is higher in the fetus than in the adult (Ballabio et al., 1989). This rise in T3 in fetal sheep 
is driven, at least in part, by cortisol upregulating hepatic and renal D1 and downregulating 
renal and placental D3 activity which, during most of gestation, converts the majority of T4 to 
biologically inactive rT3 (Forhead et al., 2006). After birth, the rise in T3 continues, stimulated 
upon exposure to the cold and responsible for initiating thermogenic mechanisms (Clarke et 
al., 1997).  
In some species including humans, maternal TH can cross the placenta and contribute to the 
fetal TH pool (Chan et al., 2009), despite the placental expression of D3 (Forhead and Fowden, 
2014). In these species, maternal THs are likely to be important in development, particularly 
before the fetal HPT axis becomes active, and can also compensate for fetal hypothyroidism, 
minimising any detrimental effects of fetal TH deficiency on development (Chan et al., 2009). 
However, in some species, including sheep, THs cannot cross the placenta (Forhead et al., 
2009), which makes the fetus dependent on its own thyroid gland and, hence, a useful 
experimental model for studying the effects of hypothyroidism in utero.  
THs are important to development throughout gestation, influencing metabolism, growth and 
differentiation (Erenberg et al., 1974, Fowden and Silver, 1995). THs are particularly crucial to 
the development of the central nervous system (Chan et al., 2009), but they are also involved 
in maturation of tissues including the liver, lungs and heart, often acting in cooperation with 
cortisol  (Mai et al., 2004, Erenberg et al., 1974, Forhead and Fowden, 2014). THs have also 
been shown to play an important role in development of fetal skeletal muscle (Lee et al., 2014) 





Hormone molecular signalling pathways 
The action of cortisol is mediated through its binding to cytosolic receptors which then rapidly 
translocate into the nucleus (Guertin et al., 1983). The predominant regulatory mechanism of 
GCs is in up- or down- regulation of transcription of its target genes (Guertin et al., 1983, 
Groner et al., 1983). The hormone-receptor complex binds with the GC responsive element 
upstream of the target gene and interactions with chromatin and other nuclear regulatory 
proteins ensure an appropriate cell- and environment-specific response (Rousseau, 1984, 
Oakley et al., 1996). Further GC-mediated cellular response mechanisms are thought to be via 
regulating mRNA stability and altering expression at the level of translation (Newton et al., 
1998, Lee et al., 1988, Han et al., 1990, Meyuhas et al., 1987).  
Thyroid hormones can exert effects in the cell directly at the plasma membrane or in the 
cytoplasm but, like GCs, the predominant mechanism involves T3 binding to the nuclear THR 
to give genomic effects (Anyetei-Anum et al., 2018). THRs are encoded by 2 genes to generate 
THRα and THRβ isoforms, of which THRα is the predominant form expressed in pre- and 
postnatal skeletal muscle (White et al., 2001). Like the GR, the THR is a ligand-activated 
transcription factor which mediates a cellular response through the activation or repression 
of target gene expression (Wu and Koenig, 2000). Conversely, unliganded THR suppresses the 
normal T3 signalling, for example through their binding corepressors at a positively-regulated 
TH locus (Wulf et al., 2008). Upon binding T3, THRs bind to the DNA either as homodimers or 
as a heterodimer with a retinoid X receptor, and also bind cofactors to mediate the suitable 
cellular response to the hormone (Wulf et al., 2008). This direct binding and transcriptional 
regulation accounts for the more rapid TH response which is apparent within 6 hours, followed 
by an indirect response mediated by intermediate regulators after a 48 hour lag period 
(Weitzel et al., 2001).  
As discussed in Section 1.2.6, the association between thyroid hormones (TH) and 
mitochondrial biogenesis has been well documented. In this example, the rapid response of 
TH signalling is thought to be due to TH-mediated transcriptional regulation of target genes 
such as the transcriptional coactivator, PGC1α (Weitzel et al., 2001). Specifically, upon T3 
binding to the nuclear THR, the complex binds to a thyroid response element (TRE) in the 
promoter region, 4 kilobases upstream of the transcriptional start site of PGC1α (Wulf et al., 
2008). Expression is upregulated, at least in part, due to an increase in histone acetylation and 




response genes, including PGC1α, have been hypothesised to be responsible for regulating 
the second wave of TH-induced gene expression, involving genes with, as yet, no identified 
TRE such as NRF1 and 2 (Weitzel and Iwen, 2011, Wulf et al., 2008). Overall, several factors 
are involved in mediating TH-driven mitochondrial biogenesis, but PGC1α is thought to be a 
crucial element in this pathway and its regulation is relatively well understood. Whether this 
is true in fetal skeletal muscle, however, is unclear.  
 
1.3.2 Skeletal muscle development 
The majority of skeletal muscle fibres are formed during mid-gestation, with myoblast 
proliferation replaced by terminal differentiation of the fibres during late gestation (Brown, 
2014). Thus the number of fibres is generally set in utero, with late gestation and postnatal 
muscle growth involving predominantly hypertrophy and not hyperplasia (White et al., 2010). 
Therefore, conditions during intrauterine development can have consequences on muscle 
structure and functional capacity, as well as whole body metabolism long after birth (Brown, 
2014).  
Late gestation is important in skeletal muscle structural and functional development (Javen et 
al., 1996). Both cortisol and THs are reported to be involved in the maturation of skeletal 
muscle over this period. Both these hormones are required for the downregulation of insulin-
like growth factor-I (IGF-I) expression in skeletal muscle, thereby playing an indirect role in the 
transition from proliferation to differentiation (Forhead et al., 2002). T3 in particular is also 
believed to have a direct role in the terminal differentiation of fibres through upregulating 
myogenesis genes, as shown in vitro (Carnac et al., 1992). Ovine fetuses thyroidectomised (TX) 
during the second half of gestation show multiple differences in skeletal muscle development 
compared with sham-operated controls. Muscles of TX fetuses have reduced protein and DNA 
content, slower contraction and relaxation times and a reduced contractile force (Erenberg et 
al., 1974, Finkelstein et al., 1991). 
Muscle fibres are subdivided into 2 main classifications: type I fibres which are slow twitch 
fibres carrying out predominantly oxidative metabolism, and type II fibres which are fast 
twitch. The latter are further classified as type IIa, oxidative/glycolytic, and type IIx, glycolytic, 
fibres. The fibre types can be identified by their expression of different myosin heavy chain 




distinct characteristics, for example type I fibres contain a higher abundance of mitochondria 
and have a higher rate of insulin-stimulated glucose uptake than type II fibres which contain 
more glycogen (Goodyear et al., 1991, Fernandez et al., 1995). 
Muscles generally consist of a heterogeneous mixture of fibre types, with the ratio dependent 
on the muscle function and the frequency of neuronal stimulation, as well as TH exposure 
(Gambke et al., 1983). The different fibre phenotypes are expressed in utero but remain plastic 
into adulthood when an increase in the ratio of type I:type II fibres is seen in response to 
impaired TH signalling and exercise (Green et al., 1984b, Yu et al., 2000) whereas a decrease 
in the type I:type II ratio is associated with insulin resistance (Stuart et al., 2013). In precocial 
species, including sheep, development of both slow and fast twitch fibres must occur prior to 
birth to enable immediate neonatal muscle function (Finkelstein et al., 1991). The fibre type 
ratio is sensitive to prenatal insult; ovine hyperthermia, associated with fetal growth 
restriction, hypoxia and hypoglycaemia, has been shown to lower the proportion of oxidative 
fibres (Yates et al., 2016). THs appear to be important in regulating fibre type with 
hypothyroidism during ovine fetal development resulting in a shift towards an increased 
proportion of type II fibres compared with euthyroid controls (Finkelstein et al., 1991). Both 
IUGR and reduced fetal TH exposure impair the structural and functional development of fetal 
skeletal muscle as well as the oxidative capacity of the tissue. 
 
1.3.2.1 Skeletal muscle chosen for this study 
For the current study 3 muscles were used: biceps femoris (BF), semitendinosus (ST) and 
superficial digital flexor (SDF). The BF and ST are commonly studied muscles in the fetus (Yates 
et al., 2016, Jellyman et al., 2012, Forhead et al., 2009) whereas the SDF has not been the 
focus of much research, particularly in the sheep. All 3 are hind limb muscles of mixed fibre 
type. However, they carry out distinct roles, have different maximal power outputs and 
elasticity parameters and, therefore, may show different maturational profiles towards term 
(Wilson and Lichtwark, 2011). The BF and ST are both hamstring muscles, used for extending 
the hip and flexing the stifle during locomotion (Frandson et al., 2013). They are located 
adjacent to one another and have a similar fibre type ratio (Yates et al., 2016). They do, 
however, differ in their innervation, blood supply and developmental profile of myogenic 
markers (Yates et al., 2016, Woodley and Mercer, 2005, Rab et al., 1997, Deveaux et al., 2003). 




preventing ankle extension while walking (McGuigan and Wilson, 2003). The role of the SDF, 
as a muscle-tendon unit, is in increasing the efficiency of locomotion, displaying substantial 
elastic energy recovery, while the larger, proximal muscles including the BF and ST are 
required for increasing workload when running (McGuigan and Wilson, 2003, McGuigan et al., 
2009). Thus, the BF and ST can generate more mechanical power through fibre shorting, 
whereas the SDF generates force through predominantly isometric contraction (Biewener, 
1998). In addition, the structure of the SDF is quite different to the BF and ST; the SDF contains 
accessory ligaments throughout the muscle joined with short, multipennate, fibres in contrast 
to the parallel fibre arrangement of the fusiform BF and ST (McGuigan and Wilson, 2003, 
Butcher et al., 2010).  
Studying these muscles with their differing structure and function should give an insight into 
whether there are muscle specific differences in the development and regulation of 
mitochondrial function over late gestation.  
 
1.3.3 Fetal metabolism 
The transition to extrauterine life is associated with a significant metabolic challenge. Firstly, 
the energy demands are rapidly upregulated as organs need to take on new roles; skeletal 
muscle must be able to support locomotion and thermogenesis for the first time. The 
increased energy requirement for the new postnatal activities is predominantly provided by 
the mitochondrial supply of ATP via oxphos, and as such, the oxygen consumption of certain 
tissues including liver and brain increases rapidly at birth (Klein et al., 1983). Furthermore, in 
tissues like adipose tissue increased mitochondrial activity occurs for non-shivering 
thermogenesis, by which energy is released as heat by uncoupling the mitochondrial proton 
gradient from ATP production (Simonyan et al., 2001). However, this is not the only challenge 
during the perinatal period; there is an increased risk of excessive ROS production and the 
associated oxidative damage due to fluctuating partial pressure of oxygen (pO2) associated 
with the uterine contractions of labour, followed by the rise in pO2 after birth with the onset 
of pulmonary gas exchange (Rogers et al., 1998, Minai et al., 2008). However, relatively little 





1.3.3.1 Substrate availability 
Metabolic development in terms of substrate delivery, production and storage is relatively 
well understood (Jones and Rolph, 1985). Fetal metabolism relies predominantly on 
carbohydrates, with the majority of fetal glucose obtained from the maternal circulation (Hay 
et al., 1981, Morriss et al., 1973). At birth, however, the neonate must be able to access a 
supply of metabolic substrates before the onset of enteral nutrition (Fowden et al., 1998). 
During late gestation, there is a cortisol-driven increase in glycogen deposition in tissues 
including the liver and skeletal muscle, alongside a rise in the activity of glycogenolytic 
enzymes (Barnes et al., 1978, Jones and Rolph, 1985, Fowden et al., 1991). The fetal expression 
of hepatic and renal gluconeogenic enzymes has also been reported to increase towards term 
in a cortisol-dependent manner (Fowden et al., 1993), with gluconeogenesis responsible for 
around 75% of the glucose requirements of the neonatal ruminant (Nafikov and Beitz, 2007). 
At birth, therefore, skeletal muscle can draw initially on its own glycogen stores as well as 
obtaining glucose from the circulation. This is reflected in the skeletal muscle and liver 
glycogen stores being rapidly diminished within hours of birth (Mellor and Cockburn, 1986).  
In addition to glucose, adult skeletal muscle metabolises lipids. Fatty acids are able cross the 
placenta from maternal to the fetal circulation in some species (Hull, 1975). However, in 
sheep, the role of lipids in fetal metabolism, in particular lipids of maternal origin, is thought 
to be minimal (James et al., 1971). Fetal skeletal muscle does, however, have the capacity for 
lipid oxidation and therefore may metabolise FAs when glucose levels are low, in line with the 
metabolic flexibility seen in adult tissues, as discussed in Section 1.2.1.1 (James et al., 1971, 
Morriss et al., 1973, Beatty and Bocek, 1970).  The fetus has been shown to be capable of 
lipogenesis and, as with glycogen, lipid deposition occurs during fetal maturation 
predominantly in adipose tissue and liver, but also in skeletal muscle (Hull, 1975, Christie et 
al., 1985, Beatty and Bocek, 1970). At birth, lipid mobilisation due to neural stimulation of 
adipocytes and the loss of prostaglandin inhibition (Mostyn et al., 2003) results in a rapid 
increase in the circulating FA concentration (Vanduyne et al., 1965) and lipids become an 
important source of fuel postnatally (Mellor and Cockburn, 1986). Fatty acids, both from 
mobilisation of stores laid down during fetal life, and from intake of the high-fat content 






1.3.3.2 Mitochondrial development 
Relatively few studies have investigated mitochondria during development. Those which have, 
have used a number of species and different tissues and the changes in mitochondrial density, 
structure and function are summarised in Table 1.2. Some of the developmental changes in 
fetal mitochondria may be regulated by maturational hormones. THs are important for 
regulating whole body fetal oxygen consumption (Fowden and Silver, 1995, Lorijn et al., 1980), 
likely to be largely due to the TH acting on skeletal muscle (Forhead and Fowden, 2014). THs 
are also important for the upregulation of mitochondrial protein content and oxphos capacity 
in fetal porcine muscle, with a TH-dependent increase in ANT possibly playing a role in 
regulating metabolic rate (Herpin et al., 1996). Both cortisol and T3 have been implicated in 
the increased UCP expression in adipose tissue (Mostyn et al., 2003, Gnanalingham et al., 
2005a, Gnanalingham et al., 2005b, Schermer et al., 1996). However, few studies have looked 
at skeletal muscle mitochondrial function during the perinatal period, and little is known about 






Table 1.2 Mitochondrial changes during development 
Species Tissue Developmental period studied 
(proportion of gestation or 
incubation period) 
Mitochondrial change during 
development 
Reference 
Human Heart ~0.2 to ~0.35 ↑CS (a), ↑CIV and ATP synthase 
(a,p), ↑mtDNA 
(Marin-Garcia et al., 2000) 
Chick Heart 
Skeletal muscle (hind limb) 
0.4 to 1.0 
0.5 to 1.0 
↑ CII and CIV (a) 
↑CII and CIV (a) 
(Greenfield and Boell, 1968) 
Sheep Perirenal adipose tissue 0.55 to 0.65 ↑density (Gemmell and Alexander, 
1978) 
Rat Brain 0.65 to 1hour postnatal ↑RCR (Nakai et al., 2000) 
Human Skeletal muscle 
(quadriceps) 
Neonates: born preterm to full-
term; 0.65 to 1.0 
↑respiratory capacity, ↑CS (a) (Sperl et al., 1992) 
Rat Liver 0.7 to 10 days postnatal ↑CII and III (a) (Jakovcic et al., 1971) 
Sheep Perirenal adipose tissue 0.9 to 1.0 ↑UCP1 (p) (Mostyn et al., 2003) 
Rabbit Heart 0.9 to 4 days postnatal ↑density, ↑cristae density (Smith and Page, 1977) 




1.4 Aims and Hypotheses 
The first hypothesis of this thesis has two inter-related parts: (i) that there would be an 
increase in mitochondrial number and oxidative capacity in fetal skeletal muscle towards term 
in preparation for the increased energy demands immediately after birth and (ii) because this 
would increase the potential for excessive ROS production and oxidative damage during 
labour and delivery, there would be a simultaneous upregulation of mitochondrial 
mechanisms to protect against this risk. The second hypothesis was that cortisol and thyroid 
hormones would play an important role in regulating mitochondrial development in 
preparation for extrauterine life given their known roles in prepartum maturation of other 
physiological systems. 
The specific aims of this project were two-fold: 
1) To determine whether any changes occur in skeletal muscle mitochondrial number and 
function over the last third of gestation and in the first two days of neonatal life and 
2) To determine whether the maturational hormones, cortisol and T3 play a regulatory 















2 General Methods 
 
2.1 Animals 
All animal procedures were regulated under the UK Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review by the University of Cambridge Animal 
Welfare and Ethical Review Body (AWERB). This thesis presents data from a total of 35 
pregnant Welsh Mountain ewes of known gestational age (23 bearing twins and 12 bearing 
single fetuses) and 6 newborn twin lambs (1 from each of 6 ewes).  
 
2.1.1 Breeding  
The non-pregnant ewes were purchased from farms in Wales and were bred to Welsh 
Mountain rams on site in the research facility at the University of Cambridge. Welsh Mountain 
sheep are seasonal breeders, which naturally have a short breeding season of 3-4 months and 
an oestrus cycle of 14-19 days. In order to manipulate the breeding cycle and allow for time-
dated pregnancy and breeding throughout the year, intra-vaginal progesterone sponges were 
used. Sponges were inserted for 12-14 days and at the end of this period pregnant mares’ 
serum gonadotropin (PMSG; 8 IU/kg Folligon; Intervet UK Ltd, Cambridge, UK) was injected 
for those outside the natural breeding season. The drop in progesterone alongside high 
gonadotropin triggers oestrus to occur outside the normal period.  
Gestational age was calculated from the first day on which the ewe had a raddle-ink mark. 
Ultrasound scans were carried out after 60, 80 and 100 days in order to confirm pregnancy 
and determine how many fetuses the ewe was carrying. 
 
2.1.2 Housing and Husbandry 
All pregnant ewes were group housed. Ewes were preferentially kept outside in the pasture 
or, during winter, were kept in a barn. Ewes kept indoors had free access to hay and water. 






Twenty-nine of the pregnant ewes underwent surgery to manipulate the fetal endocrine 






Table 2.1 Summary of animal experimental procedures used throughout the thesis.  
Experimental 
Procedure 
Twin or Single Gestational Age 
at Surgery 
Age at Tissue 
Collection 




Unoperated Fetus Twin N/A 102-105dGA 6 6 (2:4) 3 
Unoperated 
Newborn 
Twin N/A 1-2 days 6 6 (3:3) 3 
Anaesthetised 
(sham procedure) 
Single 130dGA 130dGA 1 1 (1:0) 5,6 
Fetal TX or sham 
operation 
Twin 102-105dGA 125-129dGA 6 6 TX (3:3) 
6 sham (3:3) 
3,4,6 
Fetal TX or sham 
operation 
Twin 102-105dGA 140-145dGA 6 6 TX (2:4) 
6 sham (2:4) 
3,4 
Saline infusion or 
T3 infusion 
Twin 116-119dGA 127-130dGA 5 4 saline infused 
(4:0) 
5 T3 infused (3:2) 
4,6 
Saline infusion Single 118-119dGA 128-131dGA 5 5 (3:2) 5,6 
Cortisol infusion Single 118-119dGA 128-131dGA 6 6 (3:3) 5 




2.2.1 Preparation for Surgery 
2.2.1.1 Sterilisation of surgical equipment 
Catheters which were to be inserted into the fetal vein and artery were made from 1mm bore 
PVC tubing (Altec, St Austell, UK) cut to 1.2m in length. A 15cm piece of 0.86mm diameter PVC 
tubing (Microtube Extrusions, New South Wales, Australia) was inserted at one end of the 
catheter to a depth of 0.5cm and secured in place with cyclohexanone (Technicon, Dublin, 
Ireland). The seal was tested to ensure the join was secure and there were no air leaks. 
Catheters which were to be inserted into the maternal femoral artery were made from 1mm 
bore PTFE (Altec). These were cut to 1.2m and a 30cm mark drawn onto the catheter. All 
catheters were double bagged and gas-sterilised using ethylene oxide for 48 hours and then 
kept in room air for a minimum of 24 hours before use.  
Surgical drapes, gowns and towels were packaged into metal drums to be steam-sterilised 
using an autoclave. Surgical instruments, sutures, swabs and diathermy tip were packed, 
wrapped in a drape and also steam-sterilised. Pins, blunt needles and trays, all required for 
the daily blood sampling of catheterised animals were steam-sterilised in self-seal sterilisation 
pouches.  
 
2.2.1.2 Animal preparation 
Ewes had an additional ultrasound scan immediately prior to surgery to confirm the number 
of fetuses and that there were no obvious complications. Ewes were brought into the holding 
pens at least 24 hours before the day of surgery in order to acclimatise them to where they 
would be held post-surgery. Here the ewes were in an individual pen with at least one other 
sheep in the same room. The ewes had free access to hay and water, until food (but not water) 








2.2.2 Surgical Procedures 
On the day of surgery, after scanning, the ewes were brought into the pre-operative 
preparation room and their neck shorn in order to expose the position of the jugular vein. The 
shorn area was cleaned with ethanol and anaesthesia was induced by an intravenous bolus 
injection of Alfaxalone (1.5-2mg/kg Alfaxan; Jurox). The ewe was immediately transferred 
onto the preparation table in the supine dorsal position and, using a laryngoscope, intubated 
with an endotracheal tube (8.0mm ID, 10.9mm OD; 30mm cuff diameter Portex® Tracheal 
Tube; Smiths Medical International Ltd., Kent, UK). Anaesthesia was maintained by 1.5-2% 
isofluorane in oxygen (Isoflo; Zoetis, London, UK). The abdomen, from the bottom of the rib 
cage until the top of the hind limbs was shaved and, if the ewe was to be catheterised, the 
right flank was also shaved. Pre-surgery analgesia was given to the ewe as a subcutaneous 
injection (55mg carprofen; Rimadyl; Zoetis). 
The ewe was then transferred into the surgery room and onto the operating table where the 
4 limbs were secured to the table with adjustable ropes. From this point, the anaesthesia was 
maintained by 1.5-2% isofluorane in 5:1 oxygen:nitrous oxide mixture using positive pressure 
ventilation in an automatic set-up (Manley Pulmovent Model MPP; Ohmeda, GE Healthcare, 
Amersham, UK). The tidal volume was set at approximately 10ml/kg and pressure was 
20cmH2O. Waste gases were scavenged. Throughout the maintenance of anaesthetic the ewe 
was closely monitored and records taken of the heartrate, pO2, pCO2 and breathing rate at 
approximately 10 minute intervals. The oxygen flow rate or the percentage isofluorane could 
be adjusted accordingly.  
All shaved areas were washed using swabs by wiping from the midline where the incision 
would be made and working outwards in order to cover the whole area. Initially, HibiScrub 
Surgical Scrub (4% w/v chlorhexidine gluconate diluted 1:10 in 80% ethanol; Mölnlycke Health 
Care Ltd., Lancashire, UK) was applied. Secondly, iodine solution (7.5% w/v povidone-iodine; 
Animalcare Ltd, York, UK) was applied and any excess removed before 100% ethanol was 
applied and the area thoroughly dried. From this point aseptic techniques were followed.  
An incision (~15cm) was made through the abdominal skin to the side of the mammary vein, 
and any bleeding controlled using monopolar diathermy (Solstar Diathermy; G.U. 
manufacturing Co. Ltd., London, UK). The underlying fascia and peritoneum were cut to 





Before making an incision into the uterus, each fetus was manipulated in order to make a 
small incision (~5cm) by the fetal head using the diathermy, avoiding any major vessels and 
placentomes. All membranes were cut and the head and neck were brought through the 
incision and clamps put in place to minimise amniotic fluid loss. A 1-2cm incision was made in 
the fetal neck and blunt dissection used to locate the thyroid glands which were then removed 
by cauterisation. The incision was sewn up using continuous stitching and the fetus placed 
back into the uterus. All membranes were brought together and tightly tied to prevent fluid 
loss and the uterus was sewn up by continuous infolding of the uterine wall. Intra-amnion 
antibiotics were given (560mg benzylpenicillin; Crystapen, Genus Pharmaceuticals, Newbury, 
Berkshire, UK). The whole procedure was then repeated on the second fetus, although after 
making the incision on its neck the thyroid glands were exposed but left intact.  
The uterus was replaced and the peritoneum sewn up using interrupted stitches and the skin 
sewn using continuous stitching to allow the skin to heal (Polypropylene non-resorbable 
suture; Ethicon, Livingstone, UK). Ewes received intramuscular antibiotics of 15mg/kg 
Depocillin (Intervet UK Ltd) and 20mg/kg Terramycin (Zoetis). In some cases, where the ewes 
coughed post-surgery, this was supplemented with a third antibiotic: 2mg/kg Draxxin 
(Tulathromycin; Zoetis) given intramuscularly on the day of surgery and 3 days following 
surgery.  A tubular bandage was put around the abdomen of the ewe for additional support 
(Tubigrip; Mölnlycke Health Care Ltd).  
 
2.2.2.2 Catheterisation 
After exposure of the uterus, each fetus was manipulated in order to make a small incision 
(5cm) by the fetal hindlimbs by diathermy. All membranes were cut and the hindlimbs were 
brought through the incision and clamps put in place to minimise amniotic fluid loss. An 
incision was made using the diathermy into the inner thigh between the knee and the femoral 
triangle. Blunt dissection was used to locate branches of the femoral artery and vein. Two 
pieces of ligature were wrapped around each vessel using an aneurysm needle and a clamp 
was placed onto the artery. A sterilised catheter was filled with saline (0.9%; Aqupharm; 
Animalcare Ltd) containing heparin (100units/ml; Wockhardt UK Ltd, Wrexham, UK) and the 
end cut to length (~10cm) diagonally to a point.  A small horizontal cut was made into the 




catheter end fed into the vessel towards the abdomen. The catheter was tied into place and 
the patency of the catheter tested by drawing blood into the catheter before flushing in 5ml 
heparin-saline, clamping under pressure and placing a sterilised pin into the end of the 
catheter. This was repeated with the fetal femoral vein. Antibiotics were given to the fetus 
(560mg benzylpenicillin); half were given via the venous catheter and half via the intra-
amniotic route. The incision was closed around the protruding catheters which were 
subsequently secured to the fetal skin to minimise pull on the catheter due to fetal 
movements. The amnion and uterus were sewn up as described previously (Section 2.2.2.1) 
around the catheters. When applicable, the process was repeated on the second fetus, using 
catheters of different colours to differentiate between each fetus and the vein or artery. The 
catheters were exteriorised at the dorsal flank of the ewe, the uterus returned and the 
peritoneum and skin sutured as described in section 2.2.2.1. 
An incision was made into the maternal femoral triangle and blunt dissection used to locate a 
branch of the superficial femoral artery. As with the fetal artery, a ligature was put in place 
around the vessel and a clamp put in place to cut the blood supply. A sterilised PTFE catheter 
was filled with heparin-saline and inserted 30cm through a small incision made into the vessel 
wall. The catheter was secured and 5ml heparin-saline was flushed through the catheter, 
clamped under pressure and pinned. The catheter was threaded subcutaneously to be 
exteriorised through the same point in the dorsal flank of the ewe as the fetal catheters and 
the incision at the leg was sutured using polypropylene non-resorbable suture (Ethicon) as for 
the abdominal skin. The ewe was turned onto her side and a PVC-coated, zip-opening bag 
sewn to the skin in which the exteriorised catheters were contained. Ewes received 
intramuscular antibiotics and a tubular bandage was used for support as described previously 
(Section 2.2.2.1).  
 
2.2.3 Post-surgery care 
The ewes were taken off anaesthetics and supplied with oxygen until they took breaths 
unaided. At this point the endotracheal tube was removed and they were transferred into a 
cot for recovery. They were closely monitored until they were standing and eating and were 
able to be transferred to the individual holding pen.  Here they were given hay, water and 




following surgery ewes were given a further dose of 15mg/kg Depocillin and their wellbeing 
was regularly checked. Pens were swept daily and cleaned thoroughly on a twice-weekly basis. 
One week following surgery ewes carrying thyroidectomised fetuses had their tubigrip 
bandage removed and one week later the abdominal skin sutures were taken out. Pregnancy 
continued until 125-129d (n=6 ewes) or 140-145d (n=6 ewes). Those in the latter group were 
able to be group housed indoors following the removal of their sutures.  
All ewes which had undergone catheterisation were kept in the individual holding pens until 
they were euthanised in order to maintain sterility.  
 
2.2.3.1 Blood Sampling 
All catheters were flushed daily with 5ml heparin-saline and a 0.4ml blood sample was taken 
from the fetal and maternal arteries in order to monitor the fetal and maternal well-being. As 
soon as possible after the sample was taken, blood glucose and lactate levels were measured 
using a YSI 2300 Stat Plus glucose and lactate analyser (YSI Incorporated, Ohio, USA) and blood 
pH, haemoglobin, pO2, percentage oxygen saturation, pCO2 and HCO3 levels were measured 
using an ABL90 Flex Analyzer (Radiometer, Crawley, UK). In addition, throughout the infusion 
period (section 2.2.3.2) 4ml blood was taken from the fetal artery into heparin coated tubes. 
Samples were centrifuged at 5000rpm at 4°C for 5 minutes and the plasma stored at -20°C for 
future hormone analysis.  
 
2.2.3.2 Infusion  
Following a recovery period of at least 5 days after surgery a larger PVC-coated, zip-opening 
bag was secured to the tubigrip bandage over the position of the catheter-containing bag on 
the side of the ewe. The fetal vein catheters were connected to a syringe held in a pump set 
to infuse 3ml over a 24 hour period, with this set-up held in the larger bag. With the 
catheterised twin, one of each pair was randomly assigned to receive a continuous infusion of 
T3 (8-12µg/kg/day; Sigma-Aldrich, Gillingham, Dorset, UK) while the other twin received a 
continuous saline infusion (0.9%NaCl, 3ml/day) into the femoral vein. The fetuses were 
infused for a 5-day period until they were 127-130d (Table 2.1). Singleton fetuses were 




(Hydrocortisone as the sodium succinate); Pharmacia, Kent, UK) or a continuous saline 
infusion (0.9%NaCl, 3ml/day) into the femoral vein. The fetuses were infused for a 5-day 
period until they were 128-131d (Table 2.1).  
 
2.2.4 Tissue and plasma collection 
2.2.4.1 Fetuses 
Before euthanasia of uncatheterised animals, a 10ml blood sample was taken from the 
maternal jugular vein, divided into heparin and EDTA coated tubes which were kept on ice. 
The ewes were euthanised by an intravenous overdose of anaesthetic (200mg/kg sodium 
pentobarbitone; Pentoject, Animalcare Ltd,). Immediately the breathing and the heartbeat 
had stopped, the abdomen and uterus were opened in order to expose the fetus(es). A 10ml 
blood sample was taken from the umbilical artery of each fetus which was divided into heparin 
and EDTA coated tubes and kept on ice. All blood samples were centrifuged at 5000rpm at 4°C 
for 5 minutes and the plasma stored at -20°C for future hormone analysis. Fetuses were 
euthanised by an injection of a lethal dose of sodium pentobarbitone into the umbilical vein 
(200mg/kg). The umbilical cord was tied and cut to deliver the fetus. With twins, it was 
randomised as to which twin (TX/sham or T3/saline infused) was delivered first. 
Immediately following fetal euthanasia, the fetus was weighed and biometric measurements 
taken including the crown-rump length (CRL) and limb lengths. Samples of the 3 skeletal 
muscle types, biceps femoris, semitendinosus and superficial digital flexor were immediately 
dissected and weighed. A portion from the centre of each muscle (Kohn and Myburgh, 2007) 
was collected into preservation medium (section 2.3.2). A second portion of the muscle, also 
from the central region was fix-frozen by being immersed in phosphate buffered saline (PBS; 
Oxoid Limited, Basingstoke, UK) in order to remove blood from the section, before transferring 
to isopentane, which had been pre-cooled using dry ice, for 20 seconds. The fix-frozen tissue 
was then stored at -80°C until required and the remaining tissue was snap-frozen in liquid 
nitrogen and stored at -80°C. Other tissues including the brain, heart, liver, lung, gastro-
intestinal tract, kidneys, adrenal glands and gonads were also collected, weighed and fixed 
and frozen for separate studies beyond the scope of this thesis.  All frozen samples were kept 





2.2.4.2 Newborn Lambs 
One lamb from a pair of 1-2 day old twins, where the ewe had not undergone any form of 
surgery, was selected randomly for tissue collection. A 10ml blood sample was collected from 
the jugular vein for hormone analysis. The lambs were euthanised by an intravenous overdose 
of anaesthetic (200mg/kg sodium pentobarbitone). Biometric measurements were taken, and 
tissues dissected, weighed and collected as for the fetuses.  
 
2.3 Experimental Procedures 
2.3.1 Plasma Hormone concentrations 
Fetal and neonatal plasma hormone concentrations were measured in previously unthawed 
aliquots of heparinised plasma using immunoassays and samples were run in duplicate. 
Cortisol values were measured using a commercial enzyme-linked immunoassay for human 
serum and plasma (IBL International, Hamburg, Germany), previously validated for use with 
sheep plasma (Vaughan et al., 2016). Two control samples (68.7±1.5ng/ml and 
214.3±4.5ng/ml) were run in duplicate across the 5 plates. From the results of the control 
samples the calculated inter-assay variation was 4.80% and the intra-assay variation was 
2.65%. The limit of detection of the assay was 5.2ng/ml as determined by the value of 2 
standard deviations subtracted from the zero standard value averaged across the 5 plates. 
The cross reactivity of the assay, as stated by the manufacturer, was 1.4% for corticosterone, 
7% for 11-desoxy-cortisol, 0.4% for 17α-OH-progesterone and 0.9% for desoxycorticosterone 
which have been previously detected in fetal sheep plasma (Thomas et al., 1976, Jensen et al., 
1988, Magyar et al., 1981).  
Fetal total T3 and T4 were measured using radioimmunoassays  (RIA; MP Biomedical; Santa 
Ana, USA) previously validated for use with sheep plasma (Lanham et al., 2011). For the total 
T3 RIA kit, interassay variation was 7.59% and intra-assay variation was 2.28%. The limit of 
detection of the assay was 0.1ng/ml. The cross reactivity of the assay, as stated by the assay 
manufacturer, was 0.18% for T4 and 0.44% for T2. For the T4 total mAb RIA kit, interassay 
variation was 4.57% and intra-assay variation was 3.04%. The limit of detection of the assay 
was 11.3ng/ml. The cross reactivity of the assay, as stated by the assay manufacturer, was 1% 





2.3.2 Biochemical Composition 
2.3.2.1 Water content 
100-200mg samples of frozen tissue were cut, weighed, allowed to defrost at room 
temperature and freeze-dried for 24 hours (Edwards Modulyo Freeze-Dryer System; Edwards 
Limited, Crawley, UK). Samples were reweighed and the percentage water content of the 
tissue was calculated.  
 
2.3.2.2 Protein Content 
Frozen skeletal muscle samples (55mg ± 10%) were cut on dry ice and placed in tubes for 
homogenisation (FastPrep Lysing Matrix A; MP Biomedical) with 300µl lysis buffer (20mM 
Trizma-hydrochloride (pH7.5), 150mM NaCl, 1mM Na2EDTA, 1mM EGTA, 1% Triton, 2.5mM 
sodium pyrophosphate, 1mM β-glycerophosphate, 1mM sodium orthovanadate and 
containing cOmplete mini protease cocktail inhibitor (Sigma)). The samples were ribolysed at 
6000rpm for 2x30 seconds with 5 minutes on ice in between. 200µl more lysis buffer was 
added, tubes were ribolysed for a further 30 seconds at 6000rpm and kept on ice for 20 
minutes in order to dissociate the proteins. Tubes were centrifuged at 10,000rpm for 10 
minutes at 4°C, the supernatant collected and centrifuged at 14,000rpm for 15 minutes at 4°C. 
The supernatant was collected and kept on ice. 
The protein concentration of the samples was determined using a Bicinchoninic Acid (BCA) 
assay (Sigma). Bovine serum albumin (BSA; 1mg/ml; Sigma) was diluted to produce a standard 
curve on each 96-well assay plate. All samples from groups to be directly compared were run 
in duplicate on the same plate. Protein content is expressed as mg protein per gram tissue 
(wet weight) and as mg protein/mg dry weight. 
 
2.3.2.3 Glycogen content 
Samples of frozen tissue (~100mg) were powdered, weighed and homogenised in 500µl ice 
cold distilled water. 100µl homogenate was incubated in acetate buffer (pH4.5) at 55°C in a 
water bath for 10 minutes before amyloglucosidase (70 units/reaction) was added and 
incubated at 55°C for a further 10 minutes. Reaction mixtures were also set up for each sample 
omitting the amyloglucosidase. The reaction was halted upon addition of 500µl of 0.3M zinc 




contents were centrifuged for 10 minutes at 3000rpm. The glucose concentrations of the 
supernatants were measured using a YSI 2300 Stat Plus glucose and lactate analyser (YSI 
Incorporated) and the tissue glycogen content (mg) per gram of tissue wet weight and per mg 
dry weight was calculated.  
 
2.3.2.4 Lipid Content  
The lipid content of the BF muscle was determined using the Folch method (Folch et al., 1957). 
Frozen tissue chunks (~100mg) were cut into small pieces, weighed and ribolysed in 1ml Folch 
mixture (2:1 chloroform:methanol) for 6x30 seconds at 6000rpm in FastPrep tubes containing 
Lysing Matrix C (MP Biomedical). 200µl of water was added and the samples shaken for 1.5 
hours. Tubes were centrifuged at 15000rpm for 10 minutes and 400µl was collected from the 
lipid phase into pre-weighed soda glass specimen tubes. The contents were dried at 37°C in a 
heat block overnight and the remaining lipid weighed after 24 hours. The lipid content is 
expressed as mg lipid/g tissue and mg lipid/mg dry tissue weight. 
 
2.3.3 Respirometry 
Respirometry was carried out as described previously for skeletal muscle samples (Pesta and 
Gnaiger, 2012, Kuznetsov et al., 2008). Immediately after euthanasia, a small section of all 3 
muscles were collected into ice cold biopsy preservation medium (BIOPS; pH7.1 solution 
containing 10mM Ca-EGTA buffer, 0.1µM free Ca2+, 1mM free Mg2+, 20mM imidazole, 20mM 
taurine, 50mM K-MES, 0.5mM ditriothreitol (DTT), 6.56mM MgCl2, 5.77mM ATP and 15mM 
phosphocreatine). Samples were kept in BIOPS medium on ice for dissection of the sample 
into 2-3mg pieces. Connective tissue was removed and the individual fibres teased apart by 
blunt dissection. Fibre plasma membranes were permeabilised in saponin solution (100µg/ml 
BIOPS; Sigma-Aldrich), gently rocking for 20 minutes at 4°C. Permeabilised samples were 
transferred into MiR05 (pH7.1 solution containing 20mM HEPES, 0.46mM EGTA, 2.1mM free 
Mg2+, 90mM K+, 10mM Pi, 20mM taurine, 110mM sucrose, 60mM lactobionate and 1g/l BSA) 
for 2 x 5 minute washes on ice to remove excess saponin and wash out intracellular 
metabolites.  
Four Clark-type electrodes (Strathkelvin Instruments, Glasgow, UK) were used for the 




and pump. 500µl MiR05 was added to each chamber, allowed to warm to 37°C and computer-
calibrated to air-saturated respiratory medium following stirring (210.3μM oxygen) prior to 
each experiment. One permeabilised muscle sample was added to each chamber, which was 
then sealed ensuring all air bubbles were removed. After a baseline period, substrates were 
introduced into the chambers according to 3 different protocols as outlined in Figure 2.1 
(Gnaiger, 2012).  
Protocol 1) Malate (2mM; Sigma) and pyruvate (Py; 5mM; Sigma) were added followed by ADP 
(10mM; Sigma). Py, the product of glycolysis as the first stage in carbohydrate metabolism, is 
transported into the mitochondrion and converted to Acetyl-CoA which enters the TCA cycle 
(Figure 1.1). Thus, protocol 1 measured oxphos via complex 1, limited by flux via the TCA cycle 
(Gnaiger, 2012). 
Protocol 2) Malate (2mM) and palmitoyl-carnitine (PC; 40µM; Sigma) were added before ADP 
(10mM). PC is transported into the mitochondrion and processed before entering the β-
oxidation pathway (Figure 1.2). Oxygen consumption following this protocol is believed to be 
limited by the β-oxidation capacity (Gnaiger, 2012). Py was added subsequently, and the 
proportion of the maximal oxygen consumption accounted for by PC-supported oxygen 
consumption could be determined.  
Protocol 3) Malate (2mM) and glutamate (10mM; Sigma) were added followed by ADP 
(10mM) and succinate (10mM; Sigma), a well-established protocol to measure the maximal 
total electron flux through complexes I and II of the ETS (Pesta and Gnaiger, 2012). Rotenone 
(0.5µM; Sigma), an inhibitor of complex I activity, was added and the chamber was 
reoxygenated after the addition of rotenone by lifting the seal for ~1 minute. Oxygen 
consumption was not significantly affected upon the addition of rotenone, and there were no 
differences between treatment groups which may be due to insufficient time of rotenone 
exposure for its uptake and inhibitory effect. Therefore, the results following rotenone 
addition have not been presented. 
The rate of oxygen uptake was calculated after the addition of the tissue and each substrate. 
Results were excluded if the rate of oxygen uptake over the baseline period, before substrates 
were added, exceeded 0.001µmol oxygen/minute as this would indicate insufficient 
permeabilisation of the cell membrane. A measure of the leak state respiration was taken 




when the rate of oxygen consumption stabilised following ADP addition. The respiratory 
control ratio (RCR) was then calculated as the ratio of respiration rate after the addition of 
ADP to the respiration rate before ADP. All RCR values for Py- and glut-supported respiration 
were within the limits of previously reported data, indicating good coupling between oxidation 
and phosphorylation and mitochondrial inner membrane integrity (Kuznetsov et al., 2008).  All 
3 protocols ended with the addition of cytochrome c (10µM; Sigma) in order to check the 
integrity of the outer mitochondrial membrane and results were excluded if there was an 
increase in oxygen consumption of 15% or more upon cytochrome c addition (Kuznetsov et 
al., 2008). The entry points of all the substrates are shown on sample traces in Figure 1.1.   
Muscle samples were removed at the end of the protocol and the chambers were thoroughly 
washed with water and 70% ethanol to remove all traces of substrates before beginning a new 
experiment. After protocol 3, 100% ethanol was used for 45 minutes in order to remove all 
traces of rotenone. The samples were dried at 80°C for 48 hours and weighed in order to 
normalise the results to the tissue dry weight. Results are given as ADP-coupled oxygen 


















Protocol 1: Carbohydrate oxidative metabolism  
 
Protocol 2: Fatty acid and carbohydrate oxidative metabolism  
 
Protocol 3: Total oxphos; metabolism through complexes I and II of the ETS 
 





2.3.4 Mitochondrial Enzyme Activity 
2.3.4.1 Sample Preparation 
Frozen muscle samples from the middle depth region of muscle (Kohn and Myburgh, 2007) 
were powdered and manually homogenised in 300µl buffer (pH 7.2; containing 20mM HEPES, 
1mM EDTA, 50mM sodium fluoride, 10mM sodium dichloroacetate and 0.1% triton). Samples 
were centrifuged for 30 seconds at 4000rpm at 4°C and the supernatant collected. The protein 
content of the supernatant was measured in duplicate using a Bicinchoninic Acid (BCA) assay 
using BSA to produce a standard curve on each 96-well assay plate.  
 
2.3.4.2 Citrate Synthase Assay 
As a putative marker of mitochondrial density (Larsen et al., 2012), citrate synthase (CS) 
activity was measured spectrophotometrically as described previously (Murray et al., 2008) 
using an Evolution 220 UV-visible spectrophotometer (ThermoScientific). Homogenised 
skeletal muscle protein (30µg) was added to the assay buffer (pH8, 20mM Tris-base) 
containing 0.1mM 5,5’-Dithio-bis(2-nitrobenzoic acid) (DTNB; Sigma). Oxaloacetate (1mM; 
Sigma) was added and the mixture warmed for 3 minutes to 37°C. Citrate synthase catalyses 
the reaction between acetyl-CoA and oxaloacetate (Equation 2.1), and the product, CoA-SH, 
reacts with DTNB to produce the absorbing product, TNB (Equation 2.2). The absorbance at 
412nm was measured at 5 second intervals for a baseline reading of 3 minutes before acetyl-
CoA (0.3mM; Sigma) was added and the absorbance measured over 9 minutes.  The maximal 
rate of change over a 3 minute period was used to determine the CS activity and every sample 
was run in duplicate. The activity is expressed per mg protein.    
 
𝐴𝑐𝑒𝑡𝑦𝑙 − 𝐶𝑜𝐴 + 𝑂𝑥𝑎𝑙𝑜𝑎𝑐𝑒𝑡𝑎𝑡𝑒 + 𝐻2𝑂 → 𝐶𝑖𝑡𝑟𝑎𝑡𝑒 + 𝐶𝑜𝐴 − 𝑆𝐻 
Equation 2.1 Reaction catalysed by citrate synthase 
𝐶𝑜𝐴 − 𝑆𝐻 + 𝐷𝑇𝑁𝐵 → 𝑇𝑁𝐵 + 𝐶𝑜𝐴 − 𝑆 − 𝑆 − 𝑇𝑁𝐵 






An initial optimisation was performed in order to determine the protein quantity to use for 
each reaction. Reaction saturation was confirmed through doubling the concentrations of 
both oxaloacetate and acetyl-CoA with no increase in CS activity. Further, readings were taken 
for an additional 15 minutes for samples of all groups to confirm no increase in maximal rate 
of change, with and without the addition of more oxaloacetate and acetyl-CoA. Citrate 
synthase (0.04 units; Sigma) replaced sample protein as a positive control.  
 
2.3.4.3 HOAD assay 
The activity of β-hydroxyacyl-CoA dehydrogenase (HOAD), part of the β-oxidation pathway, 
was measured spectrophotometrically in the BF as described previously (McClelland et al., 
2005) using an Evolution 220 UV-visible spectrophotometer (ThermoScientific). 20µg 
homogenised skeletal muscle protein was added to the assay buffer (pH7.4 containing 50mM 
imidazole and 0.1% triton X-100). NADH (0.15mM; Sigma) was added and the mixture warmed 
for 6 minutes to 37°C. The absorbance at 340nm was measured at 5 second intervals for a 
baseline reading of 3 minutes before acetoacetyl-CoA (0.1mM; Sigma) was added and the 
absorbance measured over a further 3 minutes. HOAD catalyses the conversion of 
acetoacetyl-CoA to β-hydroxyacyl-CoA while NADH is oxidised to NAD+ (Equation 2.3; Stern, 
1957). NADH absorbs 340nm wavelength light and thus the rate of change of 340nm 
absorbance over this 3 minute period was used to determine the HOAD activity. Every sample 
was run in duplicate and results are expressed per mg protein. 
𝐴𝑐𝑒𝑡𝑜𝑎𝑐𝑒𝑡𝑦𝑙 − 𝐶𝑜𝐴 + 𝑁𝐴𝐷𝐻 ↔  𝑁𝐴𝐷+ +  𝛽 − ℎ𝑦𝑑𝑟𝑜𝑥𝑦𝑎𝑐𝑦𝑙 − 𝐶𝑜𝐴 
Equation 2.3 Reaction catalysed by β-hydroxyacyl-CoA dehydrogenase 
An initial optimisation was performed in order to determine the protein quantity to use for 
each reaction. Reaction saturation was confirmed through doubling the concentrations of 
both NADH and acetoacetyl-CoA and there being no increase in HOAD activity. Further 
readings were taken for an additional 6 minutes for samples of all groups to confirm no 





2.3.5 Protein expression by Western Blotting 
2.3.5.1 Sample preparation 
Protein was extracted as described in section 2.3.2.1. The samples were diluted to give a final 
concentration of 2.5µg/µl in a 0.2M Tris-HCl solution (pH6.8) containing 8% sodium dodecyl 
sulphate (SDS), 6% DTT, 40% glycerol and bromophenol blue. Samples were heated to 80°C 
for 5 minutes, before being aliquoted and stored at -20°C until use. 
 
2.3.5.2 SDS-PAGE 
Acrylamide gels were prepared the day prior to the samples being run and kept at 4°C 
overnight. The separating gel (pH8.5, containing 0.01% SDS and 10-14% acrylamide, the 
percentage determined according to the molecular weight and relative abundance of the 
protein of interest; Table 2.2) was pipetted into the chamber created between glass plates. 
Isobutanol was layered over the gel to ensure the gel set evenly and it was left to set for at 
least 30 minutes. The isobutanol was removed and any remaining was washed away and the 
plates blotted dry. The stacking gel (pH6.8 containing 4% acrylamide and 0.1% SDS) was 
prepared, pipetted onto the separating gel, a 15- or 21-well plastic comb inserted and left to 
set for at least 30 minutes.  
The combs were removed and the wells thoroughly washed with milliQ water. Gels were 
placed in the gel tank which was filled with electrophoresis buffer (2.5mM Tris-base, 25mM 
glycine and 0.01% SDS).  Table 2.2 gives the specific conditions when blotting for the specific 
target proteins. In general, the 1xSDS sample solutions were heated before 10µl or 20µl was 
loaded into the wells. Either a 14-well (20µl; 50µg protein) or a 21-well (10µl; 25µg protein) 
set up was used in order to compare all samples from relevant treatment groups on one gel 
and avoid comparing across gels. A pre-stained protein ladder was run alongside the samples 
for comparison of the protein band molecular weights (Thermo Scientific; 26616). 
Additionally, a well with half the protein content was run on every gel. The samples were run 
on ice for 30 minutes at 60V followed by 2.5-3.5 hours at 110V. 
Proteins were transferred to a nitrocellulose membrane (VWR, Lutterworth, UK) using a semi-
dry transfer cell (Bio-Rad Laboratories, Hemel Hempstead, UK). Filter paper, membrane and 
gel were soaked in transfer buffer (8mM tris-base, 39mM glycine, 0.037% SDS in 4:1 




The membranes were stained using Ponceau-S (Sigma) in order to normalise protein loading. 
Membranes were blocked using 5% milk protein in tris-buffered saline containing 0.1% Tween-
20 (TBS-T) for 1 hour at room temperature followed by incubation with the primary antibody 
(Table 2.2) diluted in a solution of TBS-T containing 0.02% sodium azide overnight at 4°C 







Table 2.2 Western Blotting Antibody Specifications. 





Primary Antibody Primary 
Antibody 
Dilution in TBS-T 
Secondary Antibody Secondary 
Antibody Dilution 
in TBS-T 
ETS complexes I-IV 
and ATP-synthase 
40°C for 5 
minutes 




1:250 HRP-linked sheep 
anti-mouse IgG (GE 
Healthcare; NIF825) 
1:5000 





1:1000 in 5% 
milk 
HRP-linked donkey 
anti-rabbit IgG (GE 
Healthcare; NA934V) 
1:5000 in 2.5% milk 
p-AMPKα (T172) 70°C for 5 
minutes 
10% Cell Signalling 
Technology 
#2535 (CST; New 
England Biolabs, 
Hitchin, UK) 
1:1000 HRP-linked donkey 
anti-rabbit IgG (GE 
Healthcare; NA934V) 
1:5000 in 2.5% milk 
AMPKα 70°C for 5 
minutes 
12% CST #2532 1:1000 HRP-linked donkey 
anti-rabbit IgG (GE 
Healthcare; NA934V) 
1:5000 in 2.5% milk 
TBS-T, tris-buffered saline containing 0.1% Tween-20; ETS, electron transfer system; ANT1, adenine nucleotide translocase 1; 




Excess primary antibody was removed in 2x20 minutes washes in TBS-T. Membranes were 
incubated with the secondary antibody (Table 2.2) for 1 hour at room temperature, before 
excess was removed in a further 2x20 minutes washes in TBS-T. Enhanced chemiluminescence 
(ECL) detection reagent (GE Healthcare) was used to visualise the protein bands on Hyperfilm 
ECL (GE Healthcare).  
The ponceau-S staining and the protein band intensities were quantified using ImageJ 
software (http://rsb.info.nih.gov/ij/). Ponceau-S staining was analysed in order to determine 
the variance of protein loading and the band intensity of the lane with half the loaded protein 
was used in order to ensure the antibody signal was not saturated and was kept in the linear 
range. Values of protein abundance were expressed normalised to Ponceau-S staining. 
 
2.3.5.3 Primary Antibody Information  
None of the antibodies used had been previously tested for use on sheep tissue.  The specific 
targets and homology to the sheep protein (as determined using Protein Blast) are outlined in 
Table 2.3. The 5 targets of the oxphos antibody cocktail were selected as they are labile when 
the complex is disassembled and are of different molecular weights such that they are easily 







Table 2.3 Western blotting antibodies: target protein information 
Target Subunit against which the antibody was 
raised 
Homology to sheep protein Molecular weight (kDa) 
Oxphos antibody 
cocktail: Complex I 




cocktail: Complex II 




cocktail: Complex III 




cocktail: Complex IV 
Cytochrome c oxidase (human; temperature 
sensitive)  
96% 57 (band at 40) 
Oxphos antibody 
cocktail: ATP-synthase 
ATP synthase F1 α subunit (cow) 99% 53 
ANT1 Synthetic peptide based on human ANT1 
amino acids 35-84 
100% 33 
p-AMPKα (T172) Synthetic peptide based on the human 
sequence 
98% 62 
AMPKα Synthetic peptide based on the human 
sequence 
98% 62 
TBS-T, tris-buffered saline containing 0.1% Tween-20; ETS, electron transfer system; ANT1, adenine nucleotide translocase 1; (p)AMPKα, 






2.3.6 Gene Expression 
2.3.6.1 RNA Extraction 
The work area used for RNA extraction was cleaned with 70% ethanol and RNAseZAP 
(ThermoScientific) prior to use. Frozen skeletal muscle samples were powdered using a pestle 
and mortar on dry ice. In batches of up to 10 samples, the powdered tissue was added to 1ml 
Trizol (ThermoScientific) and vortexed frequently over a 5 minute period. After 5 minutes, 
200µl chloroform was added and the mixture was vortexed for 2x15 seconds, 1 minute apart. 
Tubes were centrifuged at 14000rpm for 10 minutes and 200µl of the upper aqueous phase 
was collected for RNA extraction using RNeasy Plus Mini Kit (Qiagen, Manchester, UK). 700µl 
buffer RLT Plus (containing 1% β-mercaptoethanol) and 500µl ethanol were added and the 
solution was passed through RNeasy GenElute Columns in order to bind the RNA to the silica 
membrane. The RNA was washed according to the protocol contained with the Qiagen RNeasy 
Plus Kit. To the column were added buffer RW1 (to remove biomolecules including proteins, 
carbohydrates and fatty acids while leaving RNA molecules longer than 200bp bound to the 
membrane) and buffer RPE (to remove any salt traces). Columns were centrifuged at 
10000rpm for 15 seconds and the flow-through discarded. The membrane was dried to 
remove all traces of ethanol and the RNA was eluted in 30µl of RNAse-free water. The 
concentration of the eluted RNA was measured using a Nanodrop ND-1000 
spectrophotometer and the RNA purity was assessed by the 260/280nm ratio being close to 
2.0. RNA was diluted to 50ng/µl in RNAse-free water. 
 
2.3.6.2 cDNA Synthesis 
Reverse transcription (RT) was performed to synthesise complementary DNA (cDNA; High 
Capacity cDNA Reverse Transcription Kit; Applied Biosystems, California, USA). An equal 
volume of RT mastermix (containing RT buffer, dNTP mix, random primers and reverse 
transcriptase) and RNA were combined, briefly centrifuged and RT was run according to the 
recommended protocol: 25°C for 10 minutes, 37°C for 2 hours, 85°C for 5 minutes and then 
held at 4°C for up to an hour before dilution (GenePro Thermal Cycler; Alpha Laboratories, 
Eastleigh, Hampshire, UK). Control samples were also generated in reactions omitting the 
reverse transcriptase. Control and sample cDNA were diluted 10-fold and single-use aliquots 
stored at -20°C until use. Samples of cDNA were pooled, diluted 5-fold and stored in single-





Quantitative real-time polymerase chain reaction (qRT-PCR) was performed in triplicate on a 
7500 Fast Real-Time PCR System (Applied Biosystems) using a SYBR Mastermix (MESA BLUE 
qPCR Mastermix Plus for SYBR Assay; Eurogentec, Seraing, Belgium), a reaction mix containing 
MeteorTaq HotStart DNA polymerase and an inert blue dye for the detection of double 
stranded DNA.  The primer pairs for housekeeping genes and target genes are listed in Table 
2.4. Primer sequences were used that had been previously published as referenced in Table 
2.4, or were designed using Primer Blast (Ye et al., 2012). Ensembl (Release 89; Aken et al., 
2016) was used in order to ensure all primer pairs spanned an intron, and Primer Blast was 
used to make appropriate modifications to any primer pairs originally designed for species 
other than sheep. All primers were produced by Sigma. Primers were reconstituted to 100µM, 
diluted 10-fold and stored at -20°C in aliquots. In each reaction well, 6µl SYBR Mastermix, 
0.25µl forward and reverse primers, 2.5µl DNAse-free water and 3µl cDNA sample were 
added. Following the recommended protocol for the SYBR, an initial denaturation step (5 
minutes at 95°C) was followed by 40 amplification cycles (15 seconds at 95°C and 1 minute at 
60°C). Finally, a melting curve was run in order to ensure there was a single PCR product, with 
no non-specific amplicons or primer-dimers. This was also verified using a negative control 
containing water in replacement for the cDNA, and the control sample (produced with no 
reverse transcriptase) was run for each primer pair to ensure no amplification of any genomic 
DNA remaining in the mixture. The PCR products from every primer pair were run on a 1.5% 
agarose gel containing ethidium bromide to ensure a single product that was of the correct 
size.   
Data were analysed using the 2-ΔΔCt method (Schmittgen and Livak, 2008). Gene expression 
was expressed relative to the geometric mean of 2 housekeepers: 18S and S15 ribosomal RNA, 
and set relative to 1 experimental sample. This sample was chosen as the closest to the 
average in the 104dGA age group for the ontogeny study (Chapter 3) or the average in the 
relevant ~129dGA control groups for the TX and infusion studies (Chapters 4 and 5). The data 
from this sample were excluded from the calculations of the mean and SEM. An exception to 
this was the analysis of gene expression in the ontogeny study (Chapter 3) where only S15 was 
used as a housekeeping gene because 18S expression was significantly higher in the 104dGA 
group than the other 3 ages studied in the SDF, as analysed using the standard curve method 






Figure 2.2 18S gene expression in the superficial digital flexor. N=6 per group. Different letters 





Table 2.4 Forward and reverse primer sequences used for SYBR qRT-PCR. 
Target Gene 
and Protein 





F: ATCATTCTGCCCGAGATGGTG 134 (Yates et al., 2016) 
R: TGCTTCACGGGCTTGTAGGTG 
























F: AAGGCCCACCTAATGACAGA 128 Designed using Primer 













F: ATTGGTGAGGTGCTGTCTC 186 Adapted using Primer 
Blast R: TTCTGTCATGAGATAGGCTTT 
MFN2 
MFN2 
F: CATCAGCTATACTGGCTCCAACT 68 Adapted using Primer 
Blast R: AATGAGCAAAAGTCCCAGACA 
DNM1L 
DRP1 
F: CTGACACTTGTGGACTTGCC 277 Adapted using Primer 
Blast R: CCCTTCCCATCAATACATCC 
MCU 
MCU 
F: TTCACCAGATGGCGTTCGAGTTG 143 Modified from (Henzi 
and Schwaller, 2015) R: GTGTTGCTGCATTTTCATGGCT 
MICU1 
MICU1 
F: AAACAACCAGAACACTTGGGTC 140 Modified from (Henzi 
and Schwaller, 2015) R: AGTCCACATTCTCCAAGGGTGTA 
SOD1 
SOD1 








F: ATGGCCATGGACTTGGTTCT 74 Designed using Primer 
Blast R: CGCTCTCGGTTCTGCTCAAT 
THRB 
THRβ 
F: CAGTGCCAGGAATGTCGCTTT 116 Designed using Primer 
Blast R: TTCTCCCGGTTCTCCTCAATG 
NR3C1 
GR 
F: CCCAAGGAAGGCTTGAAGAGTC 228 Modified from (Myers 
et al., 2008) R: CTCTGGGAATTCAATACTCAT 
PGC1α, peroxisome proliferator-activated receptor γ coactivator 1α; NRF1, nuclear respiratory factor 1; 
MHCI/IIa/IIx, myosin heavy chain I/IIa/IIx; UCP2/3, uncoupling protein 2/3; ANT1, adenine nucleotide translocase 
1; MFN1/2, mitofusin 1/2; DRP1, dynamin-related protein 1; MCU, mitochondrial calcium uniporter; MICU1, 





2.3.7 Histological analyses 
2.3.7.1 Freeze fixing 
Tissue samples which had been fix-frozen in isopentane (Section 2.2.4) were transferred to      
-20°C for 24 hours before tissues were to be sectioned as this reduced the tissue fracturing 
when being cut. A cryostat (OTF5030; Bright Instruments, Luton, UK) was set at a specimen 
temperature of -18°C. A small transverse region of the muscle was mounted using TissueTek® 
optimum cutting temperature (O.C.T) compound (VWR) and 10µm sections were cut and 
transferred to glass slides. The slides were kept at -20°C until required. 
 
2.3.7.2 H&E staining 
Slides were brought to room temperature before staining. The sections were brought through 
a series of xylene, 100%, 80% and 70% alcohol in order to remove excess O.C.T. and rehydrate 
the tissue. Slides were placed in Gill’s haematoxylin (Sigma) for 10 minutes, washed in running 
tap water for 5 minutes and dipped twice in acid-alcohol (1% hydrochloric acid in 70% alcohol 
solution) for differentiation. Sections were placed in running tap water for 15 minutes to halt 
differentiation and to blue the sections.  This was followed by 4 minutes in 1% eosin solution 
(made up in 76% alcohol) and excess removed by dipping in tap water. Sections were 
dehydrated through increasing alcohol concentrations to xylene. DPX (Sigma) was used as the 
mounting medium.  
An Axio Imager A1 microscope (Zeiss, Cambridge, UK) was used to view the sections. Using 
the AxioCam MRc 5, 2 representative images were taken for each section at 40x magnification 
and were used to quantify the area of the field of view accounted for by fibres by using point 
counting on imagej. A grid of 140 points was superimposed on the image. The number of 
points covering fibres and their nuclei were quantified and expressed as a percentage. 
 
2.3.7.3 Immunofluorescence 
Immunohistochemistry of MHC isoforms has been previously shown to identify fibre types in 
developing skeletal muscle (White et al., 2001). Slides were fixed in acetone at -20°C for 5 
minutes, left to air-dry and a section demarcated using a PAP pen (Agar Scientific, Stansted, 
UK). Sections were permeabilised for an hour in TBS containing 0.1% Tween-20 and 0.1% 




albumin and incubated overnight at 4°C with a mouse anti-slow skeletal myosin heavy chain 
antibody (Abcam; ab11083) diluted 1:200 in TBS-TT. Excess antibody was removed in 3x10 
minute washes of TBS-TT before incubation for 1 hour at room temperature with Alexa Fluor™ 
488-conjugated donkey anti-mouse IgG (Abcam; ab150105) diluted 1:100 in TBS-TT. Slides 
were washed in TBS-TT (3x10 minute washes) and water (2x5 minute washes), and mounted 
using Vectashield Antifade Mounting Medium (Vector, Peterborough, UK). 
An Axio Imager A1 microscope was used to take 5 images per section at 20x magnification, so 
as to image at least 100 fibres per sample. Cellprofiler was used to analyse the images 
(Carpenter et al., 2006). A pipeline was designed to identify the fibres according to threshold 
pixel intensity, size and spherical shape to distinguish adjacent fibres (Figure 2.3). The number, 



















Figure 2.3 Examples of fibre outlines as determined by Cellprofiler. A&B) saline infused singleton fetus 




2.4 Statistical analyses  
All results are presented as mean ± standard error of the mean (SEM) and analyses were 
performed using GraphPad Prism Version 6.05 for Windows (www.graphpad.com). A 
Kolmogorov-Smirnov test was applied to test for a normal distribution. When only two groups 
were compared an unpaired Student’s t-test was applied if data were normally distributed and 
n≥5 per group. When data sets were n<5, or for data which did not fit the normal distribution 
a Mann-Whitney non-parametric test was used.  For the comparison of more than two groups, 
as for comparing the age groups in the ontogeny study (Chapter 3), a one-way analysis of 
variance (ANOVA) was applied. When groups were compared by the parameters of age and 
treatment a two-way ANOVA was used. When appropriate, a Tukey’s multiple comparison 
post hoc test was applied following a significant result from one- or two-way ANOVA. The 
Pearson product-moment correlation coefficient was used to assess linear correlation 
between variables and log-transformed hormone data. Partial correlation analysis was used 
to determine which variables had the greatest association. P<0.05 was considered significant 
and P<0.1 was considered a trend throughout. Details of the specific statistical analyses used 















3 Mitochondrial function in skeletal muscle: the transition from intra- 
to extrauterine life 
 
3.1 Introduction 
Over late gestation, maturation of fetal systems occurs to enable them to take on their new 
postnatal roles that ensure survival ex utero. Maturation of many fetal tissues involves a 
switch from cellular proliferation to terminal differentiation and this switch is often 
dependent on the maturational hormone, cortisol, which shows a prepartum surge in 
concentration in the fetus in most mammalian species studied to date (Fowden et al., 1998). 
Cortisol can directly regulate tissue maturation, while in some cases its maturational effects 
are mediated by other endocrine systems (Fowden et al., 1998). An example is T3, the 
bioavailability of which is increased by cortisol near term (Forhead and Fowden, 2014). 
In skeletal muscle over late gestation, cellular proliferation is downregulated alongside a drop 
in proliferative signals including IGF-I and an upregulation of myogenesis gene expression 
associated with terminal differentiation and tissue maturation (Brown, 2014, Forhead et al., 
2002, Du et al., 2010). Thus, from late gestation, muscle growth occurs predominantly by 
hypertrophy and thus impaired proliferation in utero tends to result in a reduced muscle mass 
which remains into adulthood (Brown, 2014). Functional development of skeletal muscle over 
late gestation involves a switch from the expression of fetal myosin to the adult ‘fast’ and 
‘slow’ myosin isoforms as the fibres differentiate into their fast and slow twitch phenotypes 
(Gambke et al., 1983). The proportion of fibre types is regulated by neural input and TH 
exposure (Gambke et al., 1983). The contractile phenotype also matures towards term with 
contraction and relaxation times of fast-twitch muscles decreasing towards term and the 
opposite being true in slow-twitch muscles (Javen et al., 1996). Metabolic development of 
muscle involves the increase in glycogen storage with gestational age, alongside an increased 
expression of glycogenolytic enzymes (Fowden et al., 1991). Evidently, fetal development is 
an energy demanding process and therefore the fetal mitochondria must be capable of 
generating adequate ATP. Studies on human infant muscle suggest a rise in mitochondrial 
activity and oxidative capacity with increasing gestational age (Sperl et al., 1992, Minai et al., 




development and therefore may have an effect on neonatal and adult health. However, little 
is known about the regulation of fetal mitochondrial function. 
At birth, the energy demands of tissues increase, and, as such, an increased oxygen 
consumption occurs in tissues including the liver and brain (Klein et al., 1983). Whilst skeletal 
muscle activity does occur in utero and activity increases with gestational age, whole body 
movements decrease towards term as space becomes limited (D'Elia et al., 2001). The function 
of muscle after birth is clearly significantly greater than beforehand, and it must be able to 
function immediately to enable precocial offspring, such as sheep, to be able to stand and 
walk within hours of birth. In addition to locomotion, skeletal muscle contraction is required 
for shivering. Both locomotion and thermogenesis are highly energy-consuming processes and 
therefore the muscle must be metabolically, as well as functionally, prepared for the 
challenges posed by the transition to extrauterine life. 
One such challenge faced by the neonate at birth is the switch from a continuous placental to 
an intermittent enteral nutrient supply (Mellor and Cockburn, 1986). Thus, tissues including 
liver and muscle have endogenous stores of carbohydrate ready for rapid mobilisation at birth. 
In addition, skeletal muscle begins to metabolise lipid at birth, and fetal muscle has been 
shown to contain lipid deposits (Beatty and Bocek, 1970), although in the sheep, FAs 
metabolised by muscle postnatally are likely to come predominantly from lipolysis in the liver 
and adipose tissue (Mostyn et al., 2003, Hull, 1975).  
As well as a change in nutrient supply at birth, the fetus must be prepared to cope with a 
change from a placental to a pulmonary supply of oxygen which, in turn, requires more energy 
to support continuous breathing. The neonate is also suddenly exposed to the much higher 
atmospheric pO2 than during placental oxygen delivery and therefore it rapidly switches to 
use predominantly oxidative metabolism for ATP generation (Papa, 1996). Further, during the 
uterine contractions of labour, the fetal blood supply is no longer continuous but 
intermittently reduced, thereby exposing the fetus to hypoxia-reperfusion events (Rogers et 
al., 1998). Both these changes in oxygen exposure are associated with an increased risk of ROS 
production (Rogers et al., 1998, Aledo, 2014). Increased ETS activity, driving an increased PMF, 
is also associated with enhanced ROS production (Aledo, 2014). Therefore, the fetus is faced 
with the challenge of preparing for increased energy demands immediately after birth while 




While interest in prenatal mitochondrial function is increasing due to the hypothesis that 
altered mitochondrial development in utero may predispose a range of adult-onset diseases 
(Lee et al., 2005), very few studies have investigated development of mitochondrial function 
in fetal skeletal muscle. Skeletal muscle is a highly metabolically active tissue, both in the fetus 
and the adult (Jones and Rolph, 1985, Hoppeler, 1999) so mitochondrial development in this 
tissue is likely to be an important component of the prepartum maturational process and 
essential for the successful transition to extrauterine life. 
 
3.2 Aim 
The aim of this study was to identify any changes in the oxidative capacity of the skeletal 
muscle over late gestation and early neonatal life, in order to provide the ATP necessary for 
maturation and postnatal function. An additional aim of this study was to determine whether 
the maturational hormones, cortisol or T3, correlated with any of the mitochondrial 
parameters and, thus, may have been responsible for driving any developmental changes 
















For the ontogeny study, 18 Welsh Mountain ewes carrying twins of known gestational age 
were used. At 102-105dGA, 6 of the ewes and their fetuses were euthanised and tissue 
samples taken immediately as described in general methods (Section 2.2.4.1). Tissues were 
taken from both twins, and respirometry (general methods; section 2.3.3) was carried out. 
Results and subsequent analyses are only shown for one fetus from each pair of twins, 
selected randomly in order to try and balance males and females (Table 2.1) and an equal 
number of fetuses delivered first and second were selected. 
The remaining 12 ewes were part of a separate study (detailed in Section 2.2). Briefly, the 
twin-bearing ewes underwent surgery under general anaesthesia at 102-105dGA. One of the 
fetuses was thyroidectomised while the second was sham-operated. Pregnancy continued 
until 125-129dGA (n=6 ewes) or 140-145dGA (n=6 ewes) when ewes and fetuses were 
euthanised and tissues collected (Section 2.2.4.1). It was randomised whether the TX or sham-
operated fetus was delivered first. The sham-operated fetuses were used for this ontogeny 
study. 
In addition, 6 newborn twin lambs were studied at 1-2 days old. They were euthanised and 
tissues collected (Section 2.2.4.2). Again only 1 lamb from a set of twins was used for this 
study. The average ages for the 4 groups are given in Table 3.1.   
 
Table 3.1 Ages for the 4 groups used in the ontogeny study 
Group name: 104dGA 127dGA 143dGA Newborn 
Age: 104±0.5dGA 127±0.7dGA 143±0.9dGA 1±0.2 days 
Mean±SEM ages. dGA, days of gestational age. N=6 in each group. 
 
Details of surgery, tissue collection and experimental protocols used in this chapter are given 





3.3.2 Statistical Analyses 
To compare age groups, a one-way ANOVA was applied. Following a significant result from the 
one-way ANOVA, a Tukey’s multiple comparison post hoc test was applied in order to 
determine which groups were significantly different from each other. Whilst a normal 
distribution and equal variance are assumptions of an ANOVA, the test has been shown to be 
robust to violations of these assumptions so long as the group sizes have n≥5 (Maxwell and 
Delaney, 1990). Therefore, nonparametric tests were not performed in place of ANOVAs 
except in the cases when groups had n<5, for example due to samples being necessarily 
excluded from the respirometry datasets. When this was the case a Kruskal-Wallis non-
parametric test was performed and a Dunn’s multiple comparisons test used to determine 
which groups were significantly different from one another.  
Relationships between variables and cortisol and T3 were determined using Pearson’s 
correlation using log-transformed hormone data. Partial correlation analyses were used to 


















3.4.1 Fetal and neonatal measurements 
Plasma hormone concentrations 
The fetal plasma cortisol and T3 concentrations showed a prepartum rise (P<0.0001 for cortisol 
and P<0.05 for T3 by one-way ANOVA considering only the 3 fetal ages; Figure 3.1 A&B). The 
concentration at 143dGA was significantly higher than at 104dGA in both cases. Applying a 
one-way ANOVA to all 4 groups there was a significant effect of age (P<0.0001 in both cases), 
with the concentration of both cortisol and T3 being significantly higher in the newborn lambs 
than at the 3 gestational ages studied (Figure 3.1 A&B). Cortisol and T3 showed a significant 
positive correlation when the data from all the fetal and newborn animals were combined 
(r=0.8468, n=23, P<0.0001). There was no difference in T4 concentration between the 4 age 






Figure 3.1 Mean±SEM plasma A) cortisol, B) T3 and C) T4 concentrations in fetuses at 104 (n=6), 
127 (n=6) and 143 (n=5) days of gestational age (dGA) and newborn lambs (n=6). Different 
letters are significantly different to each other (P<0.05 by Tukey’s post hoc test following one-
way ANOVA). Lower case letters include all 4 age groups, upper case letters include 104-










Fetal biometry and muscle biochemical composition 
Increasing age had a significant effect on body weight, fetal length and femur, tibia and 
metatarsus lengths (P<0.0001 in all cases except tibia length where P<0.05; Table 3.2). The 
weights of the individual muscles also increased significantly with age (P<0.0001 in all cases; 
Table 3.2). Age did not affect the ratio of muscle:body weight in the BF or ST, but the ratio of 
SDF:body weight was affected by age (P<0.05) and was significantly higher in the newborns 
than at 127dGA (Table 3.2). 
In all 3 muscles studied, age had a significant effect on muscle glycogen content (P<0.01). In 
general, the glycogen content was higher in late gestation than at 104dGA, but were lower in 
the newborn lambs (Table 3.2). Lipid content was only measured in the BF. Here, there was a 
significant effect of age (P<0.05), but unlike glycogen, lipid content in the newborn lambs was 
higher than at 104 and 127dGA (Table 3.2). Additionally, there was a significant effect of age 
on water content, which decreased with age (P<0.0001 in all muscles) and on protein content 
which increased with age (P<0.0001 in BF and P<0.01 in SDF; Table 3.2). 
As water content differed with age, the protein, glycogen and lipid content of the muscles are 
also expressed per mg dry weight (Table 3.2) and there remained a significant effect of age on 
all 3 biochemical measurements (P<0.0001 for protein and P<0.01 for lipid and glycogen 
content). However, the increase in lipid and protein content per gram wet weight of the 
muscles with age was no longer apparent when the water content was taken into account 











Table 3.2 Biometric and biochemical measurements. 
 104dGA 127dGA 143dGA Newborn 
Body weight (kg) 1.19±0.17 a 2.54±0.10 b 3.49±0.26 c 3.34±0.14 c 
Crown-rump length (cm) 31.5±0.9 a 41.8±0.8 b 45.0±0.5 c 49.6±1.0 d 
Femur (cm) 5.8±0.4 a 9.3±0.4 b 10.3±0.3 b 12.8±0.5 c 
Tibia (cm) 8.8±0.3 a 12.3±0.3 a,b 14.5±0.5 b 12.4±0.3 b 
Metatarsus (cm) 10.0±0.3 a 14.3±0.3 a,b 16.3±0.3 b,c 17.5±0.3 c 
 Biceps femoris 
Weight (g) 5.46±0.40 a 11.02±0.46 b 13.91±1.65 b,c 15.39±1.20 c 
Muscle:body weight ratio (g:kg 
x103) 
4.86±0.45  4.34±0.08 3.96±0.15 4.61±0.31 
Water content (%) 86.8±0.4 a 83.3±0.5 b 79.3±0.6 c 78.6±0.3 c 
Protein content     (mg/g wet wt) 









Glycogen content  (mg/g wet wt) 









Lipid content          (mg/g wet wt) 










Weight (g) 1.99±0.12 a 3.90±0.23 b 5.37±0.47 c 6.83±0.48 d 
Muscle:body weight ratio (g:kg 
x103) 
1.83±0.22 1.53±0.05 1.54±0.07 2.05±0.13 
Water content (%) 86.1±0.2 a 81.7±0.5 b 79.1±0.4 c 78.4±0.2 c 
Protein content     (mg/g wet wt) 










Glycogen content  (mg/g wet wt) 













 Superficial digital flexor 
Weight (g) 0.76±0.07 a 1.57±0.05 b 2.29±0.17 c 2.87±0.18 d 
Muscle:body weight ratio (g:kg 
x103) 
0.70±0.09 a,b 0.62±0.02 a 0.66±0.02 a,b 0.86±0.05 b 
Water content (%)  85.9±0.3 a 82.2±0.3 b 78.6±0.7 c 78.3±0.3 c 
Protein content     (mg/g wet wt)  









Glycogen content  (mg/g wet wt)  














Data are presented as mean±SEM of fetuses at 104, 127 and 143 days of gestational age (dGA) 
and newborn lambs. N=6 in all groups unless stated otherwise. Different letters are 




3.4.2 Functional oxidative capacity 
Respirometry was carried out in order to determine whether the capacity for fat and 
carbohydrate-driven oxidative metabolism changed over late gestation. Pyruvate and PC were 
added as substrates, and the ADP-coupled oxygen consumption (state 3 respiration) is shown 
in Figure 3.2 and Figure 3.3 respectively. Age had a significant effect on Py-supported oxidative 
capacity in all 3 muscles (P<0.0001 in the BF and SDF and P<0.01 in ST by one-way ANOVA 
including all 4 ages). BF and SDF from newborn lambs had a higher Py-supported oxygen 
consumption than the 3 fetal age groups studied, and ST from newborns had a significantly 
higher oxygen consumption than the 104dGA and 127dGA groups (Figure 3.2 A-C). Age had a 
significant effect on the PC-driven oxygen consumption in all 3 muscles (P<0.05 in BF and ST 
and P<0.01 in the SDF), and in the ST and SDF the newborn lambs had a higher oxygen 
consumption than the two youngest fetal age groups studied (Figure 3.3 A-C).  
Applying the one-way ANOVA to the respirometry data to only the 3 fetal age groups, 
prevented the high value of the newborns from obscuring any prepartum gestational changes. 
Analysis of the fetal values alone showed that there was a significant effect of age on the Py-
supported oxygen consumption in the SDF (P<0.05) where oxygen consumption at 143dGA 
was significantly higher than at 104dGA (Figure 3.2 C).  
Combining the data from all 4 age groups, the Py- and PC-supported, ADP-coupled oxygen 
consumption values were plotted against the plasma cortisol and T3 concentrations (Figure 
3.2 and Figure 3.3). There was a significant positive correlation in all 3 muscles between 
cortisol and Py- (P<0.0001 in BF, P<0.01 in ST and P<0.001 SDF; r values given in Figure 3.2 D-
F) and PC-driven oxygen consumption (P<0.05 in BF, P<0.01 in ST and P<0.001 in SDF; r values 
given in Figure 3.3 D-F). T3 significantly correlated in all muscles with Py- (P<0.001 for BF, 
P<0.01 for ST and P<0.0001 in SDF; r values given in Figure 3.2 G-I) and PC-supported oxygen 
consumption (P<0.05 in BF, P<0.01 in ST and P<0.001 in SDF; r values given in Figure 3.3 G-I). 
Partial correlation analyses suggest T3 may be the more important hormone in regulating Py-
supported oxygen consumption in the SDF (P<0.05; Table 3.3). There was no significant 
correlation of Py- or PC- supported respirometry data in any of the muscles with T4 (data not 
shown).  
Following the measurement of PC-supported, ADP-coupled oxygen consumption, Py was 
added. The contribution of PC to the total oxygen consumption (PC:PC+Py ratio) is given in 




Oxygen consumption upon the addition of substrate before ADP was added into the chamber, 
a measure of leak state respiration, was recorded. Py-supported respiration was influenced 
by age in BF (P<0.01) and ST (P<0.0001) and in both cases the rate of oxygen consumption was 
significantly higher in the newborns than in the fetuses (Table 3.4). PC-supported oxygen 
consumption was also affected by age in the BF (P<0.05) and ST (P<0.001), with the newborn 
value being significantly higher than 127dGA (Table 3.4). The concomitant change in oxygen 
consumption before and after the addition of ADP meant that RCR did not show a trend to 
increase or decrease with age with Py or PC in any of the muscles.  
In addition to respirometry, the capacity for fat metabolism was further investigated in the BF 
by measuring the activity of the β-oxidation enzyme, HOAD.  Age had a significant effect on 
HOAD activity (P<0.0001 by one-way ANOVA) with activity increasing during late gestation to 
be higher by term and in the newborn than 104-127dGA (Figure 3.5 A). When data from all 
groups were combined there was a strong positive correlation between HOAD activity and 
both cortisol and T3 (P<0.0001 in both cases; Figure 3.5). Applying partial correlation analysis 







Figure 3.2 Pyruvate-supported, ADP-coupled oxygen consumption. A-C) Mean±SEM oxygen consumption of fetuses at 104 (n=6; blue), 127 (n=6; pink) 
and 143 (n=5-6; green) days of gestational age (dGA) and newborn lambs (n=6; purple); different letters are significantly different to each other (P<0.05 
by Tukey’s post hoc test following one-way ANOVA). Lower case letters include all 4 age groups, upper case letters include 104-143dGA groups only. 
Oxygen consumption plotted against plasma D-F) cortisol and G-I) T3 in D&G) biceps femoris, E&H) semitendinosus and F&I) superficial digital flexor. N 







Figure 3.3 Palmitoylcarnitine-supported, ADP-coupled oxygen consumption. A-C) Mean±SEM oxygen consumption of fetuses at 104 (n=6), 127 (n=5-6) 
and 143 (n=5-6) days of gestational age (dGA) and newborn lambs (n=4-6); different letters are significantly different to each other (P<0.05 by Tukey’s 
post hoc test following one-way ANOVA). Oxygen consumption plotted against plasma D-F) cortisol and G-I) T3 in D&G) biceps femoris, E&H) 
semitendinosus and F&I) superficial digital flexor. N numbers and r values are given on each graph; 104dGA blue, 127dGA pink and 143dGA green and 





Figure 3.4 The ratio of ADP-coupled PC-supported:PC+Py-supported oxygen consumption, 
presented as mean±SEM in A) biceps femoris, B) semitendinosus and C) superficial digital flexor 
of fetuses at 104 (n=6), 127 (n=5-6) and 143 (n=5-6) days of gestational age (dGA) and 
newborn lambs (n=4-6).  
 
 
Figure 3.5 β-hydroxyacyl-CoA dehydrogenase (HOAD) activity. A) Mean±SEM HOAD activity  in 
biceps femoris of fetuses at 104, 127 and 143 days of gestational age (dGA) and newborn 
lambs (n=6 for all ages); different letters are significantly different to each other (P<0.05 by 
Tukey’s post hoc test following one-way ANOVA). B&C) HOAD activity plotted against plasma 
B) cortisol and C) T3. N numbers and r values are given on each graph; 104dGA blue, 127dGA 









Table 3.3 Partial correlation analyses of cortisol and T3 with respirometry data and HOAD 
activity.  
 Biceps femoris Semitendinosus Superficial digital 
flexor 
 Pyruvate-supported state III respiration 
Cortisol 0.323 0.210 0.091 
T3 0.397 0.222 0.538 
 Palmitoylcarnitine state III respiration 
Cortisol 0.249 0.028 0.281 
T3 0.065 0.386 0.252 
 HOAD activity 
Cortisol 0.667 / / 
T3 0.159 / / 
 Glutamate and succinate state III respiration 
Cortisol 0.043 -0.141 0.210 
T3 0.436 0.497 0.378 
R values given and significant correlations highlighted in bold. N=20-23. β-hydroxyacylCoA 
dehydrogenase (HOAD) activity was not measured in semitendinosus and superficial digital 
flexor (/).  
 
Table 3.4 Leak state respiration 
Leak state respiration 
(nmolO2/min/mg dry 
weight) 
104dGA 127dGA 143dGA Newborn 
Biceps femoris 
Pyruvate 0.91±0.29 (n=5) a  1.29±0.54 a 1.13±0.13 a 3.34±0.74 b 
Palmitoyl-carnitine 0.81±0.28 (n=4) a,b 0.39±0.06 a 1.36±0.39 (n=5) a,b 2.57±0.53 
(n=4) b 
Glutamate 1.12±0.24 a 0.82±0.12 (n=5) a 2.71±0.95 (n=5) a,b 3.07±0.42 b 
 Semitendinosus 
Pyruvate 1.28±0.36 a 1.07±0.19 a 1.38±0.34 (n=5) a 4.68±0.77 b 
Palmitoyl-carnitine 1.25±0.47 a 0.66±0.05 (n=5) a 1.23±0.17 (n=5) a 3.00±0.31 b 
Glutamate 1.15±0.31 (n=4) a 1.12±0.09 (n=3) a 2.05±0.34 (n=4) a,b 3.44±0.41 b 
 Superficial digital flexor 
Pyruvate 0.77±0.17 (n=5) 1.42±0.39 1.70±0.37 (n=5) 1.80±0.37 
Palmitoyl-carnitine 0.78±0.24 1.17±0.20 1.25±0.21 1.49±0.28 
Glutamate 0.73±0.14 (n=5) a 1.07±0.31 (n=5) a 1.85±0.38 a,b 2.97±0.54 b 
Data are presented as mean±SEM. N=6 unless stated otherwise; different letters are 




Total ADP-coupled oxygen consumption was measured upon the addition of glutamate and 
succinate, which drive oxphos through CI and CII respectively. There was a significant effect of 
age on oxygen consumption in BF and SDF muscles (P<0.01 for both muscles). The oxidative 
capacity of the newborn lambs was significantly higher than at any fetal age in the BF and SDF 
(Figure 3.6).  
There was a significant correlation between total ADP-coupled oxygen consumption with 
cortisol in BF (P<0.01) and SDF (P<0.001) and T3 in all 3 muscles (P<0.001 in BF, P<0.01 in ST 
and P<0.0001 in SDF; r values given in Figure 3.6). T3 appears to play a predominant role in 
regulating total oxygen consumption in BF as shown by partial correlation analyses (P<0.05; 
Table 3.3). 
Glutamate supported leak state respiration was affected by age in all 3 muscles (P<0.05 in BF 
and P<0.01 in ST and SDF). The oxygen consumption was significantly higher in the newborn 
than at 104 and 127dGA in all 3 muscles studied (Table 3.4). RCR did not change with age in 
any of the muscles.  








Figure 3.6 Total (glutamate and succinate supported) ADP-coupled oxygen consumption. A-C) Mean±SEM oxygen consumption of fetuses at 104 (n=4-
6), 127 (n=3-5) and 143 (n=4-6) days of gestational age (dGA) and newborn lambs (n=6); different letters are significantly different to each other (P<0.05 
by Tukey’s post hoc test following one-way ANOVA). Oxygen consumption plotted against plasma D-F) cortisol and G-I) T3 in D&G) biceps femoris, E&H) 
semitendinosus and F&I) superficial digital flexor. N numbers and r values are given on each graph; significant correlations are given in a box. 104dGA 




The graphs shown in Figure 3.2, 3.3, 3.5 and 3.6 suggest that the neonatal data may heavily 
influence the correlations between mitochondrial parameters and hormone concentrations. 
Determination of the correlations following the removal of the neonate data points (Table 3.5) 
reveals that there remains a strong correlation of HOAD activity with both cortisol and T3 
concentrations. Additionally the correlation of total ADP-coupled oxygen consumption in the 
BF significantly correlated with fetal plasma cortisol concentration, and in the SDF with both 
T3 and cortisol when newborn data was removed, but all other respirometry data no longer 
correlated with the hormones. Thus, in these datasets, the newborn data is important in 
driving the significant correlations.  
 
Table 3.5 Correlations of cortisol and T3 with respirometry data and HOAD activity when 
neonatal data is omitted.  
 Biceps femoris Semitendinosus Superficial digital 
flexor 
 Pyruvate-supported state III respiration 
Cortisol 0.392 0.233 0.410 
T3 0.034 0.017 0.197 
 Palmitoylcarnitine state III respiration 
Cortisol 0.257 0.307 0.429 
T3 -0.249 0.015 0.161 
 Glutamate and succinate state III respiration 
Cortisol 0.600 0.272 0.634 
T3 0.387 -0.209 0.586 
 HOAD activity 
Cortisol 0.844 / / 
T3 0.738 / / 
R values given and significant correlations highlighted in bold. N=20-23. β-hydroxyacylCoA 
dehydrogenase (HOAD) activity was not measured in semitendinosus and superficial digital 







3.4.3 Regulating oxidative capacity 
3.4.3.1 Mitochondrial density and biogenesis 
Mitochondrial oxidative function increased over the perinatal period and in order to 
investigate the factors that may be regulating this, markers of mitochondrial oxidative 
capacity were measured. Firstly, CS activity, a putative marker of mitochondrial density, was 
shown to significantly increase with age in all 3 muscles (P<0.0001 by one-way ANOVA in all 
cases; Figure 3.7 A-C). In all muscles, CS activity was significantly higher at 143dGA than the 
younger fetal age groups and then was higher still in the newborn muscles (Figure 3.7 A-C). 
Additionally, when data from all groups were combined, there was a strong positive 
correlation between CS activity in all 3 muscles and both cortisol and T3 (P<0.0001 in all cases; 
r numbers are given in Figure 3.7). Partial correlation analyses suggest that T3 strongly 
influences CS activity in all 3 muscles (P<0.01 in BF and P<0.001 in ST and SDF; Table 3.6). In 
addition, cortisol significantly correlated with CS activity in the BF when controlling for the 
effect of T3 using partial correlation analysis, suggesting both hormones play a regulatory role 
in this muscle (P<0.01; Table 3.6).  
The gene expression of PGC1α, a key regulatory protein in mitochondrial biogenesis, was only 
significantly affected by age in the SDF (P<0.001; Figure 3.8 A-C). In contrast, gene expression 
of NRF1, normally considered to be downstream of PGC1α, was negatively affected by age in 
ST (P<0.05) and SDF (P<0.0001; Figure 3.8 D-F).  
In order to determine whether the oxidative capacity of the muscle increased in parallel with 
the increase in mitochondrial density, or whether the function per unit of mitochondrial mass 
changed with age, the respirometry data were normalised to CS activity. CS activity was 
initially converted to activity/mg dry weight for a direct normalisation. Py- and PC-supported 
and total (glutamate and succinate), ADP-coupled oxygen consumption normalised to CS 
activity is shown in Figure 3.9.  There was a significant effect of age on Py-supported and total 
oxygen consumption per mitochondrial unit in the BF (P<0.001 in both cases by one-way 
ANOVA), both showing a lower oxidative capacity per mitochondrial unit in the newborns 
compared to 104-127dGA fetuses. Applying a Mann-Whitney test revealed that the PC-
supported oxygen consumption in the BF and total oxygen consumption in the SDF were 







Figure 3.7 Citrate synthase activity. A-C) Mean±SEM activity of fetal muscle at 104, 127 and 143dGA and new born lambs (n=6 in each group); different 
letters are significantly different to each other (P<0.05 by Tukey’s post hoc test following one-way ANOVA). Activity plotted against plasma D-F) cortisol 
and G-I) T3 in D&G) biceps femoris, E&H) semitendinosus and F&I) superficial digital flexor. N numbers and r values are given on each graph; 104dGA 




Table 3.6 Partial correlation analyses of cortisol and T3 with citrate synthase activity.  
 Biceps femoris Semitendinosus Superficial digital flexor 
Cortisol 0.575 0.299 0.397 
T3 0.598 0.768 0.719 
R values given and significant correlations highlighted in bold. N=23 in each case. 
 
 
Figure 3.8 Mean±SEM relative gene expression of A-C) PGC1α and D-F) NRF1 in A&D) biceps 
femoris, B&E) semitendinosus and C&F) superficial digital flexor of fetuses at 104 (n=5), 127 
(n=6) and 143 (n=6) days of gestational age (dGA) and newborn lambs (n=6). Different letters 












Figure 3.9 Mean±SEM ADP-coupled,  A-C) pyruvate (Py),  D-F) palmitoylcarnitine (PC)-supported and G-I) total (glutamate and succinate) oxygen 
consumption normalised to citrate synthase (CS) activity in A,D&G) biceps femoris, B,E&H) semitendinosus and C,F&I) superficial digital flexor of fetuses 
at 104 (n=4-6), 127 (n=3-6) and 143 (n=4-6) days of gestational age (dGA) and newborn lambs (n=4-6). Different letters are significantly different to 




3.4.3.2 Electron transfer system activity and complex abundance 
Western blotting was used to measure the abundance of ETS CI-IV and ATP-synthase in BF, ST 
and SDF (Figure 3.10, Figure 3.11 and Figure 3.12 respectively). Age had a significant influence 
on CI-III and ATP-synthase in the BF (P<0.05 for complex I and P<0.0001 for CII and III and ATP-
synthase), CI-IV in the ST (P<0.001 for CI and II and P<0.05 for CIII and CIV) and CI-IV in the SDF 
(P<0.05 for CI, CII and CIV and P<0.0001 for CIII; all by one-way ANOVA). Significant differences 
between complex protein abundance in the different age groups are marked on the graphs in 
Figure 3.10-Figure 3.12; in all cases where there was a significant effect of age, with the 
exception of CII abundance in the SDF, the abundance at 143dGA was significantly higher than 








Figure 3.10 Protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV) by western blotting in biceps femoris. A) 
representative blots and B-F) mean±SEM relative abundance of the complexes I-IV and ATP-synthase, as labelled, of fetuses at 104, 127 and 143 days 
of gestational age (dGA) and newborn lambs. N=5 in each group for CI, II, III and V; n=3-4 per group for CIV.  Different letters are significantly different 








Figure 3.11 Protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV) by western blotting in semitendinosus. A) 
representative blots and B-F) mean±SEM relative abundance of the complexes I-IV and ATP-synthase, as labelled, of fetuses at 104, 127 and 143 days 
of gestational age (dGA) and newborn lambs. N=5 in each group.  Different letters are significantly different to each other (P<0.05 by Tukey’s post hoc 









Figure 3.12 Protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV) by western blotting in superficial digital flexor. 
A) representative blots and B-F) mean±SEM relative abundance of the complexes I-IV and ATP-synthase, as labelled, of fetuses at 104, 127 and 143 
days of gestational age (dGA) and newborn lambs. N=5 in each group for CI-IV; n=4-5 for CV.  Different letters are significantly different to each other 




3.4.3.3 Uncoupling the proton gradient 
Oxidative ATP production relies on the maintenance of the proton gradient across the IMM. 
The expression of components of the IMM known to be involved in dissipating this gradient, 
UCP2 and 3 and ANT1, were quantified. Age had a significant effect on the gene expression of 
UCP2 (P<0.01 in BF and ST and P<0.0001 in SDF) and UCP3 (P<0.001 in BF and P<0.0001 in ST 
and SDF by one-way ANOVA). The expression of both UCP2 and UCP3 was dramatically 
upregulated in the newborns compared to the fetuses at all 3 gestational ages in the 3 muscles 
studied (Figure 3.13). Applying a one-way ANOVA to only the 3 fetal groups, such that the 
newborn value did not obscure any preterm differences, revealed a significant effect of age 
on the expression of UCP3 in the ST (P<0.05) and expression at 127 and 143dGA were 
significantly higher than at 104dGA (Figure 3.13 E). Age had a positive influence on ANT1 gene 
(P<0.0001 in ST and SDF and P<0.01 in BF) and protein expression (P<0.0001 in all 3 muscles 
by one-way ANOVA; Figure 3.14). ANT1 protein expression was significantly higher at 143dGA 
than at 104dGA in all 3 muscles, and significantly higher still in newborns in the BF and SDF, 
while gene expression was significantly higher in newborns than the fetuses in all 3 muscles 
(Figure 3.14).  
 
Figure 3.13 Mean±SEM relative gene expression of A-C) uncoupling proteins (UCP) 2 and D-F) 
UCP3 in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital flexor of fetuses 
at 104 (n=5), 127 (n=4-6) and 143 (n=6) days of gestational age (dGA) and newborn lambs 
(n=6). Different letters are significantly different to each other (P<0.05). Lower case letters 






Figure 3.14 Protein and mRNA levels of adenine nucleotide translocase 1 (ANT1)  A-C) representative western blots, D-F) mean±SEM protein abundance 
(n=5 in each group)  and G-I) gene expression (n=5-6 in each group) in A,D&G) biceps femoris, B,E&H) semitendinosus and C,F&I) superficial digital flexor 
of fetuses at 104, 127 and 143 days of gestational age (dGA) and newborn lambs. Different letters are significantly different to each other (P<0.05 by 




3.4.3.4 Mitochondrial fusion and fission 
The extent of mitochondrial network fusion and fragmentation is associated with energy 
supply and demand (Schrepfer and Scorrano, 2016). Gene expression of fusion proteins, MFN1 
and MFN2, and fission protein, DRP1, were quantified using qRT-PCR (Figure 3.15). Age had a 
significant influence on expression of MFN1 in the SDF (P<0.05) and MFN2 in BF (P<0.05) and 
SDF (P<0.0001 by one-way ANOVA). In these cases there was a general increase in expression 
with age, such that the expression in the newborn was higher than 127dGA (Figure 3.15 
C,D&F). Age affected the expression of DRP1 in the SDF (P<0.01). In this case, however, 




Figure 3.15 Mean±SEM relative gene expression of A-C) mitofusin (MFN) 1 D-F) MFN2 and G-
I) dynamin-related protein 1 (DRP1), in A,D&G) biceps femoris, B,E&H) semitendinosus and 
C,F&I) superficial digital flexor of fetuses at 104 (n=3-5), 127 (n=6) and 143 (n=6) days of 
gestational age (dGA) and newborn lambs (n=6). Different letters are significantly different to 




3.4.3.5 Monitoring cellular energy status 
AMPK signalling is important for the cellular response to an increased energy demand or a 
lower ATP content. The abundance of AMPKα and its phosphorylated form, pAMPKα, was 
measured by western blotting (Figure 3.16). There was a significant effect of age on the 
abundance of AMPKα in the SDF (P<0.001 by one-way ANOVA; Figure 3.16 I) with abundance 
higher near term and in the newborn lambs than at 104dGA. However, there was no significant 
effect of age on AMPKα abundance in BF or ST, nor on pAMPKα in any of the 3 muscles studied. 
The ratio of pAMPKα:AMPKα shows a significant decrease with age in the SDF (P<0.05, one-








Figure 3.16 Protein expression of (phosphorylated) AMP-activated protein kinase α ((p)AMPKα) by western blotting. A-C) representative blots and D-F) 
mean±SEM relative abundance of pAMPKα and G-I) AMPKα in A,D&G) biceps femoris, B,E&H) semitendinosus and C,F&I) superficial digital flexor of 
fetuses at 104, 127 and 143 days of gestational age (dGA) and newborn lambs. N=5 in each group except BF pAMPKα with n=3 per group. Different 





Figure 3.17  Mean±SEM ratio between phosphorylated AMP-activated protein kinase α 
(pAMPKα) and AMPKα in A) biceps femoris, B) semitendinosus and C) superficial digital flexor 
of fetuses at 104, 127 and 143 days of gestational age (dGA) and newborn lambs. N=5 per 
group, except BF with n=3 per group. Different letters are significantly different to each other 



















3.4.4 Skeletal muscle structure and type I fibres 
The reported increase in skeletal muscle mitochondrial density may reflect an increase in 
proportion of oxidative type I muscle fibres.  In order to determine whether this was the case, 
the total fibre density was quantified using H&E stained muscle sections (Figure 3.18). There 
was a significant effect of age (P<0.01 in BF and P<0.0001 in ST and SDF by one-way ANOVA), 
with fibres accounting for a greater proportion of the muscle area in the older age groups 
(Table 3.7). Type I fibres were then stained (Figure 3.19) and the fibre number, area and 
perimeter measured. Age had a significant positive effect on all parameters measured in the 
BF and ST, as shown in Table 3.7 (P<0.05 by one-way ANOVA).  The high density of stained 
fibres in the SDF of 143dGA and newborn animals meant the individual fibres were difficult to 
separate, and thus the average fibre area, perimeter and fibre number have not been given 
for these groups. Expressing the area of type I fibres as a percentage of total fibre area shows 
the proportion of type I fibres increases with age (P<0.01 in BF and SDF and P<0.05 in ST by 
one-way ANOVA; Table 3.7). Comparing the 3 muscles, the SDF had a significantly higher MHCI 
proportion of fibre area than the ST at both 143dGA and newborn lambs.  
To gain further insight into the ontogeny of fibre type characteristics, the gene expression of 
MHCI, IIa and IIx was quantified and data are shown in Figure 3.20. MHCI significantly 
increased with age in the SDF (P<0.0001). Similarly, age only significantly influenced MHCIIa 
in SDF (P=0.0001). MHCIIx was positively influenced by age in all muscles studied (P<0.001 in 
BF and ST; P<0.05 in SDF by one-way ANOVA). When a one-way ANOVA and Tukey’s multiple 
comparisons test were applied only to the data from the 3 fetal ages, there was a significant 
effect of age on MHCI expression in the BF, and on MHIIa expression in the ST (P<0.001) where 






Figure 3.18 Representative H&E stained sections at 40x magnification in biceps femoris, semitendinosus and superficial digital flexor of fetuses at 104, 






Figure 3.19 Representative MHCI stained sections at 20x magnification in biceps femoris, semitendinosus and superficial digital flexor of fetuses at 104, 
127 and 143 days of gestational age (dGA) and newborn lambs, as labelled. Contemporaneous primary, secondary and double negative controls are 




Table 3.7 Type I fibre analyses.  
 104dGA 127dGA 143dGA Newborn 
 Biceps femoris 
Proportion of total area 









Number of type I fibres/mm2 166±6 286±84 467±71 444±62 
Average fibre cross-sectional 
area (µm2) 
274.1±30.3 a 364.9±34.7 a,b 419. ±25.6 a,b 454.6±44.0 b 
Average fibre perimeter 
(µm) 
61.9±3.6 a 71.6±3.5 a,b 78.0±2.4 a,b 82.0±4.2 b 
Proportion of total area 
accounted for by type I 
fibres (%) 
4.5±0.4 a 10.3±3.0 a,b 19.5±3.0 b 19.2±0.8 b 
Proportion of fibre area 
accounted for by type I 
fibres (%) 
7.2±0.9 a 11.9±3.1 a,b 23.2±3.6 b 23.0±0.5 a,b 
 Semitendinosus 
Proportion of total area 









Number of type I fibres/mm2 173±25 a 270±47 a,b 318±21 a,b 366±18 b 
Average fibre cross-sectional 
area (µm2) 
265.3±25.6 a 422.2±22.7 a,b 481.4±13.6 b 417.6±19.2 a,b 
Average fibre perimeter 
(µm) 
61.3±3.0 a 78.0±2.2 a,b 84.4±1.3 b 78.7±2.0 a,b 
Proportion of total area 
accounted for by type I 
fibres (%) 
4.4±0.5 a 11.5±2.3 a,b 15.3±1.1 b 15.3±1.2 b 
 
Proportion of fibre area 
accounted for by type I 
fibres (%) 
7.8±0.8  15.8±3.2  17.0±1.1  17.0±1.4  
 Superficial digital flexor 
Proportion of total area 
accounted for by fibres (%) 






Number of type I fibres/mm2 312±50 465±92 n.q. n.q. 
Average fibre cross-sectional 
area (µm2) 
274.7±31.5 302.9±43.4 n.q. n.q. 
Average fibre perimeter 
(µm) 
63.1±3.7 35.9±4.7 n.q. n.q. 
Proportion of total area 
accounted for by type I 
fibres (%) 
8.3±1.1 a 13.1±1.2 a,b 27.6±3.1 a,b 33.6±2.7 b 
Proportion of fibre area 
accounted for by type I 
fibres (%) 
16.2±4.0 a 20.2±1.2 a,b 33.6±2.7 a,b 36.1±3.4 b 
Data are presented as mean±SEM in biceps femoris, semitendinosus and superficial digital 
flexor of fetuses at 104, 127 and 143 days of gestational age (dGA) and newborn lambs. N=4 
in each group unless stated otherwise. Different letters are significantly different to each other 





Figure 3.20 Mean±SEM gene expression of A-C) MHCI, D-F) MHCIIa and G-I) MHCIIx in A,D&G) 
biceps femoris, B,E&H) semitendinosus and C,F&I) superficial digital flexor of fetuses at 104 
(n=5), 127 (n=5-6) and 143 (n=6) days of gestational age (dGA) and newborn lambs (n=4-6). 
Different letters are significantly different to each other (P<0.05). Lower case letters include all 











3.5 Discussion  
This study demonstrated that in 3 hind limb skeletal muscles, mitochondrial oxidative capacity 
increased significantly with age in a muscle- and substrate-dependent manner, with the 
oxygen consumption often significantly higher in neonatal than fetal muscles. Over late 
gestation there was an increase in mitochondrial abundance and expression of proteins 
involved in oxidative ATP production and transport, including ETS complexes and ANT1. The 
gene expression of UCP2 and UCP3 also show a significant postnatal upregulation. The fetal 
concentrations of cortisol and T3 were clearly correlated with oxidative capacity and 
mitochondrial abundance in the 3 muscles studied.  
 
3.5.1 Fetal and neonatal development 
Total body weight increased significantly over late gestation, almost tripling between 104 and 
143dGA, known to be a period of significant fetal growth (Mellor and Matheson, 1979). 
Similarly, fetal crown-rump length increased significantly between each age group studied, 
with values in accordance with previously reported values in Welsh Mountain twin and 
singleton fetuses (Lanham et al., 2011, Fowden et al., 1989). The rate of growth was higher 
between 104 and 127dGA than between 127 and 143dGA as previously shown (Fowden et al., 
1989). Hind-limb length increased with age over late gestation; the late gestation period is 
important for the growth of the hind-limb skeleton (Lanham et al., 2011). In addition, the mass 
of the 3 skeletal muscles studied increased with age, with the mass of the ST and SDF being 
significantly different between each age group. This coincided with an increased fibre density 
with age in all 3 muscles.  The type I fibre analyses suggest that, for type I fibres at least, this 
increased muscle mass and fibre density may be due to both hyperplasia and hypertrophy as 
both the number and cross sectional area of fibres were significantly influenced by age in the 
BF and ST. Maturation of muscle fibres is believed to occur during the last third of gestation, 
with hyperplasia contributing little to muscle growth from around 75% of the way through 
gestation in sheep (Du et al., 2010). As such, hypertrophy of both type I and type II muscle 
fibres has been shown to occur over the last third of gestation in ovine soleus, medial 
gastrocnemius and flexor digitorum longus, resulting in no change in the proportion of type I 
to type II fibres reported with gestational age (Javen et al., 1996). Consequently, the increase 




number of fibres maturing to take on the type I fibre phenotype and express MHCI, rather 
than a continuation of fibre proliferation.  
The water, lipid, glycogen and protein content of the fetal and neonatal muscles were 
analysed, and results expressed per wet weight fit the trends previously reported in 
biochemical composition of fetal muscle of rhesus monkeys during the second half of 
gestation (Kerr et al., 1971). Water content of all 3 muscles decreased significantly over late 
gestation with content not significantly different between 143dGA and the newborns lambs. 
In contrast, protein content increased with age, and was significantly greater in the newborns 
than at 127dGA in the BF and SDF.  
Development of fuel reserves in skeletal muscle involves the deposition of glycogen and lipid 
in preparation for the immediate postpartum period when the continuous placental supply of 
maternal nutrients ceases (Fowden et al., 1998). In the current study muscle glycogen 
increased from 104dGA and reached the level seen at term by 127dGA, an ontogenic profile 
similar to that shown previously for ovine BF muscle (Forhead et al., 2009). Glycogen content 
then fell postnatally, to be significantly lower in newborns compared with 143dGA fetuses in 
all 3 muscles. This fall in glycogen content, reflects its rapid mobilisation and metabolism to 
supply the increased energy requirement of the neonatal muscle (Mellor and Cockburn, 1986). 
Fetal lipid deposition during late gestation is also important to provide metabolic substrates 
to tissues including neonatal cardiac and skeletal muscle (Beatty and Bocek, 1970). Hepatic 
and adipose tissue account for the majority of fetal lipid stores at term (Hull, 1975).  In this 
study, lipid content was measured only in the BF, but content did increase with the highest 
value measured in the newborn lambs. Plasma free fatty acid concentration was not measured 
in this cohort, but previously has been shown to rise rapidly after birth in sheep (Vanduyne et 
al., 1965). In adult muscle, lipid droplets are situated near the mitochondria as an easily 
accessible fuel store (Hoppeler, 1999).  Our results in the BF suggest that in the first day of 
neonatal life, muscle lipid does not provide a source of circulating FAs, nor a local metabolite 
for oxphos as lipid content was not lower in neonatal than fetal muscle. However, muscle 
mitochondria over late gestation are capable of using FAs for oxidative metabolism and this is 





3.5.2 Mitochondrial oxidative metabolism  
In the current study, ovine fetal muscle has been shown to be capable of oxidative metabolism 
throughout the last third of gestation, supporting previous studies (Morriss et al., 1973). 
Throughout late gestation and in the neonates, skeletal muscle was capable of oxidative 
metabolism of both carbohydrate and lipid substrates. The contribution of lipids to fetal 
metabolism is a matter of debate, but this current study demonstrates that in sheep, as in 
primates, the fetal muscle has the capacity to carry out FA oxidation (Beatty and Bocek, 1970). 
However, fetal sheep are relatively lean and under normal circumstances in vivo are thought 
to be reliant predominantly on glucose metabolism (Hay, 2006, James et al., 1971). Similarly, 
immediately after birth, glucose is the preferred metabolic substrate, although circulating 
lipids rise early in neonatal life and reliance on FA for metabolism increases postnatally (Mellor 
and Cockburn, 1986, Vanduyne et al., 1965).  In agreement with these observations, our 
results suggest that when PC was the available substrate oxygen consumption was around 2-
3 times lower than when Py was used. This was true in all 3 muscles at all ages studied.   
Using Py or PC as the substrate, there was a general trend for state 3 respiration to increase 
with age, reaching significance for Py-supported oxygen consumption in all 3 muscles, and in 
the ST and SDF for PC-supported oxygen consumption. Similarly, there was an increased 
oxygen consumption with the combined substrate combination of succinate and glutamate 
with age in BF and SDF. However, except for Py-supported respiration in the SDF, oxygen 
consumption was not significantly higher at 143dGA than 104dGA. These data complement 
reports that total fetal oxygen consumption over the second half of gestation does not vary 
with age, and skeletal muscle is thought to account for a significant proportion of total fetal 
oxygen consumption (Acheson et al., 1957, Fowden and Silver, 1995). The oxygen 
consumption of the newborn muscle was often significantly higher than the fetal muscle at all 
3 fetal ages studied as shown for Py-supported respiration in all 3 muscles and combined 
glutamate- and succinate-supported oxygen consumption in the BF and SDF. These data 
suggest that, as hypothesised, the oxidative capacity was higher after birth in order to cope 
with the increased energy demands compared to those in utero. Tissue specific changes in 
oxygen consumption have been observed; the kidney did not show a significant change across 
the perinatal period, while liver and brain oxygen consumption was significantly increased 




suggest that the oxygen consumption of skeletal muscle increases at birth, as this tissue 
immediately takes on its new energetically demanding roles. 
 
3.5.3 Mitochondrial density and morphology changed over the perinatal period 
Following on from the finding that mitochondrial function increased with age, mitochondrial 
parameters that may contribute to the oxidative capacity were studied. Over late gestation 
there was an increase in mitochondrial density, abundance of ETS complexes and, in the SDF, 
mitochondrial fusion, in preparation for the increased demand for ATP production after birth.  
 
3.5.3.1 Mitochondrial biogenesis 
Citrate synthase activity, used as a marker of mitochondrial density, was significantly higher 
at term than earlier in gestation, and further increased in the newborn lambs in all 3 muscles 
studied. Histological studies on rabbit hearts have shown a similar increase in mitochondrial 
density over the perinatal period (Smith and Page, 1977). Alongside an increase in 
mitochondrial density, there was a significant increase in the abundance of ETS complexes I-
IV in all muscles with gestational age, with the exception of CIV in the BF where this trend did 
not reach significance. However, the abundance of all ETS complexes in the 3 muscles was not 
significantly different in the neonate compared with at 143dGA, so upregulation of ETS 
oxidative capacity occurred in advance of birth even though oxygen consumption per se did 
not increase significantly until after delivery.  
PGC1α and NRF1 are known to be involved in driving mitochondrial biogenesis. However, in 
the current study, PGC1α expression was only significantly higher in the newborns compared 
with the fetuses in the SDF and NRF1 decreased with age, reaching significance in the ST and 
SDF. Therefore, the gene expression results suggest that this pathway may not be responsible 
for the increased mitochondrial density in late gestation. That being said, and although PGC1α 
and its coactivators are regulated at the level of mRNA and protein, signalling via PGC1α is 
highly regulated at the post-translational level (Scarpulla et al., 2012). For example, PGC1α-
mediated gene expression is increased due to phosphorylation by AMPK (Scarpulla et al., 
2012). There may, therefore, be downstream modulation of PGC1α signalling over late 
gestation, which has been missed by measuring only mRNA abundance. If PGC1α in SDF is not 




other downstream components. For example, NRF2 is also implicated in global mitochondrial 
regulation involved in upregulating numerous mitochondrial genes and increasing 
mitochondrial oxidative function (Scarpulla, 2011). In the current study, the expression of 
NRF2 has not been determined and its expression may more closely follow that of PGC1α than 
NRF1, and may be acting downstream of PGC1α to drive biogenesis.  
Alternatively, the increase in PGC1α in the SDF may be regulating pathways other than 
mitochondrial biogenesis. PGC1α is also known to drive more acute responses preceding a 
detectable increase in mitochondrial number including preserving existing glycogen stores 
through increasing the capacity for FA oxidation (Smiles and Camera, 2015, Baar et al., 2002, 
Wende et al., 2007). At birth, the rapid drop in glycogen alongside the increase in muscle 
contraction, may be involved in upregulating lipid metabolism, both by driving the postnatal 
increase in PGC1α in the SDF or directly via PPAR signalling in the neonates (Philp et al., 2013). 
The increase in PGC1α expression in the SDF at birth may, therefore, be more important in 
regulating substrate usage, than mitochondrial biogenesis. Further investigation should 
involve measuring the abundance of PPARs. 
PGC1α-independent pathways for increasing mitochondrial density may also exist and would 
be interesting to investigate (Philp et al., 2010). For example, an increase in mitochondrial 
biogenesis in skeletal muscle was seen with dexamethasone treatment without upregulation 
of the NRF pathway (Weber et al., 2002). These authors suggest that this may be due to the 
synthetic GC binding directly to the mitochondrial GR to drive biogenesis independently of 
nuclear factors. Additionally, a mitochondrial specific THR is known to play a key role in 
mediating TH-dependent mitochondrial responses, including biogenesis (Marin-Garcia, 2010). 
Therefore, as these hormones rise over the perinatal period, they may have a direct effect on 
the muscle mitochondria. Alternatively, glycolytic activity in the skeletal muscle may play a 
regulatory role as pyruvate has been shown to increase mitochondrial biogenesis despite 
decreasing PGC1α in cultured myoblasts: an effect which may be due to the concomitant rise 
in PGC1α-related coactivator (PRC) a known stimulant of mitochondrial biogenesis (Philp et 
al., 2010). Overall, there is an increased mitochondrial density, but the mechanism regulating 





3.5.3.2 Fission and fusion 
In addition to the mitochondrial density and protein levels, mitochondrial morphology is 
believed to play a role in regulating oxidative function. An increased energy demand is 
associated with increased fusion and enhanced ATP production (Schrepfer and Scorrano, 
2016). The expression of MFN1 and MFN2 in the SDF and MFN2 in the BF increased 
significantly during the perinatal period. This suggests that there may be an increased 
incidence of mitochondrial fusion, particularly in the SDF with increasing age. The expression 
of MFN1 and 2 are regulated, in part, by PGC1α which was increased in the SDF (Zorzano and 
Claret, 2015). Interestingly, this is the only muscle which had an increased AMPKα protein 
expression with age, generally associated with increased rate of fission (Zhang and Lin, 2016).   
The fact that in BF and ST there seemed to be little change in expression of fusion and fission 
markers over late gestation and the perinatal period may suggest that network dynamics are 
of little importance in regulating the oxidative function at this time. However, only gene 
expression was measured. DRP1 activity, including its translocation from the cytosol to the 
mitochondria, is highly regulated by post-transcriptional processes including phosphorylation 
and nitrosylation and, therefore, it is perhaps unlikely that transcriptional regulation plays a 
large role in modulating the rate of fission (Zorzano et al., 2010, Cereghetti et al., 2008, Cribbs 
and Strack, 2007). Similarly, MFN1 and 2 are regulated post-translationally, in particular by 
ubiquitination (Zorzano and Claret, 2015). Gene expression may give a preliminary insight into 
the possible mitochondrial network dynamics over this period, but further investigation is 
required for a more reliable conclusion. 
Mitofusins are known to play additional roles in the cell, which might be important during the 
perinatal period. Mfn1-knockout cells showed long-term altered mitochondrial calcium 
handling and membrane potential, implying a role of MFN1-driven fusion in regulating the 
muscle excitation-contraction coupling (Eisner et al., 2014). MFN2 is thought to directly 
regulate metabolism and energy balance (Hernandez-Alvarez et al., 2010). Mfn2 repression in 
myotubes has been shown to result in a reduced oxygen consumption and expression of ETS 
complexes and ATP synthase, with a compensatory increase in glycolysis (Bach et al., 2003, 
Pich et al., 2005). The increase in MFN1 and 2 expression in neonatal SDF may, therefore, be 





3.5.4 The increase in mitochondrial density and protein abundance precede the increase in 
mitochondrial respiratory capacity 
For all the respirometry data, an important consideration is that the oxygen consumption is 
measured with saturating concentrations of substrates and therefore gives a measure of 
maximal capacity of the muscle mitochondria (Pesta and Gnaiger, 2012). This may not 
represent what occurs in vivo but gives an interesting consideration, as the maximal rates of 
oxygen consumption measured do not simply follow the increase in mitochondrial abundance 
and ETS protein levels. A similar disparate result has been observed in cultured myoblasts, 
where an increase in abundance of mitochondrial proteins was not accompanied by an 
increase in functional capacity (Philp et al., 2010). Furthermore, when oxygen consumption 
was normalised to mitochondrial abundance, there was a general downward trend across all 
muscles, reaching significance in the BF for Py- and total oxygen consumption. The significant 
drop in Py-supported oxygen consumption per mitochondrial unit in the BF was between 127 
and 143dGA, which supports the theory that activity is specifically repressed around birth. 
However, this was not seen so clearly in the other muscles or upon delivery of the other 
substrates.  
The discrepancy between the ontogenic profiles of mitochondrial abundance and oxidative 
capacity poses the question of which regulatory mechanisms may drive the increased activity 
at birth (or conversely remove prenatal inhibition) independently of upregulating 
mitochondrial density and protein abundance. Numerous pathways have been suggested to 
regulate activity of the mitochondrial oxphos machinery. The increased ATP consumption 
after birth may increase the activity of the ETS, as ATP binding to CIV has been shown to 
interfere with its interaction with cytochrome c (Huttemann et al., 2007). In this way, CIV 
regulation balances energy supply and demand. ETS subunits can be phosphorylated, the 
most-studied being CIV which is strongly inhibited upon phosphorylation (Huttemann et al., 
2007). Interestingly, hypoxia induces phosphorylation of CIV in neonatal cardiomyocytes (Ogbi 
and Johnson, 2006). The increased pO2 exposure after birth may, therefore, be responsible for 
driving the increased mitochondrial activity, possibly in part via ETS dephosphorylation. 
Additionally, the low oxygen availability during fetal development may, via hypoxia-inducible 
factor (HIF) signalling, reduce the activity of pyruvate dehydrogenase and ETS complexes as 
has been reported to occur during hypoxia in adult tissues (Solaini et al., 2010, Chandel et al., 




electrolyte balance may play a role. An example is calcium which will fluctuate postnatally 
upon increased muscle contraction; calcium is known to increase activity of the TCA cycle, and 
also calcium-activated phosphatases may remove inhibitory ETS complex phosphorylation 
(Huttemann et al., 2007).  
In agreement with the initial hypothesis, there is an increase in mitochondrial density and 
mitochondrial protein abundance towards term in preparation for the increased postnatal 
energy demand. However, oxidative function of the muscle mitochondria appears to be held 
back in preparation for the transition to neonatal life. Thus, there may be a mechanism in 
place to reduce the maximal activity of the ETS near term both to limit the oxygen demand in 
utero when the supply is limited and to minimise the risk of excessive ROS production during 
labour and delivery when oxygen availability fluctuates widely. 
 
3.5.5 Uncoupling the proton gradient 
Age had a significant effect on the expression of UCP2 and 3 and ANT1 in skeletal muscle, with 
an increase over the perinatal period. This may explain the increased leak state respiration 
reported with age in all 3 muscles. Although proton leak is thought to reduce the efficiency of 
oxphos, a study in hyperthyroid rats showed an increased ATP synthesis despite an increase 
in UCP expression suggesting that UCP-mediated uncoupling is of negligible importance when 
oxphos is working at maximal capacity (Short et al., 2001). Alternatively, other factors may be 
involved in regulating the rate of UCP activity for example, inhibition by guanosine 
diphosphate (GDP) binding (Short et al., 2001, Simonyan et al., 2001). The upregulation of 
ANT1 and UCPs in this study, therefore, may be related to an increased necessity of alternative 
roles of these proteins, without impacting on the efficiency of ATP production.  
ANT1 showed a significant increase in both protein and mRNA expression over late gestation, 
with a further rise after birth. Previously, an increase in ANT abundance in rat liver has been 
reported during the last 3 days of fetal development which continued to rise postnatally in 
association with the maturation of mitochondrial oxidative capacity (Schönfeld et al., 1993). 
Considering the role of ANT in transporting ATP out and ADP into the mitochondria, the rise 
in abundance with age supports the theory that the fetus is preparing for the increased energy 
demand at birth. ANT1 carries out its transport role via utilisation of the PMF, thereby 




of ANT proteins (Brand et al., 2005). An alternative explanation for the ANT1 increment may 
be in preventing PMF rising too rapidly, thereby minimising the risk of excessive ROS 
production during the transition from intra- to extrauterine life.  
UCPs also uncouple the proton gradient from ATP generation and increased significantly with 
age over the perinatal period studied. However, expression of UCP2 and UCP3 in all 3 muscles 
showed a very different profile to that of ANT1, with rapid upregulation of mRNA abundance 
in the newborns compared to any fetal values over late gestation. The primary roles of UCP2 
and 3 are currently uncertain. One field of thought is that the key function of UCP2 is in 
metabolic regulation, with increased expression associated with an increased metabolic rate 
(Barbe et al., 2001) and low abundance associated with obesity (Nordfors et al., 1998). 
However, in the immediate postnatal period, when substrate stores are being depleted and 
an increase in ATP is required, increasing UCP2 for the key purpose of increasing metabolic 
rate through futile proton cycling is, perhaps, unlikely.  As with ANT1, UCPs in neonatal skeletal 
muscle might be important in regulating ROS production. One theory for the primary role of 
UCP2 is in minimising ROS production, as macrophages from Ucp2-knockout mice showed an 
80% increase in ROS production compared to wild-type mice (Arsenijevic et al., 2000). The 
widespread expression profile means UCP2 could be crucial in minimising oxidative stress 
throughout the organism (Pecqueur et al., 2001, Pierelli et al., 2017).  
As with UCP2, the primary function of UCP3 is a matter of debate. UCP3 is upregulated in 
hypoxic skeletal muscle and is activated, in part, by superoxide (Echtay et al., 2002). Therefore, 
its upregulation may be driven by ROS produced during labour as a direct response to prevent 
excess oxidative damage (Yamada et al., 2003). There are 2 other theories which may explain 
the rapid upregulation of UCP3 expression at birth. Firstly, UCP3 has been hypothesised to 
play a role in skeletal muscle mediated thermogenesis (Simonsen et al., 1993, Astrup et al., 
1985). An upregulation of skeletal muscle UCP3 gene and protein expression has been 
reported in rodents and humans upon the induction of thermogenesis, mediating a short-term 
response to cold-exposure (Simonyan et al., 2001, Barbe et al., 2001, Gong et al., 1997, Boss 
et al., 1997). The tissues in this current study have been taken only one day after the lambs 
would have been exposed to cold, and thus the increase in UCP3 may be important in non-
shivering thermogenesis. A second apparent function of UCP3 is in the regulation of lipid 
metabolism; an upregulation of UCP3 expression has been reported in response to a high fat 




higher in the newborn than the fetuses either in preparation for, or in response to, an increase 
in circulating FA concentration.  
 
3.5.6 Muscle specific differences 
For the majority of the mitochondrial parameters measured in this study the 3 muscles 
showed a very similar profile with age. However, in some cases including AMPKα abundance 
and expression of the markers of fusion, fission and biogenesis, significance was reached only 
in the SDF. This may be due to differences in the proportion of fibre types; the SDF was the 
only muscle to show a significant rise in expression of MHCI with age and had a higher 
percentage area of MHCI fibres than the ST shown by immunostaining. In turn, the different 
structural phenotypes may reflect the different roles of the muscles; the SDF carries out a 
more sustained contraction, generating a greater force than the BF and ST, therefore requiring 
a greater abundance of oxidative fibres.  
Studies investigating the characteristics of mitochondria from different pig muscle fibres have 
shown that mitochondria from oxidative fibres have a higher abundance of β-oxidation 
proteins and a higher PC-supported respiration, with no difference in Py- or glutamate-
oxidation in comparison to mitochondria from glycolytic fibres (Glancy and Balaban, 2011). 
These authors suggest that the increased metabolic demand of oxidative muscles is matched 
by an increased mitochondrial density rather than by changes to the mitochondria 
themselves. In the current study there were no differences between respirometry data 
obtained from the 3 muscles studied, however, whether there is a greater increase in HOAD 
activity in the SDF than the BF would be interesting to investigate.  
 
3.5.7 Endocrine regulation 
Maturational hormones, cortisol and T3, rose in fetal plasma concentrations significantly 
towards term. Both hormones showed a further increase postnatally. There was a significant 
correlation of both cortisol and T3 with numerous mitochondrial parameters measured 
including oxygen consumption, CS activity and HOAD activity. Partial correlation analyses 
indicate that T3 may be the more important of the two hormones in regulating mitochondria, 
in particular mitochondrial density. The importance of THs and cortisol in regulating 





In conclusion, over late gestation there is an increase in mitochondrial parameters including 
biogenesis and abundance of ETS proteins. This increase is, however, unlikely to be driven by 
PGC1α which also rises with age in the SDF. Instead, PGC1α may be playing a role in regulating 
substrate utilisation postnatally, or controlling the mitochondrial fusion in this muscle. 
Oxidative function appears to increase postnatally in the BF, ST and SDF. Preventing the 
increase in oxidative function until after birth might reflect a protective mechanism, in which 
the mitochondria and its protein components are put in place before birth, but the activity of 
the ETS is held back to minimise the risk of oxidative damage during the process of labour and 
delivery. Further, the increased UCP expression at birth may play a protective role against 
excessive ROS production upon sudden exposure to an increased pO2 and the increased rate 





















Thyroid hormones play a key role in regulating metabolism in the adult. They are associated 
with an increased metabolic rate and regulate thermogenesis by increasing mitochondrial 
number as well as upregulating abundance of ETS complexes, TCA cycle enzymes, UCPs and 
ANT in a variety of adult tissues including liver, heart and skeletal muscle (Winder, 1979, 
Clement et al., 2002, Barbe et al., 2001, Dummler et al., 1996, Harper and Seifert, 2008, Branco 
et al., 1999). Additionally, they regulate metabolism by promoting the oxidation of lipids in 
adult rat and human skeletal muscle (Clement et al., 2002, Lombardi et al., 2009, Irrcher et al., 
2008).  
Fetal whole body oxygen consumption is also sensitive to TH regulation (Fowden and Silver, 
1995, Lorijn et al., 1980). Previous studies of fetal sheep in late gestation have reported a 
positive correlation between the whole body rate of oxygen consumption and plasma T4 
concentrations (Fowden and Silver, 1995). The data in Chapter 3 also shows a positive 
correlation between maximal oxygen consumption of skeletal muscle in vitro and plasma T3 in 
vivo in fetal sheep during the perinatal period.  In addition to their role in regulating fetal 
oxidative metabolism, THs have previously been shown to be important for growth and 
development of the fetus as a whole and its individual organs during late gestation (Shields et 
al., 2011, Forhead and Fowden, 2014). Inducing hypothyroidism during development resulted 
in impaired growth and decreased mineral content of the skeleton, reduced mass of the heart, 
lungs, gastro-intestinal tract and subcutaneous fat, increased abundance of perirenal fat and 
in altered hepatic and renal carbohydrate metabolism (Erenberg et al., 1974, Forhead et al., 
1998, Lanham et al., 2011, Forhead et al., 2009, Forhead et al., 2003, Harris et al., 2017). 
Importantly, THs are also essential for the development of skeletal muscle in the ovine fetus; 
hypothyroidism is associated with reduced muscle glycogen, protein and DNA content, altered 
structural integrity, decreased IGF-I expression, reduced growth-hormone receptor 
abundance and a decreased proportion of type I to type II fibres (Erenberg et al., 1974, 




Near term, specific developmental processes occur in order to mature tissues sufficiently to 
take on new roles at birth. As shown in Chapter 3, this includes the increase in mitochondrial 
oxidative capacity of ovine fetal skeletal muscle in preparation for the increased energy 
demand at birth. Several maturational processes during late gestation are regulated by 
hormones including T3 which rises in a cortisol-dependent manner in the fetal circulation just 
before term (Fowden et al., 1998). Specifically in skeletal muscle, THs are thought to play a 
role in downregulating proliferative signals and inducing terminal differentiation, as shown in 
ovine fetal muscle and a murine cell line respectively (Carnac et al., 1992, Forhead et al., 2002). 
TH-dependent development continues postnatally; an increase in proportion of type I fibres 
was reported in 14 day old hypothyroid piglets compared to euthyroid controls (Harrison et 
al., 1996).  
Despite the well-known role of THs in adult metabolism, few studies have investigated the 
role of THs on fetal mitochondria. The limited available data suggest that THs increase 
mitochondrial function and protein expression in fetal tissues including the liver, adipose 
tissue and skeletal muscle (Herpin et al., 1996, Schermer et al., 1996, Gnanalingham et al., 
2005b). THs continue to rise significantly postnatally (Breall et al., 1984) and during the 
perinatal period, THs are crucial in driving non-shivering thermogenesis, predominantly by 
uncoupling the mitochondrial proton gradient via UCP1 in brown adipose tissue (Clarke et al., 
1997). Additionally, the postnatal TH surge is important in the switch in myocardial substrate 
preference from carbohydrate to predominantly fatty acid shortly after birth (McClure et al., 
2005). Whether THs regulate mitochondrial parameters before birth and drive the ontogenic 
changes in metabolism in skeletal muscle is not known. 
 
4.2 Aim 
The aim of this study was to investigate the role of THs during late gestation on the 
mitochondrial oxidative capacity of ovine skeletal muscle. The aim was to determine whether 
removing THs from the developing sheep fetus during late gestation would prevent the normal 
ontogenic rise in skeletal muscle mitochondrial function, and whether preterm T3-infusion 
would prematurely increase oxidative function, mimicking the normal changes seen in 






Seventeen twin-bearing ewes underwent surgery for this study. Of these, 12 ewes carried 
fetuses which underwent surgery at 102-105dGA in which 1 fetus was thyroidectomised (TX) 
and its twin sham-operated (Section 2.2.2.1). Pregnancy continued until 125-129dGA (n=6 
ewes) or 140-145dGA (n=6 ewes) when ewes and fetuses were euthanised and tissues 
collected as described in Section 2.2.4.1. The remaining 5 ewes and their fetuses were 
catheterised at 116-119dGA (Section 2.2.2.2) and following at least 5 days post-operative 
recovery one was infused with T3 (8-12µg/kg/day; n=5 fetuses) and its twin with saline (n=4 
fetuses) for a 5 day period until euthanasia and tissue collection at 127-130dGA (Section 
2.2.3.2). 
Details of surgery, tissue collection and experimental protocols used in this chapter are given 
in Chapter 2.  
 
4.3.2 Statistical Analyses 
A two-way ANOVA was applied to data from control and TX fetuses at 127dGA and 143dGA to 
determine whether there was a significant effect of TX and/or age when all groups were 
considered. As in Chapter 3, the ANOVA was applied in all cases when all groups had n≥5 
(Maxwell and Delaney, 1990). A Tukey’s multiple comparison post hoc test was used following 
a significant two-way ANOVA result. Additionally, and in cases when n<5, a t-test or Mann-
Whitney non-parametric test was used to compare control and TX values at the same age.  
For comparison of saline and T3-infused groups the sample sizes were too small to be able to 
test for a normal distribution and, therefore, a Mann-Whitney non-parametric test was used 
to detect differences between treatment groups. P<0.05 was considered significant and P<0.1 







4.4 Results:  Effects of thyroidectomy 
4.4.1 Fetal measurements 
Fetal plasma hormone concentrations  
There was no evidence of thyroid tissue remaining in any of the TX fetuses at the time of tissue 
collection. The effectiveness of the TX was confirmed by significantly lower levels of both fetal 
plasma T3 (P<0.01) and T4 (P<0.0001; Table 4.1) in the TX relative to the sham operated twin 
at both gestational ages (Table 4.1). TX did not significantly alter fetal cortisol concentrations 
(Table 4.1). There was a significant effect of age on fetal plasma cortisol (P<0.001) and T3 
(P<0.05) with no change in plasma T4 with age (Table 4.1). TX prevented the normal increment 
in plasma concentration of T3 and cortisol with increasing gestational age (Table 4.1).  
 
Table 4.1 Fetal plasma hormone concentrations 
 127dGA control 127dGA TX 143dGA control 143dGA TX 
Cortisol (ng/ml) 12.1±1.2 14.0±2.6 42.1±6.3† 25.7±6.5 
T3 (ng/ml) 0.33±0.01 0.21±0.03* 0.60±0.1† 0.24±0.01‡ 
T4 (ng/ml) 104.9±11.7 n.d.‡ 87.8±6.2 13.4±6.6‡ 
Mean±SEM fetal plasma hormone concentrations of control and TX fetuses at 127 days of 
gestational age (dGA; n=6) and 143dGA (n=5). N.d. not detectable. ‡ are significantly different 
from controls at the same gestational age and † are significantly different from 127dGA in the 
same treatment group (P<0.05 Tukey’s post hoc test following two-way ANOVA). * are 












Fetal biometry and muscle biochemical composition 
TX did not significantly affect fetal body weight, crown-rump length or the lengths of the femur 
and tibia (Table 4.2). However, there was a significant effect of TX on metatarsus length 
(P<0.0001) with significantly shorter lengths in TX animals compared to controls at both 
gestational ages (Table 4.2). There was no effect of TX on the weights of any of the 3 muscles 
studied, nor the muscle:body weight ratio at either gestational age (Table 4.2). TX did have a 
significant effect on the muscle water content (P<0.0001 in all 3 muscles) and protein content 
(P<0.05 in BF and P<0.0001 in ST; Table 4.2). Water content was significantly higher at both 
127 and 143dGA in all 3 muscles of TX fetuses compared to controls. Protein content was 
significantly lower in the ST of TX fetuses compared with controls at both ages and in BF at 
127dGA. A significant interaction between age and TX was seen in glycogen content of the BF 
(P<0.05) and glycogen was significantly lower in BF of TX fetuses compared to controls at 
127dGA (Table 4.2). Lipid content was only measured in the BF and was significantly lower in 
TX than controls at 143dGA (Table 4.2).  
As water content differed with treatment, the protein, glycogen and lipid content of the 
muscles are also expressed per mg dry weight (Table 4.2). After correction for the water 
content, there was a significant effect of TX on the protein content in the SDF, with content 
being significantly higher in the TX than control fetuses at both ages (Table 4.2). Glycogen 
content was higher in TX than controls at 143dGA in the BF whereas lipid content per mg dry 











Table 4.2 Biometric and biochemical measurements.  
 127dGA 
control 
127dGA TX 143dGA 
control 
143dGA TX 
Body weight (kg) 2.54±0.10 2.33±0.14 3.49±0.26† 3.25±0.19† 
Crown-rump length (cm) 41.8±0.8 40.0±0.5 45.0±0.5† 44.0±0.5† 
Femur (cm) 9.3±0.4 8.8±0.2 10.3±0.3 9.8±0.3 
Tibia (cm) 12.3±0.3 11.7±0.2 14.5±0.5† 13.3±0.5 
Metatarsus (cm) 14.3±0.2 13.0±0.3‡ 16.3±0.3† 14.7±0.3†‡ 
 Biceps femoris 
Weight (g) 11.02±0.46 10.92±0.89 13.91±1.35 13.97±0.78 
Muscle:body weight ratio (g:kg 
x103) 
4.34±0.08 4.71±0.35 3.96±0.15 4.30±0.08 
Water content (%) 83.3±0.5 85.8±0.4‡ 79.3±0.6† 83.5±0.8‡ 
Protein content   (mg/g wet weight) 









Glycogen content        (mg/g wet wt) 









Lipid content                (mg/g wet wt) 










Weight (g) 3.90±0.23 3.98±0.28 0.37±0.47† 4.98±0.32 
Muscle:body weight ratio (g:kg 
x103) 
1.53±0.04 1.71±0.08 1.54±0.07 1.33±0.27 
Water content (%) 81.7±0.5 84.4±0.3‡ 79.1±0.4† 83.4±0.6‡ 
Protein content   (mg/g wet weight) 









Glycogen content        (mg/g wet wt)  












 Superficial digital flexor 
Weight (g) 1.57±0.05 1.48±0.10 2.29±0.17† 2.19±0.20† 
Muscle:body weight ratio (g:kg 
x103) 
0.62±0.02 0.63±0.02 0.66±0.02 0.67±0.03 
Water content (%)  82.2±0.3 84.8±0.3‡ 78.6±0.7† 84.0±0.4‡ 
Protein content   (mg/g wet weight) 









Glycogen content        (mg/g wet wt)  













Data are presented as mean±SEM of control and TX fetuses at 127 days of gestational age 
(dGA) and 143dGA; n=6 per group unless stated otherwise. ‡ are significantly different from 
controls at the same gestational age and † are significantly different from 127dGA in the same 
treatment group (P<0.05 Tukey’s post hoc test following two-way ANOVA). * are significantly 





4.4.2 Functional oxidative capacity 
Respirometry was used to measure the ADP-coupled oxygen consumption of permeabilised 
muscle fibres with Py or PC as substrates. Also total ADP-coupled oxygen consumption 
stimulated by both glutamate and succinate was measured. Data are shown in Figure 4.1 with 
significant two-way ANOVA results shown on the graphs. Py- and PC-supported oxygen 
consumption in the BF was significantly lower in TX than controls at 143dGA and for Py at 
127dGA (Figure 4.1 A&D). Further, total oxygen consumption was significantly lower in BF of 
TX than control fetuses at 143dGA (Figure 4.1 G). In the ST PC-supported oxygen consumption 
was lower in TX than controls at 127dGA but not at 143dGA (Figure 4.1 E). In the SDF at 
143dGA, oxygen consumption using all 3 substrate protocols was lower in TX than control 
fetuses (Figure 4.1 C,F&I). Total oxygen consumption of the SDF was also significantly lower in 
TX compared to controls at 127dGA (Figure 4.1 I). There was a significant effect of age only on 
the PC-supported oxygen uptake in the SDF (P<0.05 by two-way ANOVA) although the increase 
was seen only between control fetuses at 143 compared to 127dGA and was prevented by TX 
(Figure 4.1 F). 
Py was added following PC and ADP, and thus the PC contribution to the combined PC- and 
Py-stimulated oxygen uptake could be calculated and is shown in Figure 4.2. There is no 
significant effect of treatment or age on this ratio. Oxygen consumption after the addition of 
substrates but before ADP was added, as a measure of leak state, was not affected by age or 
TX in any of the muscles studied (data not shown). The RCR was unaffected by TX in all cases 
except PC-supported RCR in the ST at 127dGA where TX values were significantly lower than 
their sham-operated controls (P<0.05 by t-test; data not shown).   
HOAD activity was measured only in the BF. The control value was significantly higher at 
143dGA than at 127dGA, and the TX value was significantly lower than the control at both 127 
and 143dGA (Figure 4.3).  The normal ontogenic increase in HOAD activity was prevented by 









Figure 4.1 Mean±SEM ADP-coupled, A-C) pyruvate (Py), D-F) palmitoylcarnitine (PC) and G-I) glutamate and succinate stimulated (total) oxygen 
consumption in A,D&G) biceps femoris, B,E&H) semitendinosus and C,F&I) superficial digital flexor of control (n=3-6; black bars) and TX (n=4-6; grey 
bars) fetuses at 127 and 143dGA. ‡ are significantly different from controls at the same gestational age and † are significantly different from 127dGA 
in the same treatment group (P<0.05 Tukey’s post hoc test following two-way ANOVA). * are significantly different from controls at the same gestational 





Figure 4.2 The ratio of ADP-coupled PC-supported:PC+Py-supported oxygen consumption, 
presented as mean±SEM in A) biceps femoris, B) semitendinosus and C) superficial digital flexor 




Figure 4.3 Mean±SEM β-hydroxyacyl-CoA dehydrogenase (HOAD) activity in biceps femoris 
muscle of control (black bars) and TX (grey bars) fetuses at 127dGA and 143dGA. N=6 in each 
group. ‡ are significantly different from controls at the same gestational age and † are 
significantly different from 127dGA in the same treatment group (P<0.05 Tukey’s post hoc test 
following two-way ANOVA). * are significantly different from controls at the same gestational 







4.4.3 Regulating oxidative capacity 
4.4.3.1 Mitochondrial density and biogenesis 
Citrate synthase activity was measured as a putative marker of mitochondrial density and is 
given with two-way ANOVA analyses of the effect of treatment and age in Figure 4.4 A-C. In 
all 3 muscles, CS activity was significantly lower in TX than control fetuses at 143dGA. The TX 
values were also significantly lower than controls at 127dGA in the BF and ST but not the SDF.  
The normal increase in CS activity with age was prevented by TX in all 3 muscles (Figure 4.4).   
Gene expression of mitochondrial biogenesis markers, PGC1α (Figure 4.4 D-F) and NRF1 
(Figure 4.4 G-I), was measured. In the ST, PGC1α expression was significantly lower in TX than 
control at 127dGA and expression of NRF1 was significantly higher in the TX fetuses compared 
to controls at 143dGA (P<0.05). There were no differences in PGC1α and NRF1 expression 
between TX and control values in the BF and SDF.  
In order to determine whether the oxidative capacity of the muscle followed the change in 
mitochondrial density oxygen consumption was normalised to CS activity/mg dry weight 
(Figure 4.5). Py-supported oxygen consumption was significantly higher in the BF of TX than 
controls (P<0.05 by two-way ANOVA). Normalised total oxygen consumption was significantly 
higher at 143dGA in ST of TX than control fetuses (Figure 4.5). In all other cases, there was no 









Figure 4.4 Mean±SEM A-C) citrate synthase activity and normalised gene expression of D-F) PGC1α and G-I) NRF1 in A,D&G) biceps femoris, B,E&H) 
semitendinosus and C,F&I) superficial digital flexor of control (n=4-6; black bars) and TX (n=5-6; grey bars) fetuses at 127 and 143dGA.  ‡ are significantly 
different from controls at the same gestational age and † are significantly different from 127dGA in the same treatment group (P<0.05 Tukey’s post 









Figure 4.5 Mean±SEM ADP-coupled,  A-C) pyruvate (Py),  D-F) palmitoylcarnitine (PC)-supported and G-I) total (glutamate and succinate-stimulated) 
oxygen consumption normalised to citrate synthase (CS) activity in A,D&G) biceps femoris, B,E&H) semitendinosus and C,F&I) superficial digital flexor 
of control (n=3-6; black bars) and TX (n=4-6; grey bars) fetuses at 127 and 143dGA. * are significantly different from controls at the same gestational 




4.4.3.2 ETS abundance 
The protein abundance of complexes I-IV and ATP-synthase were measured using western 
blotting and the data are presented for the BF, ST and SDF in Figure 4.6, Figure 4.7 and Figure 
4.8 respectively. There was a significant effect of TX in all 3 muscles; the abundance of several 
complexes were significantly lower in muscle of TX fetuses compared with controls at both 
ages (Figure 4.6-Figure 4.8). There was a significant effect of age on ETS complex abundance 
in the controls with significantly higher values at 143dGA than 127dGA for most of the 
complexes with the exception of CIV in all 3 muscles (Figure 4.6-Figure 4.8). However, TX 










Figure 4.6 Protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV) by western blotting in biceps femoris. A) 
representative blots and B-F) mean±SEM relative abundance of the complexes I-IV and ATP-synthase, as labelled, of control (black bars) and TX (grey 
bars) fetuses at 127 and 143dGA. N=5 in each group for CI, II, III and V; n=4-5 for CIV. ‡ are significantly different from controls at the same gestational 
age and † are significantly different from 127dGA in the same treatment group (P<0.05 Tukey’s post hoc test following two-way ANOVA). * are 










Figure 4.7 Protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV) by western blotting in semitendinosus. A) 
representative blots and B-F) mean±SEM relative abundance of the complexes I-IV and ATP-synthase, as labelled, of control (black bars) and TX (grey 
bars) fetuses at 127 and 143dGA. N=5 in each case. ‡ are significantly different from controls at the same gestational age and † are significantly different 










Figure 4.8 Protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV) by western blotting in superficial digital flexor. A) 
representative blots and B-F) mean±SEM relative abundance of the complexes I-IV and ATP-synthase, as labelled, of control (black bars) and TX (grey 
bars) fetuses at 127 and 143dGA. N=5 in each group for CI, II, III and V; n=4-5 for CIV. ‡ are significantly different from controls at the same gestational 
age and † are significantly different from 127dGA in the same treatment group (P<0.05 Tukey’s post hoc test following two-way ANOVA). * are 




4.4.3.3 Uncoupling the proton gradient 
In the ST and SDF there was a significant effect of TX on the mRNA abundance of UCP2 (Figure 
4.9 A-C) and UCP3 (Figure 4.9 D-F). UCP2 expression was significantly lower in TX than controls 
in all 3 muscles at 127dGA and in the SDF at 143dGA. UCP3 expression was significantly lower 
in TX than controls of ST and SDF at 143dGA and in SDF at 127dGA. There was no significant 
effect of age on UCP2 or UCP3 expression in any muscle of either control or TX fetuses (Figure 
4.9).  
ANT1 expression was significantly affected by TX, both at the protein (Figure 4.10 A-F) and 
mRNA level (Figure 4.10 G-I). Protein expression was significantly lower in all 3 muscles of TX 
fetuses compared to their controls at both ages (Figure 4.10 D-F). Additionally, ANT1 gene 
expression was lower in all 3 muscles from TX fetuses at 143dGA compared with controls and 
ST and SDF at 127dGA (Figure 4.10 G-I). ANT1 protein expression in all 3 muscles and gene 
expression in ST and SDF was significantly higher in control muscles at 143dGA compared with 
127dGA. Again, TX prevented the ontogenic increase in ANT1 gene and protein expression 
seen in the controls (Figure 4.10).  
 
Figure 4.9 Mean±SEM relative gene expression of A-C) uncoupling protein (UCP) 2 and D-F) 
UCP3 in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital flexor of control 
(n=5-6; black bars) and TX (n=6; grey bars) fetuses at 127dGA and 143dGA. ‡ are significantly 
different from controls at the same gestational age (P<0.05 Tukey’s post hoc test following 
two-way ANOVA). * are significantly different from controls at the same gestational age 









Figure 4.10 Protein and mRNA levels of adenine nucleotide translocase 1 (ANT1)  A-C) representative western blots, D-F) mean±SEM protein abundance 
(n=5 in each group)  and G-I) gene expression (n=5-6 in each group) in A,D&G) biceps femoris, B,E&H) semitendinosus and C,F&I) superficial digital flexor 
of control (black bars) and TX (grey bars) fetuses at 127 days of gestational age (dGA) and 143dGA.  ‡ are significantly different from controls at the 
same gestational age and † are significantly different from 127dGA in the same treatment group (P<0.05 Tukey’s post hoc test following two-way 




4.4.3.4 Fusion and fission 
qRT-PCR was used to quantify mRNA levels for proteins involved in mitochondrial fusion, 
MFN1 and MFN2, and fission, DRP1. There was a significant effect of TX on MFN1 in BF and 
SDF and MFN2 expression in all 3 muscles but not on DRP1 expression (Figure 4.11). 
Comparing TX and control values at the same gestational age, MFN1 expression was 
significantly lower in TX compared with controls in SDF and ST at both ages, and MFN2 was 
significantly lower in TX compared with controls in all 3 muscles at 127dGA and in the ST and 
SDF at 143dGA (Figure 4.11).  
 
 
Figure 4.11 Mean±SEM relative gene expression of A-C) mitofusin (MFN) 1 D-F) MFN2 and G-
I) dynamin-related protein 1 (DRP1), in A,D&G) biceps femoris, B,E&H) semitendinosus and 
C,F&I) superficial digital flexor of control (black bars) and TX (grey bars) fetuses at 127dGA 
(n=3-6) and 143dGA (n=6). ‡ are significantly different from controls at the same gestational 
age (P<0.05 Tukey’s post hoc test following two-way ANOVA). * are significantly different from 





4.4.3.5 Monitoring cellular energy status 
Protein abundance of AMPKα and pAMPKα were measured using western blotting. There was 
a significant effect of TX on pAMPKα abundance in BF with abundance significantly higher in 
TX than control fetuses at 143dGA (P<0.05; Figure 4.12). There was no effect of TX on pAMPKα 
in ST or SDF, nor of AMPKα abundance in any of the 3 muscles studied (Figure 4.12). The ratio 
of pAMPKα:AMPKα in BF was significantly affected by TX with a significantly higher ratio in TX 
compared with control fetuses at 127dGA (Figure 4.13). This ratio did not differ with TX in the 










Figure 4.12 Protein expression of (phosphorylated) AMP-activated protein kinase α ((p)AMPKα) by western blotting. A-C) representative blots and D-I) 
mean±SEM relative abundance of pAMPKα and AMPKα in A,D&G) biceps femoris, B,E&H) semitendinosus and C,F&I) superficial digital flexor of control 
(black bars) and TX (grey bars) fetuses at 127 days of gestational age (dGA) and 143dGA. N=5 per group, except ST AMPKα with n=3-4 per group.  * are 





Figure 4.13 Mean±SEM ratio between phosphorylated AMP-activated protein kinase α 
(pAMPKα) and AMPKα in A) biceps femoris (n=5), B) semitendinosus (n=3-4) and C) superficial 
digital flexor (n=5) of control (black bars) and TX (grey bars) fetuses at 127dGA and 143dGA. ‡ 
are significantly different from controls at the same gestational age (P<0.05 Tukey’s post hoc 



















4.4.4 Skeletal muscle structure and type I fibres 
In order to determine whether changes in mitochondrial parameters measured reflected a 
change in density of oxidative type I fibres, muscle sections were stained with H&E to 
determine total fibre density (Figure 4.14), and immunostained to allow quantification of the 
proportion of type I fibres (Figure 4.15). In addition, the number, average cross-sectional area 
and perimeter of the type I fibres were calculated and these data are presented in Table 4.3. 
There was a significant effect of TX on total fibre density in BF and ST (P<0.001 by two-way 
ANOVA). Fibre density was significantly lower in TX BF compared with controls at 143dGA, and 
in the TX ST compared with controls at both ages (Table 4.3). At 143dGA in the ST, the number, 
cross-sectional area and perimeter of type I fibres were all significantly lower in TX compared 
with controls, as was the area accounted for by type I fibres (Table 4.3). As in Chapter 3, the 
high density of fibres in control SDF at 143dGA resulted in the fibres being difficult to separate 
so the number, area and perimeter are not given for this group. The percentage area 
accounted for by MHCI fibres was significantly lower in TX than controls at 143dGA in the SDF 
and ST.   
Further insight into the fibre phenotypes was gained through quantifying mRNA levels of MHC 
isoforms MHCI, IIa and IIx (Figure 4.16). TX significantly affected the expression of all 3 
isoforms in all 3 muscles with the significant differences between TX and control values shown 
in Figure 4.16.  Age had an effect on MHC expression in a muscle specific manner; MHCIIx was 
increased with age in ST and BF, whereas MHCI and MHCIIa expression were increased in the 







Figure 4.14 Representative H&E stained sections at 40x magnification in biceps femoris, semitendinosus and superficial digital flexor of control and TX 







Figure 4.15 Representative MHCI stained sections at 20x magnification in biceps femoris, semitendinosus and superficial digital flexor of control and TX 




 Table 4.3 Type I fibre analyses.  
 127dGA 
Control 
127dGA TX 143dGA 
Control 
143dGA TX 
 Biceps femoris 
Proportion of total area 









Number of type I fibres/mm2 286±84 178±20 467±71 225±48 
Average fibre cross-sectional area 
(µm2) 
364.9±34.7 318.6±14.0 419. ±25.6 369.5±14.4 
Average fibre perimeter (µm) 71.6±3.5  66.7±1.6 78.0±2.4 72.0±1.5 
Proportion of total area 
accounted for by type I fibres (%) 
10.3±3.0 5.8±0.9 19.5±3.0 8.2±1.8 
Proportion of fibre area 
accounted for by type I fibres (%) 
11.9±3.1 9.0±1.4 23.2±3.6 12.9±3.9 
 Semitendinosus 
Proportion of total area 









Number of type I fibres/mm2 270±47 133±34 318±21 86±5* 
Average fibre cross-sectional area 
(µm2) 
422.2±22.7 403.8±22.1 481.4±13.6 375.3±7.0* 
Average fibre perimeter (µm) 78.0±2.2 76.2±2.2 84.4±1.3 73.5±0.6* 
Proportion of total area 
accounted for by type I fibres (%) 
11.5±2.3 5.3±1.2 15.3±1.1 3.3±0.1* 
Proportion of fibre area 
accounted for by type I fibres (%) 
15.8±3.2  9.9±2.2 17.0±1.1  5.1±0.3* 
 Superficial digital flexor 
Proportion of total area 
accounted for by fibres (%) 
64.8±3.5 55.1±4.3 75.1±4.7  67.1±3.2 
Number of type I fibres/mm2 465±92 424±66 n.q. 383±107 
Average fibre cross-sectional area 
(µm2) 
302.9±43.4 300.0±23.0 n.q. 295.0±13.7 
Average fibre perimeter (µm) 65.9±4.7 65.6±2.5 n.q. 65.3±1.4 
Proportion of total area 
accounted for by type I fibres (%) 
13.1±1.2 12.5±1.6 27.6±3.1 11.0±2.9# 
Proportion of fibre area 
accounted for by type I fibres (%) 
20.2±1.2 22.5±1.9 34.6±1.9 16.2±4.2* 
Data are presented as mean±SEM in biceps femoris, semitendinosus and superficial digital 
flexor of control and TX fetuses at 127 and 143 days of gestational age (dGA). N=4 in each 
group, unless stated otherwise. ‡ are significantly different from controls at the same 
gestational age and † are significantly different from 127dGA in the same treatment group 
(P<0.05 Tukey’s post hoc test following two-way ANOVA). * are significantly different from 







Figure 4.16 Mean±SEM gene expression of A-C) MHCI, D-F) MHCIIa and G-I) MHCIIx in A,D&G) biceps femoris, B,E&H) semitendinosus and C,F&I) 
superficial digital flexor of control (black bars) and TX (grey bars) fetuses at  127 (n=5-6 per group) and 143 days of gestational age (dGA; n=6 per 
group). ‡ are significantly different from controls at the same gestational age and † are significantly different from 127dGA in the same treatment 
group (P<0.05 Tukey’s post hoc test following two-way ANOVA). * are significantly different from controls at the same gestational age (P<0.05 by t-test 




4.5 Results: Effects of T3-infusion  
4.5.1 Fetal measurements 
Fetal blood measurements 
The 5-day T3 infusion protocol resulted in a lower T4 plasma concentration compared with 
controls, although T3 concentrations were not significantly different to controls due to wide 
inter-animal variation in the T3 infused fetuses (Table 4.4, Figure 4.17A). The fetal plasma T3 
and T4 concentrations throughout the infusion period in both control and T3-infused fetuses 
are shown in Figure 4.17. The T3 infusion did significantly raise the T3 concentration compared 
to day 0 of the infusion (P<0.05, paired t-test, n=5), whereas the T3 concentration was not 
different between day 0 and day 5 of the saline-infused fetuses. The weight of the fetal thyroid 
gland showed a trend to be lower in T3-infused (0.45±0.03g) than control fetuses (0.58±0.05g; 
P<0.1 by Mann-Whitney test). Infusion of T3 had no effect on fetal cortisol concentrations 
(Table 4.4). There were also no differences in blood pH, pO2, pCO2, HCO3, haemoglobin, 
oxygen saturation, glucose or lactate between cohorts at the start of the infusion period (data 
not shown) through to day 5 of infusion in either group of fetuses (data shown in Table 4.5).   
 
Table 4.4 Fetal plasma hormone concentrations  
 Control T3-infused 
Cortisol (ng/ml) 11.0±1.6 14.5±1.5 
T3 (ng/ml) 0.41±0.06 1.73±0.56 
T4 (ng/ml) 124.2±6.0 53.9±16.2* 
Data are presented as mean±SEM of control (n=4) and T3-infused fetuses (n=5). * are 






Figure 4.17 Mean±SEM fetal plasma A) T3 and B) T4 concentrations over the 5-day T3 infusion 
period of control (n=4; circles) and T3-infused (n=5; crosses) fetuses. * are significantly different 
between control and T3-infused fetuses (P<0.05 by Mann-Whitney test).  
 
 
Table 4.5 Fetal arterial blood parameters on day 5 of infusion.  
  Control T3-infused 
Fetal arterial blood 
parameters 
pH 7.40±0.02  7.37±0.02  
pO2 (mmHg) 17.8±0.8  18.6±1.0  
pCO2 (mmHg) 51.0±0.8  50.7±1.1  
HCO3 (mmol/L) 29.6±0.9  27.5±0.5  
Haemoglobin (g/dL) 10.4±0.3 (n=3) 10.2±0.5 (n=4) 
%O2 saturation 55.6±3.5 (n=2) 57.5±2.9 (n=3) 
Glucose (mmol/L) 0.69±0.07  0.67±0.07  
Lactate (mmol/L) 0.96±0.04  1.02±0.07  
Data are presented as mean±SEM of control (n=4 unless stated otherwise) and T3-infused (n=5 










Fetal biometry and muscle biochemical composition 
The 5-day T3-infusion did not result in a significant difference in fetal body weight, body 
measurements, muscle weights, muscle:body weight ratios or muscle glycogen, lipid and 
protein content compared with the saline-infused control fetuses (Table 4.6). There was a 
trend for a lower water content in all 3 muscles of T3-infused fetuses compared with controls 
(Table 4.6). When expressed per mg dry weight, the glycogen content of BF of T3-infused 





















Table 4.6 Biometric and biochemical measurements.  
 Control T3-infused 
Body weight (kg) 2.54±0.10 2.33±0.14 
CRL (cm) 43.0±1.2 43.4±0.9 
Femur (cm) 8.8±0.3 8.8±0.3 
Tibia (cm) 12.6±0.4 13.0±0.2 
Metatarsus (cm) 14.9±0.4 15.1±0.3 
 Biceps femoris 
Weight (g) 11.02±0.46 10.92±0.89 
Muscle:body weight ratio (g:kg 
x103) 
4.34±0.08 4.71±0.35 
Water content (%)  82.3±0.4 (n=3) 80.6±0.2 (n=4) # 
Protein content           (mg/g wet wt)  





Glycogen content        (mg/g wet wt)  




0.19±0.01 (n=4) # 
Lipid content                (mg/g wet wt)  






Weight (g) 3.90±0.23 3.98±0.28 
Muscle:body weight ratio (g:kg 
x103) 
1.53±0.04 1.71±0.08 
Water content (%)  82.1±0.3 (n=3) 80.6±0.3 (n=4) # 
Protein content           (mg/g wet wt)  





Glycogen content        (mg/g wet wt)  





 Superficial digital flexor 
Weight (g) 1.57±0.05 1.48±0.10 
Muscle:body weight ratio (g:kg 
x103) 
0.62±0.02 0.63±0.02 
Water content (%)  82.6±80.7 (n=3) 80.6±0.4 # 
Protein content           (mg/g wet wt)  





Glycogen content        (mg/g wet wt)  





Data are presented as mean±SEM of control (n=4 unless stated otherwise) and T3-infused 







4.5.2 Oxidative capacity 
The oxygen consumption of permeabilised muscle fibres was measured using respirometry. 
There was no difference in ADP-coupled oxygen consumption between control and T3-infused 
cohorts using Py, PC or glutamate and succinate as substrates in any muscle (Figure 4.18). 
There was also no difference in the ratio of PC-supported:PC plus Py-supported state 3 
respiration in the 3 skeletal muscles from T3-infused fetuses compared with controls (Figure 
4.19). Leak state respiration and RCR values using Py, PC or glutamate were not affected by T3 
infusion (data not shown). HOAD activity was measured only in the BF and there was no 
significant difference between T3-infused and control fetuses (Figure 4.20).  
 
 
Figure 4.18 Mean±SEM ADP-coupled, pyruvate (Py), palmitoylcarnitine (PC) and glutamate 
and succinate stimulated (total) oxygen consumption in A) biceps femoris, B) semitendinosus 
and C) superficial digital flexor of control (n=3-4; black bars) and T3-infused (n=4-5; cross-








Figure 4.19 Mean±SEM ratio of ADP-coupled palmitoylcarnitine (PC)-supported:PC+pyruvate 
(Py)-supported oxygen consumption in A) biceps femoris, B) semitendinosus and C) superficial 




Figure 4.20 Mean±SEM β-hydroxyacyl-CoA dehydrogenase (HOAD) activity in biceps femoris 











4.5.3 Regulating oxidative capacity 
4.5.3.1 Mitochondrial abundance 
The mitochondrial density, as assessed by CS activity, was not affected by T3-infusion in BF or 
SDF, although tended to be higher in ST of T3-infused than control fetuses (Figure 4.21 A-C). 
When the Py- and PC-supported and total ADP-coupled oxygen consumption were normalised 
to CS activity, there was no difference in oxygen consumption per mitochondrial unit in any of 
the muscles studied (data not shown). The gene expression of mitochondrial biogenesis 
markers, PGC1α and NRF1, was not different in any of the muscles studied of T3-infused 
fetuses compared with controls (Figure 4.21 D-F).  
 
 
Figure 4.21 Mean±SEM A-C) citrate synthase activity and D-F) normalised gene expression of 
PGC1α and NRF1  in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital 
flexor of control (n=2-4; black bars) and T3-infused (n=3-5; cross-hatched bars) fetuses. # trend 








4.5.3.2 ETS abundance 
The protein abundance of ETS complexes I-IV and ATP-synthase were measured by western 
blotting (Figure 4.22). ATP-synthase showed a trend to be higher in the SDF of T3-infused 
fetuses compared with controls. T3 infusion did not have a significant effect on abundance of 
the other ETS complexes in any of the muscles studied. When considering all complexes and 
performing a two-way ANOVA (complex and treatment), there was a significant effect of T3-









Figure 4.22 Protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV) by western blotting. A-C) representative blots 
and D-F) mean±SEM relative abundance of the complexes in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital flexor of control 




4.5.3.3 Uncoupling the proton gradient 
There was no significant difference in the gene expression of UCP2 or UCP3 between control 
and T3-infused fetuses in any of the 3 muscles studied (Figure 4.23). The protein abundance 
of ANT1 shows a trend to be higher in the SDF of T3-infused fetuses compared with controls 
but no difference was seen in the BF or ST (Figure 4.24). ANT1 gene expression was also 
unaffected by T3 infusion in all 3 muscles (Figure 4.24).  
 
Figure 4.23 Mean±SEM normalised gene expression of uncoupling proteins (UCP) 2 and 3 in A) 
biceps femoris, B) semitendinosus and C) superficial digital flexor of control (n=2-3; black bars) 
and T3-infused (n=5; crosshatched bars) fetuses. 
 
 
Figure 4.24 Protein and mRNA levels of adenine nucleotide translocase 1 (ANT1)  A-C) 
representative western blots and D-F) mean±SEM normalised gene expression and protein 
abundance in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital flexor of 
control (n=2-4; black bars) and T3-infused (n=4-5; crosshatched bars) fetuses. # trend to differ 




4.5.3.4 Fusion and fission 
T3 infusion did not significantly affect gene expression of the fusion and fission proteins, 
MFN1, MFN2 or DRP1, in any muscle studied, although DRP1 showed a trend to be lower in 
ST of T3-infused fetuses compared with controls (Figure 4.25).  
 
 
Figure 4.25 Mean±SEM normalised gene expression of mitofusins (MFN) 1 and 2 and dynamin-
related protein 1 (DRP1) in A) biceps femoris, B) semitendinosus and C) superficial digital flexor 
of control (n=4-6; black bars) and T3-infused (n=6; crosshatched bars) fetuses. # trend to differ 
















4.5.4 Skeletal muscle structure and type I fibres 
Muscle sections were stained with H&E to quantify fibre density (Figure 4.26), and MHCI was 
stained fluorescently in order to identify type I muscle fibres (Figure 4.27). T3-infusion did not 
affect total fibre density, nor type I fibre parameters including density, cross sectional area, 
perimeter or number in any muscle (Table 4.7), or gene expression of MHCI, IIa and IIx in any 
muscle studied (Figure 4.28).  
 
Figure 4.26 Representative H&E stained sections at 40x magnification in biceps femoris, 
semitendinosus and superficial digital flexor of control and T3-infused fetuses, as labelled. 
 
 
Figure 4.27 Representative MHCI stained sections at 20x magnification in biceps femoris, 







Table 4.7 Type I fibre analyses. 
 Control T3-infused 
 Biceps femoris 
Proportion of total area accounted 
for by fibres (%; n=6) 
69.8±6.1 74.9±3.1 
Number of type I fibres/mm2 322±55 523±61 
Average fibre area (μm2) 342.4±44.6 331.9±16.1 
Average fibre perimeter (μm) 69.3±4.7 69.4±1.7 
Proportion of total area accounted 
for by type I fibres (%) 
11.0±2.5 17.0±1.6 
Proportion of fibre area accounted 
for by type I fibres (%) 
15.3±2.5 24.0±5.1 
 Semitendinosus 
Proportion of total area accounted 
for by fibres (%; n=6) 
83.6±4.3 88.5±2.9 
Number of type I fibres/mm2 239±41 314±58 
Average fibre area (μm2) 388.7±44.2 397.6±6.3 
Average fibre perimeter (μm) 73.5±4.2 75.0±0.4 
Proportion of total area accounted 
for by type I fibres (%) 
9.8±2.6 12.4±2.2 
Proportion of fibre area accounted 
for by type I fibres (%) 
13.8±2.8 16.2±3.9 
 Superficial digital flexor 
Proportion of total area accounted 
for by fibres (%; n=6) 
70.9±3.6 74.4±2.2 
Number of type I fibres/mm2 534±65 505±52 
Average fibre area (μm2) 294.8±12.0 295.2±21.5 
Average fibre perimeter (μm) 65.3±1.4 65.0±2.2 
Proportion of total area accounted 
for by type I fibres (%) 
15.5±1.4 14.5±1.0 
Proportion of fibre area accounted 
for by type I fibres (%) 
21.9±2.5 19.4±2.2 
Data are presented as mean±SEM in biceps femoris, semitendinosus and superficial digital 








Figure 4.28 Mean±SEM gene expression of MHCI, MHCIIa and MHCIIx in A) biceps femoris, B) 






















This study demonstrates that THs are important for regulating several aspects of 
mitochondrial development in skeletal muscle of fetal sheep during late gestation. 
Hypothyroidism during late gestation resulted in skeletal muscle having a significantly lower 
mitochondrial density and abundance of proteins involved in oxidative ATP production at 
term, as well as delaying maturation of the muscle structure and leading to a higher water 
content and lower fibre density relative to sham operated controls. Muscle-specific reductions 
in mitochondrial oxidative capacity and in UCP and MFN expression were also evident, 
particularly close to term, in response to TX earlier in gestation. Fetal hypothyroidism also 
prevented the normal ontogenic changes in mitochondrial function seen towards term. 
However, the 5-day T3 infusion did not prematurely increase the functional oxidative capacity 
of the muscle, nor significantly affect any of the mitochondrial parameters measured.   
 
4.6.1 Effectiveness of the hormone manipulation protocols; impact on fetal development 
TX was performed at 102-105dGA and the hormone levels measured 24-40 days post-surgery 
at ~127 and ~143dGA. Previous studies using this protocol have reported no detectable fetal 
plasma T3 or T4 at both ages (Forhead et al., 1998). However, in this cohort of animals, 
excluding T4 at 127dGA, the concentrations of the THs were close to, but did not fall below 
the limit of detection of the RIA. Concentrations of both T3 and T4 were significantly lower in 
TX fetuses than the age-matched controls at both 127 and 143dGA. In individual pairs of twins, 
the TX fetus always had a much lower concentration of T4, suggesting that cross-circulation 
was unlikely to be responsible for THs detected in the TX fetuses.  
T3 has been reported in the circulation of TX fetuses at ~127dGA following cortisol infusion, 
suggesting that there is still a source of THs present following TX (Forhead et al., 1998). This 
may be partly due to the presence of T3 sulphate which has been shown to remain in the 
circulation after TX and has been suggested to contribute to the plasma and tissue T3 
concentrations following desulphation (Wu et al., 1993). Additionally, T4 levels may be 
buffered by binding protein in the plasma, delaying their removal from the circulation 
(Hoffenberg and Ramsden, 1983). Any remaining T4 may then be converted locally to T3 
resulting in some residual T3. TX performed at a similar timing to our protocol resulted in a 
tissue-specific effect on deiodinase activity with increased D2 activity in the brain, whereas TX 




These results suggest that when TH levels are low, the fetal response is to spare T3 for the 
more vital development of the brain. Whether fetal muscle D2 is regulated by thyroid status 
has not been investigated, although in adult human muscle, activity and abundance of D2 is 
not changed in response to hypothyroidism (Heemstra et al., 2009). Measuring the deiodinase 
abundance in the muscles may give an idea of the local exposure to T3. 
A further comment on the measurement of THs in this study is that only total levels of both 
hormones have been considered. Only approximately 0.3% T3 and 0.03% T4 circulate unbound 
in the plasma and are immediately available for cellular uptake (Hoffenberg and Ramsden, 
1983). Further insight into the bioavailability of THs may come from measuring levels of the 
TH binding globulins and free TH. 
Although the TH levels did not fall to undetectable levels, biometric measurements and fetal 
observations match those previously reported following ovine TX at the same point in 
gestation (Harris et al., 2017). In particular, the metatarsus length has been previously 
reported to be shorter in TX fetuses than age-matched controls (Lanham et al., 2011).  
For this study aspects of skeletal muscle structure and biochemistry were analysed. There was 
no significant difference in muscle weight of any of the muscles studied between TX and 
control fetuses. A previous study has reported a lower muscle mass due to TX, however, in 
this case TX was performed earlier in gestation, 70-75dGA, and tissues taken at term 
(Finkelstein et al., 1991). The body weight of TX fetuses were not significantly different to 
controls as has been shown before (Erenberg et al., 1974).  As shown previously, the muscle 
mass:body weight ratio was not different in TX and control fetuses (Finkelstein et al., 1991).  
The biochemical composition of the muscles showed muscle specific changes in response to 
TX. The glycogen content was lower at 127dGA in BF of TX compared to control fetuses, but 
by term this difference was no longer observed. These results are in agreement with a 
previous study on the BF of TX fetuses (Forhead et al., 2009). However, glycogen content of 
the ST and SDF were not different at either time point between treatment groups. Previously, 
protein content of TX muscle has been shown to be lower than controls, although the muscle 
was not specified in the previous study (Erenberg et al., 1974). In the current study, protein 
content was lower in TX than control ST at both ages studied, and the BF at 127dGA. In 
addition, a lower muscle DNA content has been reported previously alongside a normal ratio 




be due to an increased water content of the fibres and/or a decrease in fibre number. Here, 
the data shows that either hypothesis may explain their observations. All 3 muscles of TX 
fetuses had a significantly higher water content than controls at both ages studied. 
Additionally, the fibre density of the BF and ST was lower in TX than control fetuses at term.  
T3-infusion in this cohort resulted in a significantly lower T4 circulating concentration which 
may reflect the T3 negative feedback on the HPT axis which has been previously reported in 
some, but not all, studies using this protocol (Forhead et al., 2003, Forhead et al., 1998, Lorijn 
et al., 1980). There was also a trend for a decrease in fetal thyroid gland mass in the T3-infused 
fetuses compared with controls, reflecting the previously identified reduction in blood flow to 
this organ and the potential reduction in TSH (Lorijn et al., 1980).  
 
4.6.2 Thyroidectomy prevented the normal prepartum development of mitochondrial function 
in skeletal muscle 
The importance of THs for development of mitochondrial function in skeletal muscle is shown 
not only by the reduction in many of the mitochondrial parameters measured in the muscles 
after TX, but also by the lack of any increment in these values between 127 and 143dGA as 
seen in their sham operated twins. As shown in Chapter 3, and replicated in this chapter, 
gestational age has a significant effect on the mitochondrial density and abundance of some 
of the ETS complexes and ANT1. TX suppressed the normal ontogenic rise in all of these 
parameters. Similarly, maturation of the skeletal muscle adult phenotype over late gestation, 
for example the increase in expression of MHCI and MHCIIa in the SDF, is not apparent in the 
muscle of TX fetuses. Therefore, THs are essential for the normal metabolic development of 
skeletal muscle mitocondria during late gestation in preparation for birth.  
 
4.6.2.1 Oxidative capacity 
This study has shown that in fetal skeletal muscle, as in adult tissue, THs are important 
metabolic regulators. The mitochondrial density in TX fetal muscle at term was lower than in 
controls coinciding with lower oxygen consumption in a muscle- and substrate-specific 
manner. Interestingly, when Py-supported state 3 respiration was normalised to CS activity, 
oxidative function per mitochondrion was higher in the TX fetuses than controls. Similarly, 




in TX than control fetuses. These results suggest there may be a compensatory mechanism in 
place to help maintain mitochondrial function when mitochondrial density is prevented from 
increasing towards term in the hypothyroid environment. THs may be regulating metabolism 
by controlling abundance of ETS complexes and ATP-synthase, several of which were lower in 
TX than control fetal muscle. Additionally, results presented here support a role of THs in 
increasing fetal metabolism through MFN1 and MFN2-driven mitochondrial fusion. THs have 
previously been shown to increase fetal metabolic rate and the results of this study support 
the hypothesis that this may be largely due to an increase in skeletal muscle metabolism 
(Fowden and Silver, 1995, Forhead and Fowden, 2014). 
 
4.6.2.2 Uncoupling the gradient 
THs in the adult increase metabolic rate, in part through decreasing the efficiency of oxphos 
by increasing the abundance of proteins known to dissipate the proton gradient. In the current 
study, THs have been shown to play a similar role in the fetus, with expression of ANT1 
significantly lower in all 3 muscles from TX than control fetuses at both 127 and 143dGA. 
Similarly, both UCP2 and UCP3 were lower in TX SDF than controls, and UCP3 expression was 
lower in ST at 143dGA and UCP2 was reduced at 127dGA in BF and ST. At birth, there is an 
increased requirement for ATP and therefore, the efficiency of oxphos should be critical for 
neonatal survival. As discussed in Chapter 3, we hypothesise that increased UCP and ANT 
expression at birth is perhaps a protective mechanism against excessive ROS production, or in 
order to carry out additional roles, for example in thermogenesis. 
Over the perinatal period, one key role of THs is in thermogenesis (Clarke et al., 1997). T3 is 
crucial for increasing the UCP1-mediated non-shivering thermogenesis in brown adipose 
tissue. Further, TH-driven thermogenesis has been associated with an upregulation of skeletal 
muscle UCP3 in humans and rodents (Barbe et al., 2001, Gong et al., 1997). The TH-
dependency of UCP3 expression in ST and SDF at term may reflect this role of THs in 
preparation for neonatal cold exposure and the immediate requirement for thermogenesis.  
This study has also shown that ANT1 expression, especially at the protein level, is dependent 
on the presence of circulating THs. A study on rats suggests that increased ANT expression 
may, at least in part, explain the TH-driven increase in metabolism in the liver and the heart 




a T3-dependent increase in ANT abundance (Portman et al., 2000). However, in adult rats, 
ANT1 expression in the heart is not sensitive to T3 (Dummler et al., 1996). In this study, there 
was a trend for higher ANT1 protein abundance in the SDF of T3-infused fetuses compared to 
controls, but no difference in the BF or ST. In the sheep fetus, therefore, ANT1 expression 
seems to be sensitive to TH availability, but as in the rat, may not be directly responsive to the 
hormone.   
 
4.6.3 Physiological impact of TX; indirect effects on skeletal muscle development 
The THR is expressed in developing pig skeletal muscle and a compensatory upregulation of 
the THR has been reported to occur in response to hypothyroidism, therefore THs may play a 
direct role in regulating the expression of mitochondrial genes (White et al., 2001, Duchamp 
et al., 1994). However, TX may also downregulate mitochondrial function indirectly by 
affecting the expression of other pathways in skeletal muscle, altering the tissue availability 
of, and tissue responsiveness to, other hormones or even affecting the development of other 
organs which in turn impact on muscle development. 
Although not measured in this study, TX ovine fetuses have been previously shown to have 
significantly higher circulating leptin and insulin concentrations, by both 129 and 143dGA 
(Harris et al., 2017).  Leptin has been shown to play a role in some aspects of fetal maturation 
and negatively correlates to fetal weight, whereas insulin is a growth factor in utero 
(Buchbinder et al., 2001, Fowden et al., 1989, Forhead et al., 2008). The leptin receptor has 
been identified in fetal sheep tissues including skeletal muscle, however, to date a role of 
leptin in skeletal muscle maturation is unknown (Forhead et al., 2008, Buchbinder et al., 2001). 
Fetal insulin, on the other hand, plays an important role in glucose uptake, oxidation and 
storage in fetal muscle (Hay, 2006). Cortisol in our cohort was lower, although not significantly, 
whereas in previous studies, conflicting data has been presented on the effect of TX on cortisol 
concentration ranging from having no effect to preventing the normal rise in cortisol at term 
(Harris et al., 2017, Forhead et al., 2002). The discrepancy may be due to the timing of tissue 
collection being just before or after a delayed cortisol surge in the TX fetuses. In addition, TX 
results in a diminished growth hormone receptor abundance in ovine skeletal muscle (Forhead 
et al., 2002). The muscle expression of IGF-I, a fetal growth factor, is lower in TX fetuses 
compared to controls, although circulating IGF-I and IGF-II is not different (Forhead et al., 




may be involved in the diminished metabolism of the TX skeletal muscle, although the roles 
of the individual hormones are not clear.  
THs are essential for the normal development of the brain, with hypothyroidism associated 
with reduced neuronal density, branching and synaptic contacts and myelination (Horn and 
Heuer, 2010). Neuronal stimulation and TH are both responsible for determining the 
proportions of skeletal muscle fibre types (Gambke et al., 1983). In the current study, TX 
caused a decreased proportion of type I fibres in the ST and reduced the expression of MHCI, 
MHCIIa and MHCIIx in all muscles studied. Similarly, a decreased proportion of type I fibres 
due to TX has been reported previously in the gastrocnemius and extensor digitorum longus 
muscles and may be, in part, due to impaired neuronal development (Finkelstein et al., 1991). 
Indeed, the axonal conduction velocity of the nerve stimulating the gastrocnemius was 
significantly slower in TX than control fetuses at term resulting in a delayed maturation of the 
muscle contractile properties (Finkelstein et al., 1991). In a separate study, removal of the 
pituitary gland did not alter fibre type proportions, although it did reduce the average fibre 
cross-sectional area as shown in the current study for type I fibres in the ST (Javen et al., 1996). 
Although removal of the pituitary gland affects both the HPT and HPA axes, the negative 
impact on skeletal muscle development was less severe than after TX which may be due to a 
slower decline in TH availability, or due to the central nervous system development being less 
impaired (Javen et al., 1996).  
TX clearly affects numerous aspects of development at the cellular, tissue and whole body 
level and it is difficult to separate out the roles of individual components when considering 
the whole physiological system.  
 
4.6.4 T3 infusion is not sufficient to drive prepartum skeletal muscle maturation 
Despite the striking phenotype associated with TX, infusion of T3 for 5 days did not affect 
skeletal muscle structural and mitochondrial maturation. Of the parameters measured, water 
content of the 3 muscles showed a trend to decrease with T3-infusion, ANT1 and ATP synthase 
protein abundance showed a trend to be higher in SDF of T3-infused than control fetuses and 
mitochondrial density was higher in the ST of T3-infused than control fetuses but again this did 




muscle have been reported to be impaired by TX but not prematurely driven by T3 infusion 
(Forhead et al., 2002, Forhead et al., 1998). 
As discussed above, TX was performed early in gestation, giving up to 40 days of an altered 
endocrine environment. During this time the development of numerous physiological systems 
is affected which may interact to impair skeletal muscle development. The T3 infusion 
protocol, however, alters the endocrine environment over a much shorter time-scale. The 
predominant action of THs are long-term effects mediated through altered gene expression 
(Wu and Koenig, 2000). Therefore, 5 days may not be sufficient to up- or down-regulate target 
pathways in time to have a measurable effect, although T3-infusion has been shown to 
stimulate maturational changes in other tissues (Forhead et al., 2003, Forhead et al., 2006, 
Lorijn et al., 1980).  
Removal of the thyroid gland in the sheep fetus means that, apart from minimal local TH stores 
and sulphated THs, the concentration of THs are low and there is little the organism can do to 
compensate for this. Conversely, T3-infusion can have a direct negative feedback on the HPT 
axis, and this seemed to be occurring in this cohort as we measured a decreased circulating T4 
concentration, and the thyroid gland tended to be smaller in the infused fetuses compared to 
controls. A further consideration here is that the lack of T3 effects may be due to the 
concomitant decrease in T4. Certainly, the total oxygen consumption of the fetus was more 
closely correlated to T4 than T3 (Fowden and Silver, 1995). Alternatively, although circulating 
T3 was higher at the end of the infusion period than at the start, the skeletal muscle local 
bioavailability and activity has not been determined; T3-infusion may affect the deiodinase 
activity and abundance of the THR. In mouse muscle cell lines, a decrease in D3 and increase 
in D2 is associated with the terminal differentiation stage of myogenesis, although whether 
this is TH-regulated is not clear (Bloise et al., 2017, Dentice et al., 2010). However, in the sheep 
fetal liver the activity of D1 increases with T3-infusion, suggesting that near term, there is a 
positive feedback of T3 upregulating the conversion of T4 to T3 (Forhead et al., 2006). 
Determining the iodinase activity in ovine fetal skeletal muscle in response to T3 would give 
further insight into the potential for a T3 response.  
Perhaps the most likely explanation as to why T3-infusion did not have a significant effect on 
mitochondrial parameters measured is that its infusion alone was insufficient to drive 
maturation without all the other changes normally experienced by the fetus in the prepartum 




but as shown in Chapter 3, correlated to numerous aspects of mitochondrial development and 
tended to be lower in TX than control fetuses at term. Therefore, a delayed prepartum rise in 
cortisol may be part of the potential explanation for the lack of skeletal muscle maturation 
near term in TX fetuses. In the next chapter the role of cortisol in driving fetal skeletal muscle 
metabolic maturation will be discussed.  
 
4.6.5 Conclusion 
THs are essential permissive factors for the development of mitochondrial function in ovine 
skeletal muscle over late gestation but T3 alone is insufficient to prematurely induce the 






















In precocial species, skeletal muscle is required immediately at birth to take on the roles of 
locomotion and thermogenesis. Its energy requirement therefore increases rapidly. During 
late gestation maturation of skeletal muscle occurs in preparation for these new roles and the 
increased energy demands, in part by alterations in mitochondrial activity. As previously 
shown in Chapter 3, there is an age-related increase in mitochondrial number, oxidative 
capacity and expression of a variety of mitochondrial genes over the perinatal period in ovine 
skeletal muscle. These changes are occurring in parallel with a surge in fetal plasma cortisol 
which is known to drive prepartum maturation in other fetal tissues (Fowden et al., 1998). 
Additionally, a rise in cortisol before term due to stresses, including malnutrition, also has an 
impact on fetal development (Jensen et al., 2002). However, whether cortisol regulates 
energetic aspects of skeletal muscle maturation is unknown. 
 In the adult, the predominant roles of glucocorticoids are in regulation of glucose metabolism 
and immunosuppression in response to stress (Newton, 2000). However, some studies have 
implicated glucocorticoids in upregulating overall metabolic rate by increasing mitochondrial 
number and function in adult rat skeletal muscle as well as in various cell lines in culture 
including mouse muscle cells (Morgan et al., 2016, Scheller et al., 2000, Weber et al., 2002). 
This is likely to be driven predominantly via altered nuclear gene expression, but may be 
coordinated in part by direct glucocorticoid interaction with mitochondrial DNA to modify its 
transcription rate (Marin-Garcia, 2010, Scheller et al., 2000, Demonacos et al., 1995). In the 
fetus, an increased cortisol concentration associated with fetal hypoxaemia was suggested to 
increase the expression of mitochondrial proteins in the lung and brown adipose tissue, 
although whether cortisol is the predominant driving factor in this situation remains unclear 
(Gnanalingham et al., 2005a, Mostyn et al., 2003). Cortisol does, however, play a role in fetal 
metabolism. In the liver it is required for the deposition of glycogen and the increase in 
glycogenolytic and gluconeogenic enzyme activities over late gestation, thereby ensuring a 




1993). However, cortisol infusion in the sheep fetus does not alter its total rate of oxygen 
consumption (Ward et al., 2004). 
In order to determine whether cortisol plays a role in regulating mitochondrial function in fetal 
skeletal muscle, ovine fetuses were catheterised at ~118dGA and infused with cortisol at a 
constant rate for a 5-day period until ~130dGA. This well-established protocol has been shown 
previously to elevate fetal cortisol levels up to values seen close to term and to lead to 
morphological and functional changes in a range of fetal tissues that mimic the prepartum 
maturational processes essential for neonatal survival (Fowden et al., 1996). This 5-day 
cortisol infusion has been shown to slow fetal growth (Fowden et al., 1996) and reduce 
placental glucose transport (Ward et al., 2004). In skeletal muscle, the 5-day cortisol infusion 
protocol has been shown to significantly downregulate IGF-I expression consistent with the 
inhibitory effect of cortisol on fetal growth (Forhead et al., 2002, Li et al., 2002). Additionally, 
cortisol affects the insulin signalling pathway in fetal skeletal muscle with potential effects on 
growth and glucose metabolism (Jellyman et al., 2012). Finally, cortisol infusion has been 
shown to affect mitochondria in fetal adipose tissue through changes in the expression of 
uncoupling proteins (Gnanalingham et al., 2005b) but little is known of the effects of cortisol 
on mitochondria in fetal skeletal muscle. 
 
5.2 Aim 
The aim of this study was to determine whether preterm cortisol infusion upregulates 
mitochondrial biogenesis and oxidative function in skeletal muscle of fetal sheep, thereby 











Twelve ewes carrying singleton fetuses were used for this study. Eleven ewes and fetuses were 
catheterised at 118-119dGA (Section 2.2.2.2). Six of the fetuses were infused with cortisol (2-
3mg/kg/day) and 5 with saline for a 5-day period until 128-131dGA when both ewe and fetus 
were euthanised and tissues collected (Section 2.2.4.1). The remaining ewe and fetus 
underwent a sham surgery without catheterisation or infusion. Euthansia and tissue collection 
took place at 130dGA and results from this animal were included with the saline-infused 
control fetuses.  
Details of surgery, tissue collection and experimental protocols used in this chapter are given 
in Chapter 2.  
 
5.3.2 Statistical Analyses 
A Kolmogorov-Smirnov test was applied to test for a normal distribution. A t-test was used to 
compare the data from cortisol and saline-infused fetuses if data were normally distributed. 
If the assumption of normality was not realised, or the number of samples was too small to 
determine whether the data followed a normal distribution, a Mann-Whitney non-parametric 













5.4.1 Fetal measurements 
Fetal blood measurements 
The fetal plasma cortisol and T3 concentrations were significantly higher in the cortisol-infused 
fetuses than in controls, with no difference in fetal plasma T4 with treatment (Table 5.1). The 
fetal plasma cortisol concentration throughout the infusion period in both control and 
cortisol-infused fetuses is shown in Figure 5.1. No differences were seen in blood pH, pO2, 
pCO2, oxygen saturation, haemoglobin, HCO3, glucose or lactate between cortisol-infused and 
control groups at the start of the infusion period (data not shown). However, on day 5 of the 
infusion, glucose concentrations were significantly higher in cortisol-infused than control 
fetuses (Table 5.2).  
 
Table 5.1 Fetal plasma hormone concentrations  
 Control Cortisol-infused 
Cortisol (ng/ml) 8.4±1.7 49.2±2.4* 
T3 (ng/ml) 0.43±0.03 0.70±0.14* 
T4 (ng/ml) 122.0±9.5 131.6±4.0 
Data are presented as mean±SEM of control (n=6) and cortisol-infused (n=6) fetuses. * are 
significantly different from control fetuses (P<0.05 by t-test). 
 
 
Figure 5.1 Mean±SEM fetal plasma cortisol concentrations over the 5-day infusion period of 
control (n=5; circles) and cortisol-infused (n=6; squares) fetuses. * significantly different from 




Table 5.2 Fetal arterial blood parameters as measured on day 5 of infusion.  
 Control Cortisol-infused 
Fetal arterial blood 
parameters 
pH 7.34±0.02 (3) 7.39±0.01 (5)  
pO2 (mmHg) 17.5±2.8 (3) 21.5±1.1 (5) 
pCO2 (mmHg) 54.5±2.2 (3) 50.1±1.3 (5) 
HCO3 (mmol/L) 27.6±2.8 (3) 28.4±0.5 (5) 
Haemoglobin (g/dL) 10.8±0.4 (3) 9.7±0.6 (4) 
%O2 saturation 56.6±2.5 (3) 56.9±3.7 (5) 
Glucose (mmol/L) 0.62±0.04 (3) 1.15±0.15 (6) * 
Lactate (mmol/L) 1.02±0.09 (3) 1.21±0.08 (6) 
Data are presented as mean±SEM and the n number is given in brackets.* significantly 
different from control fetuses at the same age (P<0.05 by Mann-Whitney test). 
 
 
Fetal biometry and muscle biochemical composition 
There was no significant difference in body weight, muscle weight or the muscle to body 
weight ratio of any of the 3 muscles between cortisol and saline-infused fetuses (Table 5.3). 
There was a trend for glycogen content to be higher in the ST of cortisol-infused than control 
fetuses, but there were no other significant differences in glycogen content between the 
cortisol-infused and control fetuses in the BF or SDF, nor in lipid content which was only 
measured in the BF (Table 5.3). Protein content was not different in any of the muscles of 
cortisol-infused compared to control fetuses (Table 5.3). However, the water content of the 
BF and ST was significantly lower in cortisol-infused than control fetuses, with no significant 
difference in the SDF (Table 5.3). When the water content was taken into account by 
expressing data per mg dry weight, the trend for increased glycogen content in the ST with 
cortisol treatment was lost, whereas protein content tended to be lower in the ST of cortisol-








Table 5.3 Biometric and biochemical measurements.  
 Control Cortisol-infused 
Body weight (kg) 3.05±0.12  2.96±0.15  
CRL (cm) 43.3±0.6 43.8±0.5 
Femur (cm) 9.9±0.7 9.2±0.3 
Tibia (cm) 13.9±0.5 13.4±0.2 
Metatarsus (cm) 15.6±0.3 15.3±0.3 
 Biceps femoris 
Weight (g) 13.07±0.61  12.30±0.87  
Muscle:body weight ratio (g:kg 
x103) 
4.28±0.09  4.14±0.14  
Water content (%)  82.1±0.2 80.5±0.2* 
Protein content           (mg/g wet wt) 





Glycogen content        (mg/g wet wt) 





Lipid content                (mg/g wet wt)  







Weight (g) 4.78±0.29  4.36±0.30  
Muscle:body weight ratio (g:kg 
x103) 
1.56±0.05  1.47±0.07  
Water content (%)  81.7±0.1 79.6±0.4* 
Protein content           (mg/g wet wt)  





Glycogen content        (mg/g wet wt)  





 Superficial digital flexor 
Weight (g) 2.06±0.17  1.97±0.09  
Muscle:body weight ratio (g:kg 
x103) 
0.67±0.03  0.67±0.03  
Water content (%)  80.9±0.3 79.8±0.5 
Protein content           (mg/g wet wt)  





Glycogen content        (mg/g wet wt)  







Data are presented as mean±SEM of control and cortisol-infused fetuses (n=6 in all cases unless 
stated otherwise). * significantly different to control (P<0.05 by t-test) and # trend to differ 





5.4.2 Oxidative capacity 
Respirometry was carried out measuring the oxygen consumption of permeabilised muscle 
using carbohydrate (Py) or lipid (PC) as substrates and ADP. BF muscle from cortisol-infused 
fetuses had a significantly higher ADP-coupled, Py-supported rate of oxygen consumption 
than controls whereas there was no difference with PC as the substrate (Figure 5.2 A). 
Conversely, the capacity for ADP-coupled, PC-supported oxygen consumption was 
significantly higher in SDF from cortisol-infused fetuses compared with controls with a trend 
for a higher oxygen consumption with Py as the substrate (Figure 5.2 C). Cortisol infusion had 
no effect on oxidation of either substrate in ST muscle (Figure 5.2 B). An additional 
respirometry protocol was carried out using glutamate and succinate as substrates to measure 
total oxphos through ETS CI and II. The total ADP-coupled oxygen consumption was higher in 
SDF of cortisol-infused fetuses compared with controls but did not differ with treatment in 
either the BF or ST (Figure 5.2). There was no significant difference in state 3 respiration 
between muscle types in either treatment group. 
Using a protocol in which ADP-coupled, PC-supported oxygen consumption was measured, 
followed by further addition of Py, the ratio of PC-supported:PC+Py-supported ADP-coupled 
oxygen consumption was determined and shown in Figure 5.3. There was no significant 
difference in this ratio between cortisol-infused and controls in any of the 3 muscles studied.  
PC-supported oxygen consumption before the addition of ADP was higher in SDF of cortisol-
infused than control fetuses (1.30±0.21 and 0.69±0.17nmol oxygen/minute/mg dry weight 
respectively; P<0.05) but not in the BF or ST. Py- or glutamate-supported leak state respiration 
did not differ with treatment in any of the 3 muscles. The RCR was not different between 
control and cortisol-infused fetuses using any of the substrates in any muscle studied. 
HOAD activity, as a marker of β-oxidation activity, was measured only in the BF muscle and 
was unaffected by treatment (Figure 5.4), in line with the finding that there was no difference 






Figure 5.2 Mean±SEM ADP-coupled, pyruvate (Py), palmitoylcarnitine (PC) and glutamate and 
succinate supported (total) oxygen consumption in A) biceps femoris, B) semitendinosus and 
C) superficial digital flexor of control (n=5-6; black bars) and cortisol-infused (n=5-6; dashed 
bars) fetuses. * is significantly different from controls of the same experimental protocol 





Figure 5.3 Mean±SEM ratio of ADP-coupled palmitoylcarnitine (PC)-supported:PC+pyruvate 
(Py) oxygen consumption in A) biceps femoris, B) semitendinosus and C) superficial digital 






Figure 5.4 Mean±SEM β-hydroxyacyl-CoA dehydrogenase (HOAD) activity in biceps femoris 
muscle of control (n=6; black bars) and cortisol-infused (n=5; dashed bars) fetuses.   
 
 
5.4.3 Regulating oxidative capacity 
5.4.3.1 Mitochondrial density and biogenesis 
In order to determine whether any changes in oxidative function reflected changes in 
mitochondrial density, the putative marker of mitochondrial mass, CS activity, was measured 
in all muscles of both treatment groups. In addition, gene expression of markers of 
mitochondrial biogenesis, PGC1α and NRF1, was quantified. Cortisol infusion did not alter 
mitochondrial density, PGC1α or NRF1 in BF and ST (Figure 5.5 A,B,D,E). There was a trend for 
higher mitochondrial density in the SDF of cortisol infused than control fetuses (Figure 5.5 C). 
Gene expression of PGC1α, but not NRF1, in the SDF was significantly higher in cortisol-infused 





Figure 5.5 Mean±SEM A-C) citrate synthase activity and D-F) normalised gene expression of 
PGC1α and NRF1  in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital 
flexor of control (n=4-6; black bars) and cortisol-infused (n=5-6; dashed bars) fetuses.                    * 
significantly different to control (P<0.05 by t-test) and # trend to differ from control (P<0.1 by 
t-test).  
 
The measured protein and water content of the muscles were used to express CS activity per 
mg dry weight in order to normalise respirometry data to mitochondrial density. When 
normalised, there remained a trend for higher Py-supported oxygen consumption, but not PC-
supported and total (glutamate and succinate) ADP-coupled oxygen consumption in the BF of 
cortisol-infused than control fetuses (Figure 5.6 A). Cortisol infusion had no effect on the 
normalised rates of Py and PC-supported and total (glutamate and succinate) ADP-coupled 







Figure 5.6 Mean±SEM ADP-coupled, pyruvate (Py),  palmitoylcarnitine (PC)-supported and 
total (glutamate and succinate) oxygen consumption normalised to citrate synthase (CS) 
activity in A) biceps femoris, B) semitendinosus and C) superficial digital flexor of control (n=5-
6; black bars) and cortisol-infused (n=4-6; dashed bars) fetuses. # trend to differ from control 
values of the same experimental protocol (P<0.1 by t-test).  
 
 
5.4.3.2 Electron transfer system abundance 
To further investigate the mitochondrial oxidative capacity, the abundance of the ETS 
complexes I-IV and ATP-synthase were measured by western blot. The abundance of CI was 
significantly higher in BF of cortisol-infused fetuses compared with controls, whereas none of 
the other complexes differed with treatment (Figure 5.7 A&D). Additionally, no differences of 
the abundance of any of the ETS complexes were seen between treatment groups in the ST or 









Figure 5.7 Protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV) by western blotting. A-C) representative blots and 
D-F) mean±SEM relative abundance of the complexes in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital flexor of control (n=5-6; 




5.4.3.3 Uncoupling the proton gradient 
Despite the minimal change in mitochondrial density, cortisol may influence the efficiency of 
ATP production by regulating expression of IMM proteins associated with proton leak. UCP2 
and UCP3 expression was not significantly different between control and cortisol-infused 
fetuses in any of the 3 muscles studied (Figure 5.8). Cortisol-infusion resulted in a significantly 
higher ANT1 gene expression in the ST and SDF and ANT1 protein abundance in the SDF than 
found in the saline infused fetuses (Figure 5.9). 
  
 
Figure 5.8 Mean±SEM normalised gene expression of uncoupling proteins (UCP) 2 and 3 in      A) 
biceps femoris, B) semitendinosus and C) superficial digital flexor of control (n=4-6; black bars) 










Figure 5.9 Protein and mRNA levels of adenine nucleotide translocase 1 (ANT1)  A-C) representative western blots and D-F) mean±SEM normalised gene 
expression and protein abundance in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital flexor of control (n=5-6; black bars) and 





5.4.3.4 Mitochondrial fusion and fission 
In addition to mitochondrial number, mitochondrial function is believed to be influenced by 
the level of fusion and fragmentation of the mitochondrial network. Thus, gene expression of 
MFN1, MFN2 and DRP1 were quantified. There was no difference in expression of any of these 
genes in BF (Figure 5.10 A). There was a trend for greater MFN2 expression in the ST (Figure 
5.10 B) and significantly higher MFN2 expression in the SDF of cortisol-infused than control 
fetuses (Figure 5.10 C). Cortisol did not influence gene expression of either MFN1 or DRP1 in 
the 3 muscles studied.  
 
 
Figure 5.10 Mean±SEM normalised gene expression of mitofusins (MFN) 1 and 2 and dynamin-
related protein 1 (DRP1) in A) biceps femoris, B) semitendinosus and C) superficial digital flexor 
of control (n=4-6; black bars) and cortisol-infused (n=6; dashed bars) fetuses. * significantly 













5.4.3.5 Monitoring cellular energy status 
In order to determine whether the increased mitochondrial oxidative capacity in the BF and 
SDF were driven by changes in the AMPK signalling pathway, the protein abundance of both 
AMPKα and pAMPKα were measured using western blotting. There were no significant 
differences in these protein abundances or their ratio between the cortisol-infused and 
control fetuses in either muscle (Figure 5.11).  
 
 
Figure 5.11 Protein expression of (phosphorylated) AMP-activated protein kinase α 
((p)AMPKα) by western blotting. A-B) representative blots and C&D) mean±SEM relative 
abundance of the pAMPKα, AMPKα and the ratio between the two in A&C) biceps femoris, 









5.4.4 Skeletal muscle structure and type I fibres  
Mitochondrial density may reflect the relative proportions of muscle fibre types and thus the 
muscle fibre density and phenotype were analysed. Sections of the 3 skeletal muscles were 
stained using H&E and point counting was used to determine the proportion of the field of 
view occupied by muscle fibres (Figure 5.12). There was a trend for higher fibre density in the 
SDF from the cortisol-infused fetuses compared with the controls but no differences were 
seen between treatment groups in the other 2 muscles (Table 5.4).  
Immunohistochemistry was used to stain type I fibres (Figure 5.13). Cortisol did not affect the 
type I fibre number, perimeter, cross-sectional area or percentage of the total area in any of 
the muscles studied (Table 5.4). Gene expression of MHCI, IIa and IIx was also quantified. Gene 
expression of MHCIIx was higher in the BF of cortisol than saline-infused fetuses with no 
difference in MHCI or MHCIIa (Figure 5.14 A). There was also no difference between 
treatments in the expression of MHCI, MHCIIa or MHCIIx in the ST and SDF (Figure 5.14 B&C).  
 
 
Figure 5.12 Representative H&E stained sections at 40x magnification in biceps femoris, 






Figure 5.13 Representative MHCI stained sections at 20x magnification in biceps femoris, 




Figure 5.14 Mean±SEM gene expression of MHCI, MHCIIa and MHCIIx in A) biceps femoris, B) 
semitendinosus and C) superficial digital flexor of control (n=5; black bars) and cortisol-infused 










Table 5.4 Type I fibre analyses.  
 Control Cortisol-infused 
 Biceps femoris 
Proportion of total area accounted 
for by fibres (%; n=6) 
78.2±4.3 86.4±1.9 
Number of type I fibres/mm2 452±89 478±71 
Average fibre area (μm2) 373.3±50.3 378.7±27.8 
Average fibre perimeter (μm) 72.8±5.0 73.8±2.5 
Proportion of total area accounted 
for by type I fibres (%) 
15.5±2.0 17.4±1.6 
Proportion of fibre area accounted 
for by type I fibres (%) 
19.8±1.2 20.2±1.7 
 Semitendinosus 
Proportion of total area accounted 
for by fibres (%; n=6) 
82.1±4.0 87.8±1.7 
Number of type I fibres/mm2 346±45 282±78 
Average fibre area (μm2) 443.9±41.9 482.5±37.2 
Average fibre perimeter (μm) 79.7±3.9 82.9±3.3 
Proportion of total area accounted 
for by type I fibres (%) 
15.1±1.7 13.6±3.6 
Proportion of fibre area accounted 
for by type I fibres (%) 
17.4±2.2 15.5±4.1 
 Superficial digital flexor 
Proportion of total area accounted 
for by fibres (%; n=6) 
74.5±2.6 81.4±2.6 # 
Number of type I fibres/mm2 511±16 643±97 
Average fibre area (μm2) 324.9±24.5 337.6±15.6 
Average fibre perimeter (μm) 68.8±2.8 71.3±1.3 
Proportion of total area accounted 
for by type I fibres (%) 
16.1±1.1 21.3±2.8 
Proportion of fibre area accounted 
for by type I fibres (%) 
20.9±2.0 27.2±4.3 
Data are presented as mean±SEM in biceps femoris, semitendinosus and superficial digital 
flexor of control and cortisol-infused fetuses. N=4 in each group, unless stated otherwise. # 








This study shows that cortisol regulates some aspects of mitochondrial function in a muscle 
specific manner during late gestation. Elevating the fetal circulating cortisol prematurely to 
term concentrations resulted in an increase in the oxidative function of the SDF, presumably 
driven by the increase in its mitochondrial density. In addition, there was an increased 
expression of ANT1 and MFN2 in the SDF which may aid the increase in oxidative production 
of ATP through regulating its transport and the dynamics of the mitochondrial network 
respectively.  
 
5.5.1 Fetal growth and muscle development 
The 5-day cortisol infusion protocol resulted in cortisol levels being significantly higher than 
controls at each day of the protocol, and brought cortisol levels up to those reported 
previously in near term singleton ovine fetuses (Mostyn et al., 2003) and to the values found 
in the control 143dGA group of twin fetuses in Chapter 3. Cortisol infusion also raised the T3 
concentration without affecting T4 levels as has been reported previously (Mostyn et al., 
2003). Fetal blood glucose levels were higher in the cortisol-infused fetuses than controls as 
has been shown in some but not all previous studies of sheep (Fowden et al., 1996, Ward et 
al., 2004). Using the same infusion protocol as in the current study, cortisol has been shown 
to slow the rate of fetal growth measured individually as  CRL increment (Fowden et al., 1996). 
However, in the current study, there were no differences in CRL or body weight between the 
treatment groups. This probably reflects analysis of a cohort rather than of individuals. 
The mass of the 3 muscles studied also did not show any difference in response to early 
cortisol exposure and nor did the muscle protein or lipid content. Previous studies in fetal 
sheep during late gestation have reported a cortisol-driven decrease in protein accretion 
primarily due to increased proteolysis, however tissue-specific protein metabolism was not 
investigated (Milley, 1995).  The ST glycogen content showed a trend to increase in response 
to cortisol infusion, whereas the glycogen content of the BF and SDF was unaffected by 
treatment. Cortisol is believed to play a role in skeletal muscle glycogen deposition over late 
gestation, and cortisol infusion into fetal pigs resulted in an increased glycogen levels in the 
psoas muscle (Fowden et al., 1985, Fowden et al., 1991). However, previous studies on fetal 
sheep have shown cortisol infusion to have no effect on skeletal muscle glycogen content 




Water content of the BF and ST was significantly lower in the cortisol-infused than control 
fetuses. Cortisol, therefore, appears to have a maturational influence on the skeletal muscle 
structure. However, it had a minimal effect on the fibre density and proportion of type I fibres.  
Overall, prematurely elevating cortisol in the fetus had minimal impact on fetal growth and 
muscle structure, and alone is unlikely to explain the change in muscle structure observed in 
Chapter 3.   
 
5.5.2 Cortisol had a muscle-specific effect on skeletal muscle mitochondria 
As shown in Chapter 3, age had a significant effect on, and cortisol significantly correlated 
with, the mitochondrial oxidative capacity, as well as mitochondrial density and expression of 
several mitochondrial proteins in BF, ST and SDF during late gestation and the perinatal 
periods. This chapter shows that cortisol increased the oxidative capacity of the SDF in 
accordance with its increased mitochondrial density and expression of ANT1 and MFN2. These 
findings are consistent with previous observations of increased oxygen consumption in 
neonatal sheep exposed to maternally administered dexamethasone during fetal 
development (Clarke et al., 1998). Very few studies have looked at the SDF and therefore little 
is known about its developmental or its metabolic profile. However, the function of the SDF is 
known and, unlike the hamstring muscles, the SDF generates a high level of force through 
isometric contraction as it controls the positioning of the lower limb during both standing and 
locomotion (Biewener, 1998, McGuigan et al., 2009). The continuous use of this muscle 
necessitates a high oxidative capacity, and in the current study, the proportion of oxidative 
type I fibre area has been shown to be greater in the SDF than then ST. Perhaps the response 
to cortisol needs to be more rapid to ensure maturity of the postural muscles required to allow 
the lamb to stand after birth.  
The differential effects of cortisol on the different muscles may also reflect variations in 
muscle GR expression. The GR abundance of the muscles studied here has not been 
quantified. In adult muscle, GR abundance is higher in type I than type II fibres (Perez et al., 
2013). Therefore, GR abundance may be greater in the more oxidative fetal muscles including 
the SDF earlier in gestation than in the other muscles, explaining the more rapid response of 
the SDF to the cortisol infusion. Alternatively, the SDF maturation may rely predominantly on 
cortisol for its metabolic maturation whereas other factors may be of greater importance in 




have been shown to be more responsive to THs (White et al., 2001). Therefore, the SDF may 
be less dependent on T3 for mitochondrial maturation than muscles with a higher proportion 
of fast-twitch muscle fibres.  
The oxygen consumption using all 3 respirometry protocols was higher in the cortisol-treated 
than control SDF, although this only reached significance for PC-supported and total oxygen 
consumption. This suggests that cortisol may generally increase the activity of the 
mitochondrial oxidative pathways and play a role in upregulating FA-oxidation in this muscle. 
Previously, mitochondria from slow-twitch fibres have been shown to possess a higher 
capacity for FA oxidation (Glancy and Balaban, 2011), and the current results suggest this may 
be regulated by cortisol in utero. HOAD activity was only measured in the BF where PC-
supported oxygen consumption was not upregulated by cortisol. Measuring HOAD activity in 
the SDF would help to determine whether β-oxidation is upregulated by cortisol in the SDF.  
The abundance of ETS complexes I-IV was not different in the SDF of cortisol infused compared 
with control fetuses which suggests that the cortisol-induced increase in oxidative capacity is 
not due to changes in complex abundance although there may be cortisol-dependent 
mechanisms by which ETS activity is enhanced. In contrast to the SDF, only Py-supported 
oxygen consumption was increased with cortisol treatment in the BF, as was the expression 
of CI, suggesting carbohydrate metabolism may be of greater importance in the BF postnatally. 
However, this increase in oxygen consumption was not associated with an increase in 
mitochondrial density as occurred in the SDF. This suggests that cortisol acts through a 
different mechanism in regulating mitochondrial oxidative capacity in the 2 muscles.   
Overall, cortisol regulates some aspects of mitochondrial function in the SDF and BF, but 
cannot fully explain the ontogenic rise in skeletal muscle mitochondrial respiratory capacity, 
particularly in the ST. Potential explanations are discussed below. 
 
5.5.3 Cortisol does not drive mitochondrial development in late gestation in all muscles 
Few previous studies have looked at the effects of GCs on mitochondria, but those which have 
suggest GCs upregulate mitochondrial activity in skeletal muscle (Weber et al., 2002). 
However, in this previous study the synthetic GC, dexamethasone was used, which is more 
potent than natural GCs and can bind to mineralocorticoid receptors as well as GRs (Jellyman 




on the insulin signalling pathway in developing sheep skeletal muscle (Jellyman et al., 2012). 
Therefore, whether GCs play a metabolic role in vivo cannot be assumed from dexamethasone 
studies. Additionally, the previous study was carried out on adult rat quadriceps and soleus 
muscles, and the sheep fetal muscles in the current study may not necessarily respond in the 
same way. A model of developing muscle has been studied, in which mitochondria from a 
developing mouse muscle cell line were shown to respond to dexamethasone (Weber et al., 
2002). However, conclusions drawn from in vivo and in vitro results across different species 
are variable. GC treatment on a human hepatic cell line and adult rat liver suggest that GCs 
are likely to act directly on the mitochondria to increase transcription, however, no increase 
in mitochondrial protein abundance or activity was reported in a separate study on adult rat 
liver in vivo (Weber et al., 2002, Scheller et al., 2000, Mansour and Nass, 1970). In addition to 
species differences, tissue differences are apparent in the mitochondrial response to cortisol 
in the fetus; in the current study there was no difference in UCP expression in the skeletal 
muscle, whereas UCP2 increased in the perirenal adipose tissue of fetal sheep using the same 
cortisol infusion protocol (Gnanalingham et al., 2005b). These tissue specific effects of cortisol 
on the mitochondria may explain why cortisol infusion has little effect on the total fetal oxygen 
consumption by the sheep (Ward et al., 2004) and emphasise that further work is needed to 
fully understand the role of GCs on fetal oxidative metabolism.  
The response to cortisol is primarily via regulating gene expression. However, cortisol is also 
known to influence post-transcriptional processes and translation (Newton, 2000). Therefore, 
the fact that cortisol has been shown to have limited effect on the mRNA abundance of the 
genes of interest studied here does not rule out the possibility of it playing a regulatory role 
on these pathways, although any cortisol-driven activation or inhibition of downstream 
pathways did not manifest in a measurable change in oxygen consumption in the BF or ST.  An 
example of a GC-target protein is the GR itself, the transcription of which is reduced and the 
rate of degradation increased upon dexamethasone treatment in rat adult liver (Dong et al., 
1988). Cortisol-driven downregulation of the GR may be in part responsible for repressing the 
HPA negative feedback in the lead up to term in the sheep fetus (Challis et al., 2001). However, 
in the fetal perirenal adipose tissue, cortisol infusion has been shown to upregulate expression 
of the GR, perhaps to amplify the maturational effects of cortisol near term (Gnanalingham et 
al., 2005b). Whether cortisol regulates expression of its receptor in fetal skeletal muscle has 




cortisol infusion may be minimising the effect of premature GC-signalling when other factors, 
normally altered near term, are not present.  
The lack of effect of cortisol in muscles such as ST may be due to insufficient time to activate 
the downstream pathways as cortisol levels normally rise over 10-15 days before term in the 
sheep (Silver and Fowden, 1988). This may affect both the direct and indirect actions of 
cortisol in stimulating tissue maturation. As well as increasing the bioavailability of T3, cortisol 
regulates numerous other endocrine systems in the lead up to term. These include increasing 
the circulating catecholamine concentrations and decreasing skeletal muscle IGF-I expression 
(Fowden et al., 1998). Additionally, there is altered hormone signalling, for example cortisol 
has been shown to increase the abundance of the leptin-receptor in the fetal lung and β-
adrenenoreceptors in the fetal liver (De Blasio et al., 2015, Apatu et al., 1990). Cortisol may 
play a role in regulating mitochondrial function but 5 days of cortisol infusion alone may be 
insufficient to induce mitochondrial maturation without the other changes which occur 
alongside the cortisol surge near term. 
  
5.5.4  Conclusion 
Overall, this study shows that cortisol can upregulate specific aspects of mitochondrial 
function and density in a muscle-specific manner. This variable responsiveness of muscles to 
cortisol may reflect the density of type I fibres, the sensitivity to cortisol per se or the 











6 General Discussion 
 
6.1 Overall summary 
The results of this thesis support the initial hypothesis that the oxidative capacity of skeletal 
muscle would increase during the perinatal period to meet the extra energy demands of the 
new muscular activities required after birth. In the 3 ovine hind limb muscles studied, the BF, 
ST and SDF, the oxidative function was higher in the neonate than earlier in gestation. This 
occurred in association with an ontogenic increase in mitochondrial density, abundance of ETS 
complexes and expression of ANT1 and UCPs in these muscles over the perinatal period. The 
later changes in ANT1 and UCPs would also help minimise excessive ROS production during 
the fluctuations in oxygen availability associated with labour, delivery and exposure to 
atmospheric oxygen levels for the first time.  
In Chapter 3, skeletal muscle mitochondrial oxidative capacity and density from control 
fetuses were correlated positively with the plasma concentrations of both cortisol and T3 
during the perinatal period. When fetal hypothyroidism was induced by thyroidectomy, 
mitochondrial density was reduced both at 127dGA and near term in all 3 hind limb muscles 
studied, and respiratory capacity was also lowered particularly near term. In addition, 
thyroidectomy prevented the normal ontogenic increase in several mitochondrial parameters 
towards term, including mitochondrial density, ETS complex abundance and ANT1 expression. 
However, raising the T3 concentration prematurely before term did not affect mitochondrial 
function in any of the muscles. In contrast, elevation of fetal cortisol concentration to term 
values earlier in gestation did affect some aspects of muscle mitochondrial function, albeit in 
a tissue specific manner. The BF and SDF of cortisol infused fetuses showed an increased 
capacity for oxidative metabolism of carbohydrates and FAs respectively, whereas the ST was 
unaffected by treatment consistent with its lower density of oxidative type I fibres. When data 
from all groups across the 3 chapters were combined, irrespective of age and treatment, both 
the concentrations of cortisol and T3 retained a significant positive correlation with oxygen 
consumption and with CS activity in all 3 muscles and with HOAD activity, measured only in 
the BF (Table 6.1). CS activity correlations are presented in Figure 6.1, and partial correlation 
analyses of these data suggest that both cortisol and T3 are important in regulating activity in 
all 3 muscles studied. In support of the initial hypothesis, the results collectively suggest that 




function in ovine skeletal muscle during the perinatal period, consistent with their known roles 
as maturational signals in the preparation for the transition from intra- to extrauterine life in 
other fetal tissues (Fowden et al., 1998).   
 
Table 6.1 Correlation analyses of cortisol and T3 with respirometry data and HOAD activity. 
 Biceps femoris Semitendinosus Superficial digital 
flexor 
 Pyruvate-supported state III respiration 












 Palmitoylcarnitine state III respiration 












 Glutamate and succinate state III respiration 












 HOAD activity 
Log10Cortisol (ng/ml) r=0.6237 
P<0.0001 
/ / 
Log10 T3 (ng/ml) r=0.7652 
P<0.0001 
/ / 
N=47-55. β-hydroxyacylCoA dehydrogenase (HOAD) activity was not measured in 









Figure 6.1  Citrate synthase activity plotted against plasma A-C) cortisol and D-F) T3 in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial 
digital flexor. N numbers and r values are given on each graph. 104dGA blue, 127dGA pink (sham, full circle; TX, empty circle), 143dGA green (sham, 
full circle; TX, empty circle), 130dGA catheterised twins maroon (saline-infused, circles; T3-infused, triangles), 130dGA catheterised singletons (saline-




6.2 Limitations of the study 
Most studies and analytical techniques have their limitations and the data presented in this 
thesis is no exception. The respirometry protocol used in this study follows a well-established 
methodology, previously published for skeletal muscle (Pesta and Gnaiger, 2012, Kuznetsov 
et al., 2008). Using permeabilised muscle fibres allows for mitochondrial function to be 
measured while the cellular system is kept intact, maintaining mitochondrial interactions with 
the cytoskeleton and endoplasmic reticulum. This approach also permits ATP consumers to 
remain present in the system which allows coupling of ATP consumption with production and, 
hence, an assessment of total oxidative function most closely resembling that in vivo 
(Kuznetsov et al., 2008). However, the physiological relevance of the high pO2, and saturating 
concentrations of substrates used in this protocol for fetal metabolism is perhaps more 
debateable. This protocol will give the maximal rates of oxygen consumption of the tissues 
(Pesta and Gnaiger, 2012) and the data obtained therefore gives information on any changes 
in maximal oxidative capacity over the perinatal period.  
With permeabilisation, the substrates used in the respirometry protocols can be directly 
transported into the mitochondria and feed into the TCA cycle or β-oxidation. Therefore, only 
the internal mitochondrial oxidative pathways could be studied with no allowance for changes 
in cytosolic pathways or cellular transport mechanisms which may influence the availability of 
substrates in intact fibres (Jorgensen et al., 2017). In particular, the rate of glycolysis may have 
an important role in determining the substrate availability for mitochondrial oxphos. Indeed, 
there may be a greater reliance on anaerobic glycolysis for ATP production in the fetal muscle 
towards term as there was minimal upregulation of oxidative function of the muscle despite 
the increase in mitochondrial density in the current study. 
Throughout this study, CS activity was used as a marker of mitochondrial density, as has shown 
to be a good marker in adult human skeletal muscle (Larsen et al., 2012). However, this may 
not be the case in the fetus. Citrate synthase catalyses the first step in the TCA cycle, and 
therefore activity may rise over the perinatal period in accordance with our hypothesis of 
increasing the activity of mitochondrial metabolic pathways (Marin-Garcia et al., 2000). A 
limitation of this study, therefore, is that there is not an additional marker of mitochondrial 





Within a muscle there are regional differences in mitochondrial parameters; deeper regions 
have been associated with a more oxidative phenotype and a higher CS activity in the pig 
semitendinosus and rat quadriceps respectively (Markham et al., 2009, Kohn and Myburgh, 
2007). Additionally, there are differences in the MHC expression along the length of the rat 
quadriceps; in the deeper region of the muscle there was a lower MHCI content at the distal 
than at the proximal end (Kohn and Myburgh, 2007). Throughout the study, care was taken to 
study a central region of muscle for the respirometry and histology, and where possible for 
assays on the remaining frozen muscle. In addition to variation across the muscle, there are 
intracellular differences in the mitochondria within the myocytes with 2 functionally distinct 
subpopulations, subsarcolemmal (SS) and intermyofibrillar (IMF) responsible for sustaining 
activity of membrane transporters and contractile machinery respectively (Kuznetsov et al., 
2006, Lundby and Jacobs, 2016). In adult muscle, the SS mitochondria are the smaller 
population but have a higher oxidative state, calcium content and capacity for FA oxidation 
(Kuznetsov et al., 2006, Hoppeler, 1999). Both populations show plasticity, for example, the 
density of both increase in response to exercise with a greater fold-increase reported in SS 
mitochondria (Hoppeler et al., 1985, Samjoo et al., 2013, Lundby and Jacobs, 2016). Thus, 
changes in the relative size of the 2 populations may have contributed to ontogenic and 
hormonally induced changes in mitochondrial function observed in the fetal skeletal muscles, 
although respirometry of permeabilised fibres does not allow the subpopulations to be 
studied separately (Kuznetsov et al., 2008). Fractionation of the subpopulations of muscle 
mitochondria would be required to address this but study of isolated mitochondria provides 
little information about their physiological function in vivo.  
A further limitation of this study is the small sample sizes which can ethically be considered 
when using larger animal species, such as the sheep, for experimental research. This can 
influence the conclusions drawn; in particular a non-significant result may reach significance 
if the sample size were greater. Power calculations (such as in Equation 6.1) can be applied to 
data in order to give the sample size which would be required in order to reject the null 
hypothesis. Using the pyruvate-supported oxygen consumption of cortisol compared to 
saline-infused fetuses (Figure 5.2) as an example, the value for the cortisol-infused fetuses 
were higher in all muscles compared with controls. This difference reached significance in the 
BF, however was not significant in the ST and showed only a trend in the SDF. Power 




dataset, would be sufficient to reject the null hypothesis if there were 18 samples in each 
group for the ST and the example power calculation for the ST is given below (Chow et al., 
2008). 




𝑧1−𝛼 2⁄ + 𝑧1−𝛽
𝜇𝐴 −  𝜇𝐵
)2 
Where:  k=ratio of sample sizes of the 2 groups (k=1 in our case) 
  σ=standard deviation 
  µ=mean 
α=type I error=0.05  
β=type II error. 1-β=power=0.8  
Equation 6.1 Power calculation in order to determine the sample size required to compare 2 
means for a 2-tailed t-test.  
 
In the case of Py-supported, ADP-coupled oxygen consumption in the ST: 






𝑛 = 18 
 
6.3 Future studies 
6.3.1 Endocrine regulation of mitochondrial oxidative capacity 
Overall, the results suggest that both cortisol and T3 are involved in the developmental 
regulation of mitochondrial function in ovine skeletal muscle. However, the relative 
importance and the individual effects of the two hormones in these regulatory processes is 
difficult to establish with the current data.  Neither cortisol nor T3 infusion between 125 and 
130 days of gestation fully recapitulated the developmental changes in mitochondrial density 
and expression of key genes and proteins seen towards term, despite the increased T3 
concentrations in the cortisol infused fetuses. In addition, cortisol concentrations have been 
shown to be lower in TX than control fetuses at term (Harris et al, 2017) similar to the trend 
seen in the current study. Studying mitochondrial function both in term fetuses 
adrenalectomised to prevent the normal prepartum rise in cortisol and T3 and after combined 




effects of these hormones are independent or are primarily dependent on cortisol but 
effected in part by the cortisol induced rise in T3. Similar cortisol-dependent, T3 mediated 
maturational effects are seen with other processes in fetal ovine tissues such as the liver and 
lungs (Fowden et al., 2001, Forhead et al., 2000, Forhead and Fowden, 2002).  
Preliminary measurements of the expression of GR and THR in some of the muscles may help 
to understand variabilities observed between treatment and age groups. The mRNA 
abundance of THRα and THRβ isoforms in the ST over the perinatal period showed no effect 
of age on the gene expression of THRα (Figure 6.2 A). However, THRβ mRNA levels increased 
with age (P<0.05 by one-way ANOVA) with the expression in the newborns significantly higher 
than at 104dGA (Figure 6.2 B). These results are in agreement with a study on skeletal muscle 
in fetal pigs, in which the THRβ expression increased over late gestation and continued to 
increase postnatally with expression correlating with plasma cortisol concentration over the 
perinatal period (White et al., 2001). In the brain, this late upregulation of THRβ has also been 
reported and was associated with the TH-sensitive period of neuronal maturation (Forrest et 
al., 1991). Preliminary data from the BF, however, suggests there was no difference between 
expression of either THR isoform when comparing control and T3-infused fetuses (Figure 6.3). 
Similarly, the GR gene expression was measured across the 4 age groups in the SDF and there 
was no effect of age (Figure 6.2 C). Further investigation of the ontogenic and hormone 
dependence of the tissue specific abundance of these receptors may help explain the effects 






Figure 6.2 Mean±SEM normalised gene expression of A) thyroid hormone receptor α (THRA) B) 
THRB in the semitendinosus and C) glucocorticoid receptor (GR) of fetuses at 104 (n=5), 127 
(n=5-6) and 143 (n=6) days of gestational age (dGA) and newborn lambs (n=6). Different letters 







Figure 6.3 Mean±SEM normalised gene expression of thyroid hormone receptor α (THRA) and 
THRB in biceps femoris, of control (n=3; black bars) and T3-infused (n=4-5; crosshatched bars) 
fetuses.  
 
Altered abundance of the GR and THR, alongside plasma hormone binding proteins will affect 
the levels of hormone available to the skeletal muscle. Determining a method of assessing the 
bioavailability of the hormones to the tissue, independently of the parameters measured in 
this study, would be useful for future analyses to understand the extent to which the 
endocrine manipulation protocols are able to impact on muscle physiology. In adult muscle, 
cortisol is known to play a role in regulating nutrient availability during stress and thus acts to 
decrease glucose uptake and induce protein catabolism (Salehzadeh et al., 2009, Tarpenning 
et al., 2001), and well-characterised transcriptional targets of GCs include monamine oxidase 
A and apolipoprotein D (Wang et al., 2010). However, age and tissue specific profiles of co-
activator and co-repressor expression, required in order to ensure an appropriate cellular 
response means that whether this is also true in fetal muscle at this particular time in 
development has not been shown (Rousseau, 1984, Oakley et al., 1996). Thus, this information 
cannot be directly applied to the current study. Upon hormone binding to the cytosolic GR or 
THR, the complexes translocate to the nucleus and, following a decreased hormonal signal, 
the receptors are then exported to the cytosol over a period of hours (Walther et al., 2003). A 
potential alternative method of monitoring cellular hormonal bioavailability could be to 
determine the fraction of receptor present in the nucleus compared with the cytosol either 
by histological or biochemical methods. Therefore, monitoring the fraction of nuclear 

































In twins, activation of the HPA axis occurs later in gestation than in singleton sheep fetuses 
(Gardner et al., 2004, Edwards and McMillen, 2002). Fetal concentrations of cortisol therefore 
rise later in gestation in twins than singleton fetuses (Edwards and McMillen, 2002). Twins 
also have a lower birthweight than singletons which is partly explained by the physical space 
restriction in utero and the division of the maternal nutrient supply (Gardner et al., 2007, 
Brown, 2014). However, there is now evidence that physiological differences between twins 
and singletons begin early on in gestation and pre-determine the fetal growth resulting in a 
smaller birthweight for twins (Hancock et al., 2012).  The restriction on fetal growth may have 
implications on skeletal muscle development and in the current study, the body and muscle 
weights were lower in control twins than singletons at ~130dGA from Chapters 4 and 5. When 
the maternal nutrient supply is divided between two growing fetuses, the skeletal muscle 
development may be particularly vulnerable to impaired nutrient supply (Brown, 2014). As 
well as a suppressed function of the HPA axis which may be due to reported hypothalamic 
epigenetic modifications, twinning has been associated with a lower basal insulin 
concentration over late gestation (Begum et al., 2012, Rumball et al., 2008b, Green et al., 
2011, Rumball et al., 2008a, Gardner et al., 2004). The different endocrine environment may 
represent a mechanism by which twin physiology may impact on skeletal muscle growth and 
development.  
In the current study, correlations between the mitochondrial parameters and the 
concentrations of cortisol and T3 were more significant when the smaller number of singleton 
fetuses were excluded which suggests that there are differences in mitochondrial 
development between singletons and twins (Figure 6.1 and Table 6.2).  More detailed analyses 
of the mitochondrial data from the control singleton and twin animals at ~130dGA in Chapters 
4 and 5 indicate that muscle from twins and singletons does differ significantly in certain 
aspects of mitochondrial function. These differences are present despite similar fetal 
concentrations of cortisol and T3 in the two groups at this age (Table 4.1, Table 4.4 and Table 
5.1; P>0.05). The CS activity was significantly higher in the singletons than the twins in the SDF 
(P<0.05 by t-test) and tended to be higher in the BF and ST as well (Figure 6.4 A-C). In addition, 
the abundance of some of the ETS complexes were different between the singletons and twins 
(Figure 6.4 D-F). Applying a two-way ANOVA to the protein abundance of the ETS complexes, 
singletons were significantly different than twins for the BF (P<0.0001) and ST (P<0.05). 




twins (P<0.05 by Mann-Whitney test). There was no difference in the oxygen consumption 
rates, nor protein abundance of ANT1 in the muscles from twins compared with singletons, 
although ANT1 gene expression was significantly higher in the BF of singletons than twins 
(P<0.05; data not shown).  The extent and muscle specific nature of the differences in 
mitochondrial development between twins and singletons need to be investigated further. 
 
Table 6.2 Hormone correlations with CS activity combining all twin fetal data. 

























Figure 6.4 Mean±SEM A-C) citrate synthase activity and D-F) protein expression of electron transfer system complexes I-IV (CI-IV) and ATP-synthase (CV)  
in A&D) biceps femoris, B&E) semitendinosus and C&F) superficial digital flexor of twins (black bars; n=3-4) and singletons (white bars; n=3-5). * 




In adults, there are major differences in skeletal muscle metabolism between the sexes which 
have been related to difference in sex steroid concentrations (Green et al., 1984a, Simoneau 
et al., 1985).  Sex of the fetus and the sex-combination of the twins are also known to have an 
effect on the growth and development of a number of physiological systems in utero with 
males often being heavier than females throughout gestation (Luke et al., 2005, Gardner et 
al., 2007).  Sex of the fetus has also been shown to affect fetal responses to environmental 
challenges during late gestation (Giussani et al., 2011, Clark et al., 2007, Gonzalez-Bulnes et 
al., 2015). In the current study, an effort was made to balance males and females in all groups 
(Table 2.1) but the only group large enough to directly compare males and females was a 
group of control twins formed by combining sham-operated and saline-infused fetuses from 
Chapter 4 (n=3 females and n=7 males). In this cohort, males tended to be heavier than 
females (P<0.1 by Mann-Whitney test) but there were no differences between the sexes in CS 
activity, total oxidative capacity or biochemical measurements in any of the muscles studied. 
Further studies are needed to establish whether mitochondrial function is sex-linked during 
intrauterine development.    
 
6.3.2 Development of other aspects of muscle mitochondrial function 
Protection against oxidative stress at birth 
Although the capacity for oxidative metabolism is put in place before birth, activity is rapidly 
upregulated after birth. One of the key hypotheses of this thesis is that the delay in activating 
oxidative function is perhaps as a protective mechanism, to prevent the excessive ROS 
production and tissue oxidative damage over the perinatal period. Markers of oxidative 
damage were not measured in this cohort, however, previously an increased lipid 
peroxidation has been reported in cord blood during parturition in humans (Rogers et al., 
1998). Future work should include looking at markers of tissue oxidative stress, including 
markers of protein and lipid oxidation (Horscroft et al., 2015, Tarry-Adkins et al., 2013). This 
would confirm the necessity for protective mechanisms and determine whether manipulating 
the endocrine environment impacts on the tissue oxidative damage.  
Further protection from oxidative stress may also be provided in fetal tissues by the availability 
of ROS-detoxifying enzymes, SODs and catalase. SOD1 and SOD2 are both expressed in 




specific (Fukai and Ushio-Fukai, 2011). The expression of SODs, in particular SOD2, has been 
shown to remain low throughout gestation in fetal rat tissues, including brain, liver and limb 
tissues until birth when their hepatic expression rose over the first few weeks of life (Mackler 
et al., 1998, Pittschieler et al., 1991). Preliminary data from the fetal and neonatal lambs in 
the current study showed no effect of age on the mRNA abundance of SOD1 (measured only 
in BF; Figure 6.5 A). However, SOD2 expression did increase with age (measured only in SDF 
where P<0.0001 by one-way ANOVA; Figure 6.5 B), where expression was significantly higher 
at 143dGA compared with earlier in gestation, and further increased in the newborn lambs. 
This suggests that expression of the mitochondrial SOD may be raised before birth in 
preparation for the increase in ROS production which would be expected in response to labour 
and exposure to a higher pO2 postnatally.  
 
Figure 6.5 Mean±SEM normalised gene expression of A) superoxide dismutase (SOD) 1 in 
biceps femoris and B) SOD2 in superficial digital flexor of fetuses at 104 (n=5), 127 (n=6) and 
143 (n=6) days of gestational age (dGA) and newborn lambs (n=6). Different letters are 





Calcium homeostasis and signalling 
Mitochondria are able to accumulate calcium which has important implications on cellular and 
organelle function. Mitochondrial calcium has been shown to increase oxidative capacity, to 
play a role in coupling energy production and requirement in muscle and has been associated 
with muscle growth (Mammucari et al., 2015, Duchen, 2000). However, excessive 
mitochondrial calcium uptake, particularly when associated with periods of oxidative stress, 
is associated with mitochondrial degradation and apoptosis and, in particular, plays a role in 
ischaemia-reperfusion injury and cell death (Duchen, 2000, Kalogeris et al., 2012). Over late 
gestation, whether an increase or decrease in calcium uptake into the mitochondria would be 
of greater benefit in skeletal muscle is difficult to predict.  
Calcium is taken into the mitochondrial matrix through the mitochondrial calcium uniporter 
(MCU) utilising the proton circuit (De Stefani et al., 2011, Duchen, 2004). There is a huge 
driving force for the cations to enter the matrix and therefore cation channels need to be 
carefully gated. The MCU is controlled by regulatory elements in the mitochondrial calcium 
uptake (MICU) family. MICU1 is thought to primarily increase calcium flux through the MCU, 
while MICU2 limits calcium uptake (Patron et al., 2014). The interaction of the two regulates 
activity of the MCU, thereby controlling calcium uptake in a tissue-specific manner to prevent 
the adverse effects of calcium overload but guarantee the stimulation of ATP generation 
(Patron et al., 2014).   
Preliminary data shows no effect of age on MCU gene expression in the BF (Figure 6.6 A) but 
age did affect the expression of MICU1 in the SDF (P<0.0001 by one-way ANOVA; Figure 6.6 
B). The expression of MICU1 was similar in the 3 fetal age groups studied, but was significantly 
upregulated in the newborns compared with the fetuses (Figure 6.6), perhaps to protect 
against the damaging effects of calcium accumulation during the ischaemia-reperfusion 
events associated with labour. Postnatally, MICU1 upregulation would be beneficial as calcium 
may play a role not only in increasing the oxidative capacity of the muscle but also in regulating 
cytosolic calcium essential for muscle contraction. A more comprehensive investigation into 
the changes in mitochondrial calcium uptake, and the regulatory mechanisms driving them, 





Figure 6.6 Mean±SEM relative gene expression of A) mitochondrial calcium uniporter (MCU) in 
the biceps femoris and B) mitochondrial calcium uptake 1 (MICU1) in superficial digital flexor 
of fetuses at 104 (n=5), 127 (n=6) and 143 (n=5-6) gays of gestational age (dGA) and newborn 
lambs (n=6). Different letters are significantly different to each other (P<0.05 by Tukey’s post 











6.3.3 Developmental programming of mitochondrial dysfunction 
The overall aim of this project was to research the normal development of mitochondrial 
function in utero and provide some insight into how these functional changes may influence 
the health of the offspring later in life. For this research, the skeletal muscle was chosen, as a 
highly metabolically active tissue and a tissue in which altered energetics is associated with 
metabolic syndrome (Brown, 2014). Animal models of suboptimal fetal growth have been 
shown to predispose symptoms of the metabolic syndrome (Bertram and Hanson, 2001), as 
well as programme mitochondrial dysfunction, as was summarised in Table 1.1. In addition, 
stressful pregnancies resulting in suboptimal fetal growth, are associated with lower than 
normal fetal T3 levels, but higher than normal fetal cortisol concentrations, either from 
maternal or fetal origin (Forhead and Fowden, 2014, Bertram and Hanson, 2001). Therefore, 
results from our endocrine manipulation protocols may provide a mechanism by which 
suboptimal conditions in utero may programme an altered metabolic profile. 
Results from Chapter 4 suggest that a reduced TH availability, associated with compromised 
pregnancy, may have a severe detrimental impact on the development of mitochondrial 
function in utero. In addition, hypothyroidism was associated with delayed maturation of the 
muscle structure. Thus, in such cases, even at birth the cellular metabolic status may be 
affected. With additional stress during the offspring’s lifetime and the effect of aging which is 
known to be associated with reduced mitochondrial function (Sun et al., 2016), any 
complication arising prenatally may be worsened such that offspring may be at greater risk of 
disease in adulthood. Fetal exposure to high cortisol may initially be beneficial, as shown in 
Chapter 5. Exposing the fetus to higher cortisol upregulated some aspect of mitochondrial 
function in particular in the SDF. However, problems arise when the pre- and postnatal 
environments do not align and the modifications set in utero are inappropriate postnatally. 
Impaired cellular energetics will affect all metabolic processes including, for example, the 
insulin signalling response and the transport of GLUTs to the sarcolemma. As skeletal muscle 
accounts for the greatest proportion of insulin-stimulated glucose uptake (Brown, 2014), this 
impaired mitochondrial function due to exposure to an altered endocrine environment in 
utero may manifest as symptoms of metabolic syndrome. A future continuation of this study 
will involve measuring mitochondrial oxidative capacity in the skeletal muscle of adult 




determine whether altered muscle mitochondrial function associated with metabolic disease 
begins in utero and persists into adulthood.  
 
6.4 General conclusion 
Taken together, the results suggest that the capacity for ATP production increased in utero in 
advance of the extra energy requirement at birth by increasing the number of muscle 
mitochondria in a hormone-dependent manner. However, there is little evidence for any 
increase in rate of oxygen consumption per se until after delivery and the actual oxidative 
capacity per mitochondrial unit appears to decline during the perinatal period. This may be a 
mechanism to control ROS production more effectively in fluctuating oxygen availability 
during the transition to extrauterine life. Further investigation into the signalling pathways 
and regulatory mechanisms controlling the independent increase in mitochondrial number 
and oxidative capacity is crucial to understanding the strategy of coping with the transition 
from intra- to extrauterine life, which may present the biggest metabolic challenge faced by 
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